10-Q/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q/A

(Amendment No. 1)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2011

Commission file number 001-15925

COMMUNITY HEALTH SYSTEMS, INC.

(Exact name of registrant as specified in its charter)

Delaware	13-3893191
(State or other jurisdiction of	(I.R.S. Employer
incorporation or organization)	Identification Number)
4000 Meridian Boulevard	37067
Franklin, Tennessee	(Zip Code)
(Address of principal executive offices)

(Registrant’s telephone number)
615-465-7000

     Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ No o

     Indicate by check mark whether the registrant has submitted electronically and posted on its corporate web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes þ No o

     Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer þ	Accelerated filer o	Non-accelerated filer o	Smaller reporting company o
		(Do not check if a smaller reporting company)

     Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No þ

     As of July 22, 2011, there were outstanding 93,212,756 shares of the Registrant’s Common Stock, $0.01 par value.

Explanatory Note

The sole purpose of this Amendment No. 1 to Community Health Systems, Inc.’s Quarterly Report on Form 10-Q for the period ended June 30, 2011, filed with the Securities and Exchange Commission dated July 29, 2011 (the “Form 10-Q”), is to furnish Exhibit 101 to the Form 10-Q in accordance with Rule 405(a)(2) of Regulation S-T. Exhibit 101 consists of the interactive data files that were not included with the Form 10-Q, as allowed by the 30-day grace period for the first quarterly period in which detailed footnote tagging is required.

This Amendment No. 1 does not otherwise change or update the disclosures set forth in the Form 10-Q as originally filed and does not otherwise reflect events occurring after the original filing of the Form 10-Q.

Pursuant to Rule 406T of Regulation S-T, the interactive data files contained in Exhibit 101 are not deemed filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, are deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise are not subject to liability under these sections.

Item 6. Exhibits

No.	Description
4.1 *	Tenth Supplemental Indenture relating to CHS/Community Health Systems, Inc.’s 8 7/8% Senior Notes due 2015, dated as of June 30, 2011, by and among CHS/Community Health Systems, Inc., the guarantors party thereto and U.S. Bank National Association
12 *	Computation of Ratio of Earnings to Fixed Charges
31.1 *	Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2 *	Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1 *	Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2 *	Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS	XBRL Instance Document**
101.SCH	XBRL Schema Document**
101.CAL	XBRL Calculation Linkbase Document**
101.DEF	XBRL Definition Linkbase Document**
101.LAB	XBRL Label Linkbase Document**
101.PRE	XBRL Presentation Linkbase Document**

*

Previously filed or furnished, as applicable, as an exhibit to the Community Health Systems, Inc. Quarterly Report on Form 10-Q (File No. 001-15925) filed with the SEC.

**

Pursuant to applicable securities laws and regulations, we are deemed to have complied with the reporting obligation relating to the submission of interactive data files in such exhibits and are not subject to liability under any anti-fraud provisions of the federal securities laws as long as we have made a good faith attempt to comply with the submission requirements and promptly amend the interactive data files after becoming aware that the interactive data files fail to comply with the submission requirements. Users of this data are advised pursuant to Rule 406T of Regulation S-T that this interactive data file is deemed not filed or part of a registration statement or prospectus for purposes of sections 11 or 12 of the Securities Act of 1933, is deemed not filed for purposes of section 18 of the Securities Exchange Act of 1934, and otherwise is not subject to liability under these sections.

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned thereunto duly authorized.

COMMUNITY HEALTH SYSTEMS, INC.                          (Registrant)
By:	/s/ W. Larry Cash
	W. Larry Cash
	Executive Vice President, Chief Financial Officer and Director (principal financial officer)
By:	/s/ T. Mark Buford
	T. Mark Buford
	Senior Vice President and Chief Accounting Officer (principal accounting officer)

Date: August 2, 2011

Index to Exhibits

No.	Description
4.1*	Tenth Supplemental Indenture relating to CHS/Community Health Systems, Inc.’s 8 7/8% Senior Notes due 2015, dated as of June 30, 2011, by and among CHS/Community Health Systems, Inc., the guarantors party thereto and U.S. Bank National Association
12*	Computation of Ratio of Earnings to Fixed Charges
31.1*	Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2*	Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1*	Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2*	Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS	XBRL Instance Document**
101.SCH	XBRL Schema Document**
101.CAL	XBRL Calculation Linkbase Document**
101.DEF	XBRL Definition Linkbase Document**
101.LAB	XBRL Label Linkbase Document**
101.PRE	XBRL Presentation Linkbase Document**

*

Previously filed or furnished, as applicable, as an exhibit to the Community Health Systems, Inc. Quarterly Report on Form 10-Q (File No. 001-15925) filed with the SEC.

**

Pursuant to applicable securities laws and regulations, we are deemed to have complied with the reporting obligation relating to the submission of interactive data files in such exhibits and are not subject to liability under any anti-fraud provisions of the federal securities laws as long as we have made a good faith attempt to comply with the submission requirements and promptly amend the interactive data files after becoming aware that the interactive data files fail to comply with the submission requirements. Users of this data are advised pursuant to Rule 406T of Regulation S-T that this interactive data file is deemed not filed or part of a registration statement or prospectus for purposes of sections 11 or 12 of the Securities Act of 1933, is deemed not filed for purposes of section 18 of the Securities Exchange Act of 1934, and otherwise is not subject to liability under these sections.

XML



Equity Investments (Details) (USD $) In Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2011	Jun. 30, 2010	Jun. 30, 2011	Jun. 30, 2010
Summarized combined financial information of entities in which Company owns equity interest
Revenues	$ 373,448	$ 358,586	$ 746,039	$ 716,065
Operating costs and expenses	334,765	321,457	652,752	645,977
Income from continuing operations before taxes	$ 38,652	$ 37,113	$ 93,236	$ 70,045

XML



Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) (USD $) In Thousands, except Share data	Jun. 30, 2011	Dec. 31, 2010
Current assets
Allowance for doubtful patient accounts	$ 1,793,404	$ 1,639,198
Community Health Systems, Inc. stockholders' equity
Preferred stock, par value per share	$ 0.01	$ 0.01
Preferred stock, shares authorized	100,000,000	100,000,000
Preferred stock, shares issued	0	0
Common stock, par value per share	$ 0.01	$ 0.01
Common stock, shares authorized	300,000,000	300,000,000
Common stock, shares issued	93,210,424	93,644,862
Common stock, shares outstanding	92,234,875	92,669,313
Treasury stock, shares	975,549	975,549

XML



Condensed Consolidated Statements of Income (Unaudited) (USD $) In Thousands, except Share data	3 Months Ended				6 Months Ended
	Jun. 30, 2011		Jun. 30, 2010		Jun. 30, 2011		Jun. 30, 2010
Condensed Consolidated Statements of Income [Abstract]
Net operating revenues	$ 3,433,829		$ 3,080,646		$ 6,787,881		$ 6,149,258
Operating costs and expenses:
Salaries and benefits	1,384,096		1,231,559		2,763,463		2,478,240
Provision for bad debts	433,002		367,002		832,971		733,503
Supplies	449,279		430,574		907,096		852,686
Other operating expenses	654,737		559,962		1,269,530		1,116,581
Rent	62,431		60,851		125,601		122,908
Depreciation and amortization	161,376		149,779		319,531		293,682
Total operating costs and expenses	3,144,921		2,799,727		6,218,192		5,597,600
Income from operations	288,908		280,919		569,689		551,658
Interest expense, net	163,230		160,759		326,448		320,182
Equity in earnings of unconsolidated affiliates	(12,017)		(10,980)		(30,151)		(23,570)
Income from continuing operations before income taxes	137,695		131,140		273,392		255,046
Provision for income taxes	44,821		42,761		88,913		82,310
Income from continuing operations	92,874		88,379		184,479		172,736
Discontinued operations, net of taxes:
Income (loss) from operations of entities sold and held for sale	235		(2,037)		(1,443)		(1,398)
Impairment of hospitals held for sale	(39,562)				(47,930)
Loss on sale					(3,234)
Loss from discontinued operations, net of taxes	(39,327)		(2,037)		(52,607)		(1,398)
Net income	53,547		86,342		131,872		171,338
Less: Net income attributable to noncontrolling interests	18,158		16,277		35,159		31,266
Net income attributable to Community Health Systems, Inc.	$ 35,389		$ 70,065		$ 96,713		$ 140,072
Basic earnings (loss) per share attributable to Community Health Systems, Inc. common stockholders (1):
Continuing operations	$ 0.82	[1]	$ 0.77	[1]	$ 1.64	[1]	$ 1.53	[1]
Discontinued operations	$ (0.43)	[1]	$ (0.02)	[1]	$ (0.58)	[1]	$ (0.01)	[1]
Net income	$ 0.39	[1]	$ 0.75	[1]	$ 1.06	[1]	$ 1.51	[1]
Diluted earnings (loss) per share attributable to Community Health Systems, Inc. common stockholders (1):
Continuing operations	$ 0.81	[1]	$ 0.76	[1]	$ 1.62	[1]	$ 1.51	[1]
Discontinued operations	$ (0.43)	[1]	$ (0.02)	[1]	$ (0.57)	[1]	$ (0.01)	[1]
Net income	$ 0.39	[1]	$ 0.74	[1]	$ 1.05	[1]	$ 1.49	[1]
Weighted-average number of shares outstanding:
Basic	91,130,672		93,358,771		91,069,876		92,491,839
Diluted	91,783,725		94,711,919		91,960,610		93,779,001

[1] Total per share amounts may not add due to rounding.

XML



Long-Term Debt (Details Textual) (USD $)	3 Months Ended		6 Months Ended			6 Months Ended		3 Months Ended	6 Months Ended		6 Months Ended		3 Months Ended		3 Months Ended	6 Months Ended	12 Months Ended
	Jun. 30, 2011	Jun. 30, 2010	Jun. 30, 2011	Jun. 30, 2010	Nov. 05, 2010	Jun. 30, 2011 Community Health System [Member]	Jul. 25, 2007 Community Health System [Member]	Sep. 30, 2007 Community Health System [Member] Senior Notes 8.875% Due 2015 [Member]	Jun. 30, 2011 Community Health System [Member] Senior Notes 8.875% Due 2015 [Member]	Jul. 25, 2007 Community Health System [Member] Senior Notes 8.875% Due 2015 [Member]	Jun. 30, 2011 Community Health System [Member] Senior 6.50% Subordinated Notes Due 2012 [Member]	Jul. 25, 2007 Community Health System [Member] Senior 6.50% Subordinated Notes Due 2012 [Member]	Sep. 30, 2007 Community Health System [Member] Funded Term Loan Facility [Member]	Jun. 30, 2011 Community Health System [Member] Funded Term Loan Facility [Member]	Dec. 31, 2008 Community Health System [Member] Delayed Draw Term Loan Facility [Member]	Jun. 30, 2011 Community Health System [Member] Delayed Draw Term Loan Facility [Member]	Dec. 31, 2009 Community Health System [Member] Delayed Draw Term Loan Facility [Member]	Dec. 31, 2007 Community Health System [Member] Delayed Draw Term Loan Facility [Member]	Jun. 30, 2011 Community Health System [Member] Revolving Credit Facility [Member]	Jun. 30, 2011 Community Health System [Member] Line of Credit [Member]	Jun. 30, 2011 Line of Credit [Member]
Long-Term Debt (Textuals) [Abstract]
Senior secured financing under a new credit facility							$ 7,200,000,000
Principal amount of senior notes issued										3,000,000,000
Percentage of interest rate stated on senior notes										8.875%		6.50%
Net proceeds from the notes offering								3,000,000,000
Net proceeds of term loans under the Credit Facility													6,100,000,000
Debt instrument maximum borrowing capacity														6,100,000,000	200,000,000	400,000,000		300,000,000
Maturity period of debt instrument														7 years		7 years
Drawn of delayed draw term loan															100,000,000		200,000,000
Quarterly amortization payments of each term loan facility						0.25% of the outstanding amount of the term loans
Existing term loans under the Credit Facility					1,500,000,000
Increase the pricing of term loans			LIBOR plus 350 basis points
Condition for amended maturity date			If more than $50 million of the Notes remain outstanding on April 15, 2015, without having been refinanced, then the maturity date for the extended term loans will be accelerated to April 15, 2015
Maturity date of term loans remains unchanged	4,500,000,000		4,500,000,000
Amended maximum borrowing capacity under uncommitted incremental facility			1,000,000,000
Original maximum borrowing capacity under uncommitted incremental facility			600,000,000
Amended borrowing capacity from receivable transactions			2,000,000,000
Increase in borrowing capacity from receivable transactions			500,000,000
Amount of borrowing from receivable transactions to be used for repayment of existing term loans			1,700,000,000
Prepaid amount of term loan						equal to (1) 100% of the net cash proceeds of certain asset sales and dispositions by the Company and its subsidiaries, subject to certain exceptions and reinvestment rights, (2) 100% of the net cash proceeds of issuances of certain debt obligations or receivables based financing by the Company and its subsidiaries, subject to certain exceptions, and (3) 50%, subject to reduction to a lower percentage based on the Company’s leverage ratio (as defined in the Credit Facility generally as the ratio of total debt on the date of determination to the Company’s EBITDA, as defined, for the four quarters most recently ended prior to such date), of excess cash flow (as defined) for any year, commencing in 2008, subject to certain exceptions.
Loans under the Credit Facility interest rate description						Rate equal to an applicable percentage plus, at CHS’s option, either (a) an Alternate Base Rate (as defined) determined by reference to the greater of (1) the Prime Rate (as defined) announced by Credit Suisse or (2) the Federal Funds Effective Rate (as defined) plus one-half of 1.0% or (3) the adjusted London Interbank Offered Rate (“LIBOR”) on such day for a three-month interest period commencing on the second business day after such day plus 1%, or (b) a reserve adjusted LIBOR for dollars (Eurodollar rate) (as defined). The applicable percentage for Alternate Base Rate loans is 1.25% for term loans due 2014 and is 2.25% for term loans due 2017. The applicable percentage for Eurodollar rate loans is 2.25% for term loans due 2014 and 3.5% for term loans due 2017. The applicable percentage for revolving loans is 1.25% for Alternate Base Rate revolving loans and 2.25% for Eurodollar revolving loans, in each case subject to reduction based on the Company’s leverage ratio.
Maturity period of senior notes											2015
Maturity date of senior notes									Jul. 15, 2015
Percentage payment of commitment fees per annum						0.50%
Percentage payment of commitment fees Description																0.50% per annum for the first nine months after the closing of the Credit Facility, 0.75% per annum for the next three months after such nine-month period and thereafter, 1.0% per annum.
Frequency of payment									semiannually
Date of Commencing interest payment									July 15, 2015
Base for calculation of Interest									360-day year comprised of twelve 30-day months
Percentage of redemption price equal to principal amount of notes redeemed						100.00%
Payments made for term loan under Credit Facility			28,798,000	34,157,000
Principle amount of term loans to tranches														1,000,000,000
Interest paid on borrowings	101,600,000	99,900,000	327,717,000	320,150,000
Additional Long-Term Debt (Textuals) [Abstract]
Revolving credit facility																			750,000,000
Maturity period of revolving credit facility																			6 years
Debt instrument unused borrowing capacity amount																				750,000,000	37,900,000
Amount of borrowing capacity from receivable transactions including securitizations																				$ 300,000,000
Weighted-average interest rate under the Credit Facility, excluding swaps																				3.20%

XML



Subsequent Events

6 Months Ended

Jun. 30, 2011

Subsequent Events [Abstract]

SUBSEQUENT EVENTS

18. SUBSEQUENT EVENTS

     The Company evaluated all material events occurring subsequent to the balance sheet date for events requiring disclosure or recognition in the condensed consolidated financial statements.

     In July 2011, one or more subsidiaries of the Company entered into a definitive agreement to acquire substantially all of the assets of Moses Taylor Health Care System, located in northeast Pennsylvania. This healthcare system includes Moses Taylor Hospital in Scranton, Pennsylvania (217 licensed beds) and Mid-Valley Hospital in Peckville, Pennsylvania (25 licensed beds). The transaction, subject to customary federal and state regulatory approvals including review and approval by the Attorney General of the Commonwealth of Pennsylvania, is expected to be completed in late 2011 or early 2012. Also in July 2011, one or more subsidiaries of the Company entered into a definitive agreement to acquire substantially all of the assets of Tomball Regional Medical Center (357 licensed beds), located in Tomball, Texas and serving the greater northwest Houston market. The transaction, subject to customary federal and state regulatory approvals, is expected to be completed in 2011.

XML



Document and Entity Information (USD $)	6 Months Ended
	Jun. 30, 2011	Jul. 22, 2011	Jun. 30, 2010
Document and Entity Information [Abstract]
Entity Registrant Name	COMMUNITY HEALTH SYSTEMS INC
Entity Central Index Key	0001108109
Document Type	10-Q
Document Period End Date	Jun. 30, 2011
Amendment Flag	false
Document Fiscal Year Focus	2011
Document Fiscal Period Focus	Q2
Current Fiscal Year End Date	--12-31
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Filer Category	Large Accelerated Filer
Entity Public Float			$ 3,231,059,649
Entity Common Stock, Shares Outstanding		93,212,756

XML



Stockholders' Equity (Details Textual) (USD $) In Millions, except Share data	12 Months Ended		3 Months Ended	6 Months Ended	9 Months Ended		3 Months Ended	6 Months Ended
	Dec. 31, 2010	Jun. 30, 2011	Jun. 30, 2011 New open market repurchase program [Member]	Jun. 30, 2011 New open market repurchase program [Member]	Jun. 30, 2011 New open market repurchase program [Member]	Sep. 15, 2010 New open market repurchase program [Member]	Jun. 30, 2011 Predecessor open market repurchase program [Member]	Jun. 30, 2011 Predecessor open market repurchase program [Member]	Dec. 09, 2009 Predecessor open market repurchase program [Member]
Stockholders' Equity (Textuals) [Abstract]
Total capital stock, shares authorized		400,000,000
Common stock, shares authorized	300,000,000	300,000,000
Preferred stock, shares authorized	100,000,000	100,000,000
Common stock, par value per share	$ 0.01	$ 0.01
Preferred stock, par value per share	$ 0.01	$ 0.01
Preferred stock, shares outstanding		0
Additional Stockholders' Equity (Textuals) [Abstract]
Maximum Number of shares authorized for repurchase						4,000,000			3,000,000
Maximum amount of shares authorized under repurchase program						$ 100			$ 100
Condition to conclude repurchase program				Earliest of three years from the commencement date, when the maximum number of shares has been repurchased or when the maximum dollar amount has been expended.
Number of shares repurchased and retired	2,964,528		1,763,566	1,763,566	2,214,838		356,000	356,000
Weighted average price of repurchased and retired shares, per share	$ 33.69		$ 28.31	$ 28.31	$ 28.82		$ 34.24	$ 34.24

XML



Accounting for Stock-Based Compensation (Tables)

6 Months Ended

Jun. 30, 2011

Accounting for Stock-Based Compensation [Abstract]

Impact of Total Compensation Expense

	Three Months Ended						Six Months Ended
	June 30,						June 30,
	2011			2010			2011			2010
Effect on income from continuing operations before income taxes	$	(10,814	)	$	(10,655	)	$	(20,732	)	$	(20,418	)
Effect on net income	$	(6,867	)	$	(6,473	)	$	(13,165	)	$	(12,404	)

Fair value of stock options

	Three Months Ended						Six Months Ended
	June 30,						June 30,
	2011			2010			2011			2010
Expected volatility		38.1	%		35.3	%		31.5	%		33.6	%
Expected dividends		—			—			—			—
Expected term	4 years			3 years			4 years			3.1 years
Risk-free interest rate		1.35	%		1.20	%		1.73	%		1.47	%

Options outstanding and exercisable

						Weighted -
				Weighted -		Average	Aggregate
				Average		Remaining	Intrinsic
				Exercise		Contractual	Value as of
	Shares			Price		Term	June 30, 2011
Outstanding at December 31, 2010		7,834,332		$	32.08
Granted		1,329,000			37.96
Exercised		(595,431	)		30.44
Forfeited and cancelled		(64,508	)		34.84
Outstanding at March 31, 2011		8,503,393			33.10
Granted		45,000			28.12
Exercised		(23,579	)		29.98
Forfeited and cancelled		(50,342	)		32.70
Outstanding at June 30, 2011		8,474,472		$	33.08	5.8 years	$	9,910
Exercisable at June 30, 2011		5,804,556		$	32.78	4.3 years	$	7,468

Restricted stock outstanding

				Weighted -
				Average
				Grant Date
	Shares			Fair Value
Unvested at December 31, 2010		2,125,291		$	27.92
Granted		1,084,949			37.96
Vested		(962,662	)		27.27
Forfeited		—			—
Unvested at March 31, 2011		2,247,578			33.04
Granted		8,000			28.12
Vested		(12,000	)		33.49
Forfeited		—			—
Unvested at June 30, 2011		2,243,578			33.02

Deferred Director's Fee

	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2011		2010		2011		2010
Directors’ fees earned and deferred into plan	$	55	$	45	$	110	$	90
Share equivalent units		2,142		1,331		3,517		2,549

XML



Stockholders' Equity (Details) (USD $) In Thousands	3 Months Ended		6 Months Ended							6 Months Ended
	Jun. 30, 2011	Jun. 30, 2010	Jun. 30, 2011	Jun. 30, 2010	Jun. 30, 2011 Redeemable Noncontrolling Interests [Member]	Jun. 30, 2011 Common Stock [Member]	Jun. 30, 2011 Additional Paid-in Capital [Member]	Jun. 30, 2011 Treasury Stock [Member]	Dec. 31, 2010 Treasury Stock [Member]	Jun. 30, 2011 Accumulated Other Comprehensive Income (Loss) [Member]	Jun. 30, 2011 Retained Earnings [Member]	Jun. 30, 2011 Noncontrolling Interest [Member]
Reconciliation of the carrying amount of total equity, equity attributable to the Company, and equity attributable to the noncontrolling interests
Beginning Balance			$ 2,250,377		$ 387,472	$ 936	$ 1,126,751	$ (6,678)	$ (6,678)	$ (230,927)	$ 1,299,382	$ 60,913
Comprehensive income:
Net income	53,547	86,342	131,872	171,338	25,211						96,713	9,948
Net change in fair value of interest rate swaps	(8,969)	(33,694)	27,477	(45,051)						27,477
Net change in fair value of available-for-sale securities	268	476	1,338	630						1,338
Amortization and recognition of unrecognized pension cost components	807	758	1,579	5,233						1,579
Total comprehensive income	45,653	53,882	162,266	132,150	25,211					30,394	96,713	9,948
Distributions to noncontrolling interests, net of contribution			(9,828)		(19,387)							(9,828)
Purchase of subsidiary shares from noncontrolling interests			(498)		(2,792)		(498)
Other reclassifications of noncontrolling interests			272		(2,004)							272
Adjustment to redemption value of redeemable noncontrolling interests			11,842		(11,842)		11,842
Repurchases of common stock			(50,020)			(18)	(50,002)
Issuance of common stock in connection with the exercise of stock options			18,837			6	18,831
Cancellation of restricted stock for tax withholdings on vested shares			(13,113)			(3)	(13,110)
Excess tax benefit from exercise of options			4,659				4,659
Share-based compensation			20,743			11	20,732
Ending Balance	2,370,326		2,370,326		376,658	932	1,119,205	(6,678)	(6,678)	(200,533)	1,396,095	61,305
Effects of changes in the ownership interest in less-than-wholly-owned subsidiaries
Net income attributable to Community Health Systems, Inc.	35,389	70,065	96,713	140,072
Transfers to the noncontrolling interests:
Net decrease in Community Health Systems, Inc. paid-in capital for purchase of subsidiary partnership interests			(498)
Net transfers to noncontrolling interests			(498)
Change to Community Health Systems, Inc. stockholders equity from net income attributable to Community Health Systems, Inc. and transfers to noncontrolling interests			$ 96,215

XML



Goodwill and Other Intangible Assets

6 Months Ended

Jun. 30, 2011

Goodwill and Other Intangible Assets [Abstract]

GOODWILL AND OTHER INTANGIBLE ASSETS

7. GOODWILL AND OTHER INTANGIBLE ASSETS

     The changes in the carrying amount of goodwill for the six months ended June 30, 2011, are as follows (in thousands):

Balance as of December 31, 2010 (as previously reported)	$	4,199,905
Goodwill allocated to disposal and hospitals held for sale		(49,658	)
Balance as of December 31, 2010 (as adjusted)		4,150,247
Goodwill acquired as part of acquisitions during 2011		77,760
Consideration adjustments and purchase price allocation adjustments for prior year’s acquisitions		(37	)
Balance as of June 30, 2011	$	4,227,970

     Goodwill is allocated to each identified reporting unit, which is defined as an operating segment or one level below the operating segment (referred to as a component of the entity). Management has determined that the Company’s operating segments meet the criteria to be classified as reporting units. At June 30, 2011, the hospital operations reporting unit, the home care agency operations reporting unit, and the hospital management services reporting unit had approximately $4.2 billion, $35.9 million and $33.3 million, respectively, of goodwill.

     Goodwill is evaluated for impairment at the same time every year and when an event occurs or circumstances change that, more likely than not, reduce the fair value of the reporting unit below its carrying value. There is a two-step method for determining goodwill impairment. Step one is to compare the fair value of the reporting unit with the unit’s carrying amount, including goodwill. If this test indicates the fair value is less than the carrying value, then step two is required to compare the implied fair value of the reporting unit’s goodwill with the carrying value of the reporting unit’s goodwill. The Company has selected September 30 as its annual testing date. The Company performed its last annual goodwill evaluation as of September 30, 2010, which evaluation took place during the fourth quarter of 2010. No impairment was indicated by this evaluation.

     The Company estimates the fair value of the related reporting units using both a discounted cash flow model as well as an EBITDA multiple model. The cash flow forecasts are adjusted by an appropriate discount rate based on the Company’s estimate of a market participant’s weighted-average cost of capital. These models are both based on the Company’s best estimate of future revenues and operating costs and are reconciled to the Company’s consolidated market capitalization, with consideration of the amount a potential acquirer would be required to pay, in the form of a control premium, in order to gain sufficient ownership to set policies, direct operations and control management decisions.

     The gross carrying amount of the Company’s other intangible assets subject to amortization was $61.7 million at June 30, 2011 and $60.5 million at December 31, 2010, and the net carrying amount was $34.1 million at June 30, 2011 and $36.1 million at December 31, 2010. The carrying amount of the Company’s other intangible assets not subject to amortization was $44.1 million and $44.4 million at June 30, 2011 and December 31, 2010, respectively. Other intangible assets are included in other assets, net on the Company’s condensed consolidated balance sheets. Substantially all of the Company’s intangible assets are contract-based intangible assets related to operating licenses, management contracts, or non-compete agreements entered into in connection with prior acquisitions.

     The weighted-average amortization period for the intangible assets subject to amortization is approximately nine years. There are no expected residual values related to these intangible assets. Amortization expense on these intangible assets was $2.3 million and $3.1 million during the three months ended June 30, 2011 and 2010, respectively, and $4.2 million and $6.3 million during the six months ended June 30, 2011 and 2010, respectively. Amortization expense on intangible assets is estimated to be $3.9 million for the remainder of 2011, $7.1 million in 2012, $4.5 million in 2013, $2.9 million in 2014, $2.5 million in 2015 and $13.2 million in 2016 and thereafter.

     The gross carrying amount of capitalized software for internal use was approximately $396.9 million and $356.5 million at June 30, 2011 and December 31, 2010, respectively, and the net carrying amount considering accumulated amortization was approximately $219.1 million and $209.4 million at June 30, 2011 and December 31, 2010, respectively. The estimated amortization period for capitalized internal-use software is generally three years, except for capitalized costs related to significant system conversions, which is generally eight years. There is no expected residual value for capitalized internal-use software. At June 30, 2011, there was approximately $76.6 million of capitalized costs for internal-use software that is currently in the development stage and will begin amortization once the software project is complete and ready for its intended use. Amortization expense on capitalized internal-use software was $16.7 million and $11.0 million during the three months ended June 30, 2011 and 2010, respectively, and $34.7 million and $20.2 million during the six months ended June 30, 2011 and 2010, respectively. Amortization expense on capitalized internal-use software is estimated to be $37.5 million for the remainder of 2011, $75.1 million in 2012, $45.1 million in 2013, $18.1 million in 2014, $15.7 million in 2015 and $27.6 million in 2016 and thereafter.

XML



Acquisitions and Divestitures (Tables)

6 Months Ended

Jun. 30, 2011

Acquisitions and Divestitures [Abstract]

Net operating revenues and income from discontinued operations

	Three Months Ended						Six Months Ended
	June 30,						June 30,
	2011			2010			2011			2010
Net operating revenues	$	68,479		$	90,378		$	140,563		$	182,448
Income (loss) from operations of entities sold and held for sale before income taxes		392			(3,232	)		(2,280	)		(1,994	)
Impairment of hospitals held for sale		(38,600	)		—			(51,695	)		—
Loss on sale		—			—			(5,061	)		—
Loss from discontinued operations, before taxes		(38,208	)		(3,232	)		(59,036	)		(1,994	)
Income tax expense (benefit)		1,119			(1,195	)		(6,429	)		(596	)
Loss from discontinued operations, net of taxes	$	(39,327	)	$	(2,037	)	$	(52,607	)	$	(1,398	)

XML



Income Taxes (Details) (USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2011	Jun. 30, 2010	Jun. 30, 2011	Jun. 30, 2010
Income Taxes [Abstract]
Unrecognized benefit that would affect the effective tax rate	$ 7,700,000		$ 7,700,000
Decreased liabilities			0
Increase in interest and penalties			200,000
Amount of interest and penalties included in liabilities	1,500,000		1,500,000
Current unrecognized tax benefit	2,300,000		2,300,000
Cash paid for income tax	$ 25,000,000	$ 78,800,000	$ (25,697,000)	$ 79,711,000

XML



Supplemental Condensed Consolidating Financial Information (Tables)

6 Months Ended

Jun. 30, 2011

Supplemental Financial Information [Abstract]

Condensed Consolidating Balance Sheet (unaudited)

Condensed Consolidating Balance Sheet
June 30, 2011

	Parent						Other			Non-
	Guarantor			Issuer			Guarantors			Guarantors		Eliminations			Consolidated
	(In thousands)
ASSETS
Current assets:
Cash and cash equivalents	$	—		$	—		$	80,552		$	110,880	$	—		$	191,432
Patient accounts receivable, net of allowance for doubtful accounts		—			—			1,043,386			749,018		—			1,792,404
Supplies		—			—			212,873			129,395		—			342,268
Deferred income taxes		115,819			—			—			—		—			115,819
Prepaid expenses and taxes		—			17			85,760			31,681		—			117,458
Other current assets		—			—			110,501			64,608		—			175,109
Total current assets		115,819			17			1,533,072			1,085,582		—			2,734,490
Intercompany receivable		1,190,786			9,441,127			1,438,751			1,534,314		(13,604,978	)		—
Property and equipment, net		—			—			4,069,371			2,437,053		—			6,506,424
Goodwill		—			—			2,380,891			1,847,079		—			4,227,970
Other assets, net of accumulated amortization		—			117,845			594,289			644,397		—			1,356,531
Net investment in subsidiaries		1,637,169			5,856,743			2,306,109			—		(9,800,021	)		—
Total assets	$	2,943,774		$	15,415,732		$	12,322,483		$	7,548,425	$	(23,404,999	)	$	14,825,415
LIABILITIES AND EQUITY
Current liabilities:
Current maturities of long-term debt	$	—		$	49,954		$	17,073		$	3,085	$	—		$	70,112
Accounts payable		—			40			402,806			181,078		—			583,924
Current income tax payable		349			—			—			—		—			349
Deferred income taxes		8,882			—			—			—		—			8,882
Accrued interest		—			145,034			111			1		—			145,146
Accrued liabilities		7,580			567			576,614			269,568		—			854,329
Total current liabilities		16,811			195,595			996,604			453,732		—			1,662,742
Long-term debt		—			8,709,456			46,194			25,793		—			8,781,443
Intercompany payable		—			4,575,989			8,923,510			5,979,987		(19,479,486	)		—
Deferred income taxes		608,177			—			—			—		—			608,177
Other long-term liabilities		9,765			297,525			401,585			317,194		—			1,026,069
Total liabilities		634,753			13,778,565			10,367,893			6,776,706		(19,479,486	)		12,078,431
Redeemable noncontrolling interests in equity of consolidated subsidiaries		—			—			—			376,658		—			376,658
Equity:
Community Health Systems, Inc. stockholders’ equity:
Preferred stock		—			—			—			—		—			—
Common stock		932			—			1			2		(3	)		932
Additional paid-in capital		1,119,205			663,410			709,243			120,485		(1,493,138	)		1,119,205
Treasury stock, at cost		(6,678	)		—			—			—		—			(6,678	)
Accumulated other comprehensive (loss) income		(200,533	)		(200,533	)		(10,074	)		—		210,607			(200,533	)
Retained earnings		1,396,095			1,174,290			1,255,420			213,269		(2,642,979	)		1,396,095
Total Community Health Systems, Inc. stockholders’ equity		2,309,021			1,637,167			1,954,590			333,756		(3,925,513	)		2,309,021
Noncontrolling interests in equity of consolidated subsidiaries		—			—			—			61,305		—			61,305
Total equity		2,309,021			1,637,167			1,954,590			395,061		(3,925,513	)		2,370,326
Total liabilities and equity	$	2,943,774		$	15,415,732		$	12,322,483		$	7,548,425	$	(23,404,999	)	$	14,825,415

Condensed Consolidating Balance Sheet
December 31, 2010

	Parent						Other			Non-
	Guarantor			Issuer			Guarantors			Guarantors		Eliminations			Consolidated
	(In thousands)
ASSETS
Current assets:
Cash and cash equivalents	$	—		$	—		$	212,035		$	87,134	$	—		$	299,169
Patient accounts receivable, net of allowance for doubtful accounts		—			—			971,220			743,322		—			1,714,542
Supplies		—			—			196,957			132,157		—			329,114
Deferred income taxes		115,819			—			—			—		—			115,819
Prepaid expenses and taxes		118,464			116			89,172			11,466		—			219,218
Other current assets		—			41			138,923			54,367		—			193,331
Total current assets		234,283			157			1,608,307			1,028,446		—			2,871,193
Intercompany receivable		1,079,295			9,002,158			1,145,185			1,484,130		(12,710,768	)		—
Property and equipment, net		—			—			3,816,098			2,508,339		—			6,324,437
Goodwill		—			—			2,331,452			1,818,795		—			4,150,247
Other assets, net of accumulated amortization		—			131,352			625,472			595,422		—			1,352,246
Net investment in subsidiaries		1,510,062			5,315,871			2,061,532			—		(8,887,465	)		—
Total assets	$	2,823,640		$	14,449,538		$	11,588,046		$	7,435,132	$	(21,598,233	)	$	14,698,123
LIABILITIES AND EQUITY
Current liabilities:
Current maturities of long-term debt	$	—		$	49,953		$	11,063		$	2,123	$	—		$	63,139
Accounts payable		—			—			362,154			164,184		—			526,338
Current income tax payable		—			—			—			—		—			—
Deferred income taxes		8,882			—			—			—		—			8,882
Accrued interest		—			146,297			116			2		—			146,415
Accrued liabilities		7,595			567			569,991			319,113		—			897,266
Total current liabilities		16,477			196,817			943,324			485,422		—			1,642,040
Long-term debt		—			8,734,473			44,819			29,090		—			8,808,382
Intercompany payable		—			3,667,662			8,385,414			5,911,829		(17,964,905	)		—
Deferred income taxes		608,177			—			—			—		—			608,177
Other long-term liabilities		9,522			340,526			372,693			278,934		—			1,001,675
Total liabilities		634,176			12,939,478			9,746,250			6,705,275		(17,964,905	)		12,060,274
Redeemable noncontrolling interests in equity of consolidated subsidiaries		—			—			—			387,472		—			387,472
Equity:
Community Health Systems, Inc. stockholders’ equity:
Preferred stock		—			—			—			—		—			—
Common stock		936			—			1			2		(3	)		936
Additional paid-in capital		1,126,751			640,683			682,686			103,401		(1,426,770	)		1,126,751
Treasury stock, at cost		(6,678	)		—			—			—		—			(6,678	)
Accumulated other comprehensive (loss) income		(230,927	)		(230,927	)		(12,990	)		—		243,917			(230,927	)
Retained earnings		1,299,382			1,100,304			1,172,099			178,069		(2,450,472	)		1,299,382
Total Community Health Systems, Inc. stockholders’ equity		2,189,464			1,510,060			1,841,796			281,472		(3,633,328	)		2,189,464
Noncontrolling interests in equity of consolidated subsidiaries		—			—			—			60,913		—			60,913
Total equity		2,189,464			1,510,060			1,841,796			342,385		(3,633,328	)		2,250,377
Total liabilities and equity	$	2,823,640		$	14,449,538		$	11,588,046		$	7,435,132	$	(21,598,233	)	$	14,698,123

Condensed consolidating statement of income (unaudited)

Condensed Consolidating Statement of Income
Three Months Ended June 30, 2011

	Parent						Other			Non-
	Guarantor			Issuer			Guarantors			Guarantors			Eliminations			Consolidated
	(In thousands)
Net operating revenues	$	—		$	—		$	2,002,412		$	1,431,417		$	—		$	3,433,829
Operating costs and expenses:
Salaries and benefits		—			—			767,262			616,834			—			1,384,096
Provision for bad debts		—			—			259,583			173,419			—			433,002
Supplies		—			—			262,909			186,370			—			449,279
Other operating expenses		—			—			393,916			260,821			—			654,737
Rent		—			—			31,007			31,424			—			62,431
Depreciation and amortization		—			—			95,559			65,817			—			161,376
Total operating costs and expenses		—			—			1,810,236			1,334,685			—			3,144,921
Income from operations		—			—			192,176			96,732			—			288,908
Interest expense, net		—			22,212			123,347			17,671			—			163,230
Equity in earnings of unconsolidated affiliates		(35,389	)		(39,072	)		(45,752	)		—			108,196			(12,017	)
Income from continuing operations before income taxes		35,389			16,860			114,581			79,061			(108,196	)		137,695
Provision for (benefit from) income taxes		—			(18,529	)		41,364			21,986			—			44,821
Income from continuing operations		35,389			35,389			73,217			57,075			(108,196	)		92,874
Discontinued operations, net of taxes:
Income (loss) from operations of entities sold and held for sale		—			—			2,813			(2,578	)		—			235
Impairment of hospitals held for sale		—			—			(39,562	)		—			—			(39,562	)
Loss on sale		—			—			—			—			—			—
Loss from discontinued operations, net of taxes		—			—			(36,749	)		(2,578	)		—			(39,327	)
Net income		35,389			35,389			36,468			54,497			(108,196	)		53,547
Less: Net income attributable to noncontrolling interests		—			—			—			18,158			—			18,158
Net income attributable to Community Health Systems, Inc.	$	35,389		$	35,389		$	36,468		$	36,339		$	(108,196	)	$	35,389

Condensed Consolidating Statement of Income
Three Months Ended June 30, 2010

	Parent						Other			Non-
	Guarantor			Issuer			Guarantors			Guarantors			Eliminations			Consolidated
	(In thousands)
Net operating revenues	$	—		$	—		$	1,770,800		$	1,309,846		$	—		$	3,080,646
Operating costs and expenses:
Salaries and benefits		—			—			663,919			567,640			—			1,231,559
Provision for bad debts		—			—			220,065			146,937			—			367,002
Supplies		—			—			242,931			187,643			—			430,574
Other operating expenses		—			—			309,698			250,264			—			559,962
Rent		—			—			28,838			32,013			—			60,851
Depreciation and amortization		—			—			86,401			63,378			—			149,779
Total operating costs and expenses		—			—			1,551,852			1,247,875			—			2,799,727
Income from operations		—			—			218,948			61,971			—			280,919
Interest expense, net		—			28,433			118,682			13,644			—			160,759
Equity in earnings of unconsolidated affiliates		(70,065	)		(82,583	)		(27,298	)		—			168,966			(10,980	)
Income from continuing operations before income taxes		70,065			54,150			127,564			48,327			(168,966	)		131,140
Provision for (benefit from) income taxes		—			(15,915	)		46,694			11,982			—			42,761
Income from continuing operations		70,065			70,065			80,870			36,345			(168,966	)		88,379
Discontinued operations, net of taxes:
Income (loss) from operations of entities sold and held for sale		—			—			1,789			(3,826	)		—			(2,037	)
Impairment of hospitals held for sale		—			—			—			—			—			—
Loss on sale		—			—			—			—			—			—
Loss from discontinued operations, net of taxes		—			—			1,789			(3,826	)		—			(2,037	)
Net income		70,065			70,065			82,659			32,519			(168,966	)		86,342
Less: Net income attributable to noncontrolling interests		—			—			—			16,277			—			16,277
Net income attributable to Community Health Systems, Inc.	$	70,065		$	70,065		$	82,659		$	16,242		$	(168,966	)	$	70,065

Condensed Consolidating Statement of Income
Six Months Ended June 30, 2011

	Parent						Other			Non-
	Guarantor			Issuer			Guarantors			Guarantors			Eliminations			Consolidated
	(In thousands)
Net operating revenues	$	—		$	—		$	3,932,956		$	2,854,925		$	—		$	6,787,881
Operating costs and expenses:
Salaries and benefits		—			—			1,510,301			1,253,162			—			2,763,463
Provision for bad debts		—			—			499,434			333,537			—			832,971
Supplies		—			—			525,911			381,185			—			907,096
Other operating expenses		—			—			738,800			530,730			—			1,269,530
Rent		—			—			61,608			63,993			—			125,601
Depreciation and amortization		—			—			189,419			130,112			—			319,531
Total operating costs and expenses		—			—			3,525,473			2,692,719			—			6,218,192
Income from operations		—			—			407,483			162,206			—			569,689
Interest expense, net		—			50,315			244,740			31,393			—			326,448
Equity in earnings of unconsolidated affiliates		(96,713	)		(114,604	)		(77,710	)		—			258,876			(30,151	)
Income from continuing operations before income taxes		96,713			64,289			240,453			130,813			(258,876	)		273,392
Provision for (benefit from) income taxes		—			(32,424	)		86,803			34,534			—			88,913
Income from continuing operations		96,713			96,713			153,650			96,279			(258,876	)		184,479
Discontinued operations, net of taxes:
Income (loss) from operations of entities sold and held for sale		—			—			4,158			(5,601	)		—			(1,443	)
Impairment of hospitals held for sale		—			—			(47,930	)		—			—			(47,930	)
Loss on sale		—			—			—			(3,234	)		—			(3,234	)
Loss from discontinued operations, net of taxes		—			—			(43,772	)		(8,835	)		—			(52,607	)
Net income		96,713			96,713			109,878			87,444			(258,876	)		131,872
Less: Net income attributable to noncontrolling interests		—			—			—			35,159			—			35,159
Net income attributable to Community Health Systems, Inc.	$	96,713		$	96,713		$	109,878		$	52,285		$	(258,876	)	$	96,713

Condensed Consolidating Statement of Income
Six Months Ended June 30, 2010

	Parent						Other			Non-
	Guarantor			Issuer			Guarantors			Guarantors			Eliminations			Consolidated
	(In thousands)
Net operating revenues	$	—		$	—		$	3,546,129		$	2,603,129		$	—		$	6,149,258
Operating costs and expenses:
Salaries and benefits		—			—			1,342,015			1,136,225			—			2,478,240
Provision for bad debts		—			—			442,530			290,973			—			733,503
Supplies		—			—			482,632			370,054			—			852,686
Other operating expenses		—			—			613,430			503,151			—			1,116,581
Rent		—			—			58,253			64,655			—			122,908
Depreciation and amortization		—			—			170,605			123,077			—			293,682
Total operating costs and expenses		—			—			3,109,465			2,488,135			—			5,597,600
Income from operations		—			—			436,664			114,994			—			551,658
Interest expense, net		—			57,447			235,294			27,441			—			320,182
Equity in earnings of unconsolidated affiliates		(140,072	)		(166,296	)		(50,851	)		—			333,649			(23,570	)
Income from continuing operations before income taxes		140,072			108,849			252,221			87,553			(333,649	)		255,046
Provision for (benefit from) income taxes		—			(31,223	)		92,817			20,716			—			82,310
Income from continuing operations		140,072			140,072			159,404			66,837			(333,649	)		172,736
Discontinued operations, net of taxes:
Income (loss) from operations of entities sold and held for sale		—			—			6,231			(7,629	)		—			(1,398	)
Impairment of hospitals held for sale		—			—			—			—			—			—
Loss on sale		—			—			—			—			—			—
Loss from discontinued operations, net of taxes		—			—			6,231			(7,629	)		—			(1,398	)
Net income		140,072			140,072			165,635			59,208			(333,649	)		171,338
Less: Net income attributable to noncontrolling interests		—			—			—			31,266			—			31,266
Net income attributable to Community Health Systems, Inc.	$	140,072		$	140,072		$	165,635		$	27,942		$	(333,649	)	$	140,072

Condensed consolidating statement of cash flows (unaudited)

Condensed Consolidating Statement of Cash Flows
Six Months Ended June 30, 2011

	Parent						Other			Non-
	Guarantor			Issuer			Guarantors			Guarantors			Eliminations		Consolidated
	(In thousands)
Cash flows from operating activities:
Net cash (used in) provided by operating activities	$	1,490		$	(37,658	)	$	338,117		$	282,736		$	—	$	584,685
Cash flows from investing activities:
Acquisitions of facilities and other related equipment		—			—			(162,692	)		(41,572	)		—		(204,264	)
Purchases of property and equipment		—			—			(187,760	)		(163,623	)		—		(351,383	)
Proceeds from disposition of ancillary operations		—			—			—			18,464			—		18,464
Proceeds from sale of property and equipment		—			—			881			7,153			—		8,034
Increase in other non-operating assets		—			—			(58,120	)		(17,091	)		—		(75,211	)
Net cash used in investing activities		—			—			(407,691	)		(196,669	)		—		(604,360	)
Cash flows from financing activities:
Proceeds from exercise of stock options		18,831			—			—			—			—		18,831
Deferred financing costs		—			(234	)		—			—			—		(234	)
Excess tax benefit relating to stock-based compensation		4,659			—			—			—			—		4,659
Stock buy-back		(50,002	)		—			—			—			—		(50,002	)
Proceeds from noncontrolling investors in joint ventures		—			—			—			863			—		863
Redemption of noncontrolling investments in joint ventures		—			—			—			(3,303	)		—		(3,303	)
Distributions to noncontrolling investors in joint ventures		—			—			—			(30,078	)		—		(30,078	)
Changes in intercompany balances with affiliates, net		25,022			62,908			(59,406	)		(28,524	)		—		—
Repayments of long-term indebtedness		—			(25,016	)		(2,504	)		(1,278	)		—		(28,798	)
Net cash provided by (used in) financing activities		(1,490	)		37,658			(61,910	)		(62,320	)		—		(88,062	)
Net change in cash and cash equivalents		—			—			(131,484	)		23,747			—		(107,737	)
Cash and cash equivalents at beginning of period		—			—			212,035			87,134			—		299,169
Cash and cash equivalents at end of period	$	—		$	—		$	80,551		$	110,881		$	—	$	191,432

Condensed Consolidating Statement of Cash Flows
Six Months Ended June 30, 2010

	Parent						Other			Non-
	Guarantor			Issuer			Guarantors			Guarantors			Eliminations		Consolidated
	(In thousands)
Cash flows from operating activities:
Net cash (used in) provided by operating activities	$	(100,143	)	$	(43,029	)	$	539,874		$	145,090		$	—	$	541,792
Cash flows from investing activities:
Acquisitions of facilities and other related equipment		—			—			(389	)		(2,024	)		—		(2,413	)
Purchases of property and equipment		—			—			(169,311	)		(94,613	)		—		(263,924	)
Proceeds from disposition of ancillary operations		—			—			—			—			—		—
Proceeds from sale of property and equipment		—			—			2,151			156			—		2,307
Increase in other non-operating assets		—			—			(31,750	)		(32,508	)		—		(64,258	)
Net cash used in investing activities		—			—			(199,299	)		(128,989	)		—		(328,288	)
Cash flows from financing activities:
Proceeds from exercise of stock options		53,615			—			—			—			—		53,615
Deferred financing costs		—			—			—			—			—		—
Excess tax benefit relating to stock-based compensation		10,104			—			—			—			—		10,104
Stock buy-back		(12,242	)		—			—			—			—		(12,242	)
Proceeds from noncontrolling investors in joint ventures		—			—			—			5,155			—		5,155
Redemption of noncontrolling investments in joint ventures		—			—			—			(2,395	)		—		(2,395	)
Distributions to noncontrolling investors in joint ventures		—			—			—			(29,371	)		—		(29,371	)
Changes in intercompany balances with affiliates, net		48,666			64,765			(73,906	)		(39,525	)		—		—
Repayments of long-term indebtedness		—			(21,736	)		(9,996	)		(2,425	)		—		(34,157	)
Net cash provided by (used in) financing activities		100,143			43,029			(83,902	)		(68,561	)		—		(9,291	)
Net change in cash and cash equivalents		—			—			256,673			(52,460	)		—		204,213
Cash and cash equivalents at beginning of period		—			—			238,495			106,046			—		344,541
Cash and cash equivalents at end of period	$	—		$	—		$	495,168		$	53,586		$	—	$	548,754

XML



Summary of Significant Accounting Policies (Policies)

6 Months Ended

Jun. 30, 2011

Summary of Significant Accounting Policies Disclosure [Abstract]

Consolidation subsidiaries or other investments consolidated entities

     Noncontrolling interests in less-than-wholly-owned consolidated subsidiaries of the parent are presented as a component of total equity on the condensed consolidated balance sheets to distinguish between the interests of the parent company and the interests of the noncontrolling owners. Noncontrolling interests that are redeemable or may become redeemable at a fixed or determinable price at the option of the holder or upon the occurrence of an event outside of the control of the Company are presented in mezzanine equity on the condensed consolidated balance sheets.

Goodwill and Intangible Assets Goodwill

     Goodwill is allocated to each identified reporting unit, which is defined as an operating segment or one level below the operating segment (referred to as a component of the entity). Management has determined that the Company’s operating segments meet the criteria to be classified as reporting units. At June 30, 2011, the hospital operations reporting unit, the home care agency operations reporting unit, and the hospital management services reporting unit had approximately $4.2 billion, $35.9 million and $33.3 million, respectively, of goodwill.

     Goodwill is evaluated for impairment at the same time every year and when an event occurs or circumstances change that, more likely than not, reduce the fair value of the reporting unit below its carrying value. There is a two-step method for determining goodwill impairment. Step one is to compare the fair value of the reporting unit with the unit’s carrying amount, including goodwill. If this test indicates the fair value is less than the carrying value, then step two is required to compare the implied fair value of the reporting unit’s goodwill with the carrying value of the reporting unit’s goodwill. The Company has selected September 30 as its annual testing date. The Company performed its last annual goodwill evaluation as of September 30, 2010, which evaluation took place during the fourth quarter of 2010. No impairment was indicated by this evaluation.

     The Company estimates the fair value of the related reporting units using both a discounted cash flow model as well as an EBITDA multiple model. The cash flow forecasts are adjusted by an appropriate discount rate based on the Company’s estimate of a market participant’s weighted-average cost of capital. These models are both based on the Company’s best estimate of future revenues and operating costs and are reconciled to the Company’s consolidated market capitalization, with consideration of the amount a potential acquirer would be required to pay, in the form of a control premium, in order to gain sufficient ownership to set policies, direct operations and control management decisions.

Fair value of financial instruments

     Cash and cash equivalents. The carrying amount approximates fair value due to the short-term maturity of these instruments (less than three months).

     Available-for-sale securities. Estimated fair value is based on closing price as quoted in public markets.

     Trading securities. Estimated fair value is based on closing price as quoted in public markets.

     Credit Facility. Estimated fair value is based on information from the Company’s bankers regarding relevant pricing for trading activity among the Company’s lending institutions.

     Senior notes. Estimated fair value is based on the average bid and ask price as quoted by the bank who served as underwriter in the sale of these notes.

     Other debt. The carrying amount of all other debt approximates fair value due to the nature of these obligations.

     Interest rate swaps. The fair value of interest rate swap agreements is the amount at which they could be settled, based on estimates calculated by the Company using a discounted cash flow analysis based on observable market inputs and validated by comparison to estimates obtained from the counterparty. The Company incorporates credit valuation adjustments (“CVAs”) to appropriately reflect both its own nonperformance or credit risk and the respective counterparty’s nonperformance or credit risk in the fair value measurements. In adjusting the fair value of its interest rate swap agreements for the effect of nonperformance or credit risk, the Company has considered the impact of any netting features included in the agreements.

Policy related to health care entity

     In August 2010, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2010-24, which provides clarification to companies in the healthcare industry on the accounting for professional liability insurance. This ASU states that receivables related to insurance recoveries should not be netted against the related claim liability and such claim liabilities should be determined without considering insurance recoveries. This ASU is effective for fiscal years beginning after December 15, 2010 and was adopted by the Company on January 1, 2011. The adoption of this ASU increased other current assets by $2.5 million, other assets, net by $41.1 million and long-term liabilities by $43.6 million in the condensed consolidated balance sheet at June 30, 2011 and had no impact to the condensed consolidated statement of income for the three and six months ended June 30, 2011.

     In August 2010, the FASB issued ASU 2010-23, which requires a company in the healthcare industry to use its direct and indirect costs of providing charity care as the measurement basis for charity care disclosures. This ASU also requires additional disclosures of the method used to determine such costs. The Company adopted this ASU on January 1, 2011. In the ordinary course of business, the Company renders services to patients who are financially unable to pay for hospital care. Included in the provision for contractual allowances is the value (at the Company’s standard charges) of these services to patients who are unable to pay that is eliminated from net operating revenues when it is determined they qualify under the Company’s charity care policy. The estimated cost incurred by the Company to provide these services to patients who are unable to pay was approximately $28.0 million and $25.3 million for the three months ended June 30, 2011 and 2010, respectively, and $54.1 million and $50.8 million for the six months ended June 30, 2011 and 2010, respectively. The estimated cost of these charity care services was determined using a ratio of cost to gross charges and applying that ratio to the gross charges associated with providing care to charity patients for the period. Gross charges associated with providing care to charity patients includes only the related charges for those patients who are financially unable to pay and qualify under the Company’s charity care policy and that do not otherwise qualify for reimbursement from a governmental program.

     In July 2011, the FASB issued ASU 2011-07, which requires healthcare organizations that perform services for patients for which the ultimate collection of all or a portion of the amounts billed or billable cannot be determined at the time services are rendered to present all bad debt expense associated with patient service revenue as an offset to the patient service revenue line item in the statement of operations. The ASU also requires qualitative disclosures about the Company’s policy for recognizing revenue and bad debt expense for patient service transactions and quantitative information about the effects of changes in the assessment of collectibility of patient service revenue. This ASU is effective for fiscal years beginning after December 15, 2011, and will be adopted by the Company in the first quarter of 2012. The Company is currently assessing the potential impact the adoption of this ASU will have on its consolidated results of operations and consolidated financial position.

Segment reporting policy

     The Company operates in three distinct operating segments, represented by hospital operations (which includes its general acute care hospitals and related healthcare entities that provide inpatient and outpatient healthcare services), home care agency operations (which provide in-home outpatient care), and hospital management services (which provides executive management and consulting services to non-affiliated acute care hospitals). Only the hospital operations segment meets the criteria as a separate reportable segment. The financial information for the home care agencies and hospital management services segments do not meet the quantitative thresholds for a separate identifiable reportable segment and are combined into the corporate and all other reportable segment.

Condensed consolidated financial information policy

     In connection with the consummation of the Triad acquisition, CHS obtained approximately $7.2 billion of senior secured financing under the Credit Facility and issued the Notes in the aggregate principal amount of approximately $3.0 billion. The Notes are senior unsecured obligations of CHS and are guaranteed on a senior basis by the Company and by certain of its existing and subsequently acquired or organized 100% owned domestic subsidiaries.

     The Notes are fully and unconditionally guaranteed on a joint and several basis. The following condensed consolidating financial statements present Community Health Systems, Inc. (as parent guarantor), CHS (as the issuer), the subsidiary guarantors, the subsidiary non-guarantors and eliminations. These condensed consolidating financial statements have been prepared and presented in accordance with SEC Regulation S-X Rule 3-10 “Financial Statements of Guarantors and Issuers of Guaranteed Securities Registered or Being Registered.”

     The accounting policies used in the preparation of this financial information are consistent with those elsewhere in the consolidated financial statements of the Company, except as noted below:

• Intercompany receivables and payables are presented gross in the supplemental consolidating balance sheets.

• Cash flows from intercompany transactions are presented in cash flows from financing activities, as changes in intercompany balances with affiliates, net.

• Income tax expense is allocated from the parent guarantor to the income producing operations (other guarantors and non-guarantors) and the issuer through stockholders’ equity. As this approach represents an allocation, the income tax expense allocation is considered non-cash for statement of cash flow purposes.

• Interest expense, net has been presented to reflect net interest expense and interest income from outstanding long-term debt and intercompany balances.

     The Company’s intercompany activity consists primarily of daily cash transfers for purposes of cash management, the allocation of certain expenses and expenditures paid for by the parent on behalf of its subsidiaries, and the push down of investment in its subsidiaries. The Company’s subsidiaries generally do not purchase services from each other; thus, the intercompany transactions do not represent revenue generating transactions. All intercompany transactions eliminate in consolidation.

     From time to time, the Company sells and/or repurchases noncontrolling interests in consolidated subsidiaries, which may change subsidiaries between guarantors and non-guarantors. Amounts for prior periods are restated to reflect the status of guarantors or non-guarantors as of June 30, 2011.

XML



Long-Term Debt

6 Months Ended

Jun. 30, 2011

Long-Term Debt [Abstract]

LONG-TERM DEBT

12. LONG-TERM DEBT

Credit Facility and Notes

     In connection with the consummation of the acquisition of Triad in July 2007, the Company’s wholly-owned subsidiary CHS/Community Health Systems, Inc. (“CHS”) obtained approximately $7.2 billion of senior secured financing under a new credit facility (the “Credit Facility”) with a syndicate of financial institutions led by Credit Suisse, as administrative agent and collateral agent, and issued approximately $3.0 billion aggregate principal amount of 8.875% senior notes due 2015 (the “Notes”). The Company used the net proceeds of $3.0 billion from the Notes offering and the net proceeds of approximately $6.1 billion of term loans under the Credit Facility to acquire the outstanding shares of Triad, to refinance certain of Triad’s indebtedness and the Company’s indebtedness, to complete certain related transactions, to pay certain costs and expenses of the transactions and for general corporate uses. Specifically, the Company repaid its outstanding debt under the previously outstanding credit facility, the 6.50% senior subordinated notes due 2012 and certain of Triad’s existing indebtedness.

     The Credit Facility consisted of an approximately $6.1 billion funded term loan facility with a maturity of seven years, a $400 million delayed draw term loan facility with a maturity of seven years and a $750 million revolving credit facility with a maturity of six years. As of December 31, 2007, the $400 million delayed draw term loan facility had been reduced to $300 million at the request of CHS. During the fourth quarter of 2008, $100 million of the delayed draw term loan was drawn by CHS, reducing the delayed draw term loan availability to $200 million at December 31, 2008. In January 2009, CHS drew down the remaining $200 million of the delayed draw term loan. The revolving credit facility also includes a subfacility for letters of credit and a swingline subfacility. The Credit Facility requires quarterly amortization payments of each term loan facility equal to 0.25% of the outstanding amount of the term loans. On November 5, 2010, CHS entered into an amendment and restatement of its existing Credit Facility. The amendment extends by two and a half years, until January 25, 2017, the maturity date of $1.5 billion of the existing term loans under the Credit Facility and increases the pricing on these term loans to LIBOR plus 350 basis points. If more than $50 million of the Notes remain outstanding on April 15, 2015, without having been refinanced, then the maturity date for the extended term loans will be accelerated to April 15, 2015. The maturity date of the balance of the term loans of approximately $4.5 billion remains unchanged at July 25, 2014. The amendment also increases CHS’s ability to issue additional indebtedness under the uncommitted incremental facility to $1.0 billion from $600 million, permits CHS to issue Term A term loans under the incremental facility, and provides up to $2.0 billion of borrowing capacity from receivable transactions, an increase of $0.5 billion, of which $1.7 billion would be required to be used for repayment of existing term loans.

     The term loan facility must be prepaid in an amount equal to (1) 100% of the net cash proceeds of certain asset sales and dispositions by the Company and its subsidiaries, subject to certain exceptions and reinvestment rights, (2) 100% of the net cash proceeds of issuances of certain debt obligations or receivables based financing by the Company and its subsidiaries, subject to certain exceptions, and (3) 50%, subject to reduction to a lower percentage based on the Company’s leverage ratio (as defined in the Credit Facility generally as the ratio of total debt on the date of determination to the Company’s EBITDA, as defined, for the four quarters most recently ended prior to such date), of excess cash flow (as defined) for any year, commencing in 2008, subject to certain exceptions. Voluntary prepayments and commitment reductions are permitted in whole or in part, without any premium or penalty, subject to minimum prepayment or reduction requirements.

     The obligor under the Credit Facility is CHS. All of the obligations under the Credit Facility are unconditionally guaranteed by the Company and certain existing and subsequently acquired or organized domestic subsidiaries. All obligations under the Credit Facility and the related guarantees are secured by a perfected first priority lien or security interest in substantially all of the assets of the Company, CHS and each subsidiary guarantor, including equity interests held by the Company, CHS or any subsidiary guarantor, but excluding, among others, the equity interests of non-significant subsidiaries, syndication subsidiaries, securitization subsidiaries and joint venture subsidiaries.

     The loans under the Credit Facility bear interest on the outstanding unpaid principal amount at a rate equal to an applicable percentage plus, at CHS’s option, either (a) an Alternate Base Rate (as defined) determined by reference to the greater of (1) the Prime Rate (as defined) announced by Credit Suisse or (2) the Federal Funds Effective Rate (as defined) plus one-half of 1.0% or (3) the adjusted London Interbank Offered Rate (“LIBOR”) on such day for a three-month interest period commencing on the second business day after such day plus 1%, or (b) a reserve adjusted LIBOR for dollars (Eurodollar rate) (as defined). The applicable percentage for Alternate Base Rate loans is 1.25% for term loans due 2014 and is 2.25% for term loans due 2017. The applicable percentage for Eurodollar rate loans is 2.25% for term loans due 2014 and 3.5% for term loans due 2017. The applicable percentage for revolving loans is 1.25% for Alternate Base Rate revolving loans and 2.25% for Eurodollar revolving loans, in each case subject to reduction based on the Company’s leverage ratio. Loans under the swingline subfacility bear interest at the rate applicable to Alternate Base Rate loans under the revolving credit facility.

     CHS has agreed to pay letter of credit fees equal to the applicable percentage then in effect with respect to Eurodollar rate loans under the revolving credit facility times the maximum aggregate amount available to be drawn under all letters of credit outstanding under the subfacility for letters of credit. The issuer of any letter of credit issued under the subfacility for letters of credit will also receive a customary fronting fee and other customary processing charges. CHS was initially obligated to pay commitment fees of 0.50% per annum (subject to reduction based upon the Company’s leverage ratio) on the unused portion of the revolving credit facility. For purposes of this calculation, swingline loans are not treated as usage of the revolving credit facility. With respect to the delayed draw term loan facility, CHS was also obligated to pay commitment fees of 0.50% per annum for the first nine months after the closing of the Credit Facility, 0.75% per annum for the next three months after such nine-month period and thereafter, 1.0% per annum. In each case, the commitment fee was paid on the unused amount of the delayed draw term loan facility. After the draw down of the remaining $200 million of the delayed draw term loan in January 2009, CHS no longer pays any commitment fees for the delayed draw term loan facility. CHS paid arrangement fees on the closing of the Credit Facility and pays an annual administrative agent fee.

     The Credit Facility contains customary representations and warranties, subject to limitations and exceptions, and customary covenants restricting the Company’s and its subsidiaries’ ability, subject to certain exceptions, to, among other things (1) declare dividends, make distributions or redeem or repurchase capital stock, (2) prepay, redeem or repurchase other debt, (3) incur liens or grant negative pledges, (4) make loans and investments and enter into acquisitions and joint ventures, (5) incur additional indebtedness or provide certain guarantees, (6) make capital expenditures, (7) engage in mergers, acquisitions and asset sales, (8) conduct transactions with affiliates, (9) alter the nature of the Company’s businesses, (10) grant certain guarantees with respect to physician practices, (11) engage in sale and leaseback transactions or (12) change the Company’s fiscal year. The Company is also required to comply with specified financial covenants (consisting of a leverage ratio and an interest coverage ratio) and various affirmative covenants.

     Events of default under the Credit Facility include, but are not limited to, (1) CHS’s failure to pay principal, interest, fees or other amounts under the credit agreement when due (taking into account any applicable grace period), (2) any representation or warranty proving to have been materially incorrect when made, (3) covenant defaults subject, with respect to certain covenants, to a grace period, (4) bankruptcy events, (5) a cross default to certain other debt, (6) certain undischarged judgments (not paid within an applicable grace period), (7) a change of control, (8) certain ERISA-related defaults and (9) the invalidity or impairment of specified security interests, guarantees or subordination provisions in favor of the administrative agent or lenders under the Credit Facility.

     The Notes were issued by CHS in connection with the Triad acquisition in the principal amount of approximately $3.0 billion. The Notes will mature on July 15, 2015. The Notes bear interest at the rate of 8.875% per annum, payable semiannually in arrears on January 15 and July 15, commencing January 15, 2008. Interest on the Notes accrues from the date of original issuance. Interest is calculated on the basis of a 360-day year comprised of twelve 30-day months.

     Except as set forth below, CHS is not entitled to redeem the Notes prior to July 15, 2011.

     On and after July 15, 2011, CHS is entitled, at its option, to redeem all or a portion of the Notes upon not less than 30 nor more than 60 days notice, at the redemption prices (expressed as a percentage of principal amount on the redemption date), plus accrued and unpaid interest, if any, to the redemption date (subject to the right of holders of record on the relevant record date to receive interest due on the relevant interest payment date), if redeemed during the 12-month period commencing on July 15 of the years set forth below:

Period	Redemption Price
2011		104.438	%
2012		102.219	%
2013 and thereafter		100.000	%

     CHS is entitled, at its option, to redeem the Notes, in whole or in part, at any time prior to July 15, 2011, upon not less than 30 or more than 60 days notice, at a redemption price equal to 100% of the principal amount of Notes redeemed plus the Applicable Premium (as defined), and accrued and unpaid interest, if any, as of the applicable redemption date.

     Pursuant to a registration rights agreement entered into at the time of the issuance of the Notes, as a result of an exchange offer made by CHS, substantially all of the Notes issued in July 2007 were exchanged in November 2007 for new notes (the “Exchange Notes”) having terms substantially identical in all material respects to the Notes (except that the Exchange Notes were issued under a registration statement pursuant to the Securities Act of 1933, as amended). References to the Notes shall also be deemed to include the Exchange Notes unless the context provides otherwise.

     As of June 30, 2011, the availability for additional borrowings under the Credit Facility was $750 million pursuant to the revolving credit facility, of which $37.9 million was set aside for outstanding letters of credit. CHS has the ability to amend the Credit Facility to provide for one or more tranches of term loans in an aggregate principal amount of $1.0 billion, which CHS has not yet accessed. CHS also has the ability to add up to $300 million of borrowing capacity from receivable transactions (including securitizations) under the Credit Facility, which has not yet been accessed. As of June 30, 2011, the weighted-average interest rate under the Credit Facility, excluding swaps, was 3.2%.

     The Company paid interest of $101.6 million and $99.9 million on borrowings during the three months ended June 30, 2011 and 2010, respectively, and $327.7 million and $320.2 million for the six months ended June 30, 2011 and 2010, respectively.

XML



Cost of Revenue

6 Months Ended

Jun. 30, 2011

Cost of Revenue [Abstract]

COST OF REVENUE

3. COST OF REVENUE

     Substantially all of the Company’s operating costs and expenses are “cost of revenue” items. Operating costs that could be classified as general and administrative by the Company would include the Company’s corporate office costs at its Franklin, Tennessee office, which were $47.8 million and $42.4 million for the three months ended June 30, 2011 and 2010, respectively, and $89.5 million and $80.2 million for the six months ended June 30, 2011 and 2010, respectively. Included in these amounts is stock-based compensation expense of $10.8 million and $10.7 million for the three months ended June 30, 2011 and 2010, respectively, and $20.7 million and $20.4 million for the six months ended June 30, 2011 and 2010, respectively.

XML



Fair Value (Tables)

6 Months Ended

Jun. 30, 2011

Fair Value [Abstract]

Financial assets and liabilities recorded at fair value on a recurring basis

	June 30,
	2011		Level 1		Level 2		Level 3
Available-for-sale securities	$	33,097	$	33,097	$	—	$	—
Trading securities		38,709		38,709		—		—
Total assets	$	71,806	$	71,806	$	—	$	—
Fair value of interest rate swap agreements	$	297,526	$	—	$	297,526	$	—
Total liabilities	$	297,526	$	—	$	297,526	$	—

	December 31,
	2010		Level 1		Level 2		Level 3
Available-for-sale securities	$	31,570	$	31,570	$	—	$	—
Trading securities		35,092		35,092		—		—
Total assets	$	66,662	$	66,662	$	—	$	—
Fair value of interest rate swap agreements	$	340,526	$	—	$	340,526	$	—
Total liabilities	$	340,526	$	—	$	340,526	$	—

Assets recorded at fair value on a nonrecurring basis

	June 30,
	2011		Level 1		Level 2		Level 3
Hospitals held for sale	$	122,632	$	—	$	—	$	122,632
Total	$	122,632	$	—	$	—	$	122,632

XML



Stockholders Equity

6 Months Ended

Jun. 30, 2011

Stockholders' Equity & Comprehensive Income [Abstract]

STOCKHOLDERS' EQUITY

9. STOCKHOLDERS’ EQUITY

     Authorized capital shares of the Company include 400,000,000 shares of capital stock consisting of 300,000,000 shares of common stock and 100,000,000 shares of preferred stock. Each of the aforementioned classes of capital stock has a par value of $0.01 per share. Shares of preferred stock, none of which were outstanding as of June 30, 2011, may be issued in one or more series having such rights, preferences and other provisions as determined by the Board of Directors without approval by the holders of common stock.

     On September 15, 2010, the Company commenced a new open market repurchase program for up to 4,000,000 shares of the Company’s common stock, not to exceed $100 million in repurchases. This program will conclude at the earliest of three years from the commencement date, when the maximum number of shares has been repurchased or when the maximum dollar amount has been expended. During the three and six months ended June 30, 2011, the Company repurchased and retired 1,763,566 shares at a weighted-average price of $28.31 under this program. The cumulative number of shares that have been repurchased and retired under this program through June 30, 2011 is 2,214,838 shares at a weighted-average price of $28.82 per share.

     On December 9, 2009, the Company commenced the predecessor open market repurchase program for up to 3,000,000 shares of the Company’s common stock, not to exceed $100 million in repurchases. This program concluded in September 2010 when purchases approximated the total permitted maximum dollar amount allowed under the program. During the three and six months ended June 30, 2010, the Company repurchased and retired 356,000 shares at a weighted-average price of $34.24 under this program. During the year ended December 31, 2010, the Company repurchased and retired 2,964,528 shares, which is the cumulative number of shares that were repurchased under this program, at a weighted-average price of $33.69 per share.

     The following schedule presents the reconciliation of the carrying amount of total equity, equity attributable to the Company, and equity attributable to the noncontrolling interests for the six-month period ended June 30, 2011 (in thousands):

				Community Health Systems, Inc. Stockholders
													Accumulated
	Redeemable						Additional						Other								Total
	Noncontrolling			Common			Paid-in			Treasury			Comprehensive			Retained		Noncontrolling			Stockholders’
	Interests			Stock			Capital			Stock			Income (Loss)			Earnings		Interests			Equity
Balance, December 31, 2010	$	387,472		$	936		$	1,126,751		$	(6,678	)	$	(230,927	)	$	1,299,382	$	60,913		$	2,250,377
Comprehensive income:
Net income		25,211			—			—			—			—			96,713		9,948			106,661
Net change in fair value of interest rate swaps		—			—			—			—			27,477			—		—			27,477
Net change in fair value of available-for-sale securities		—			—			—			—			1,338			—		—			1,338
Amortization and recognition of unrecognized pension cost components		—			—			—			—			1,579			—		—			1,579
Total comprehensive income		25,211			—			—			—			30,394			96,713		9,948			137,055
Distributions to noncontrolling interests, net of contributions		(19,387	)		—			—			—			—			—		(9,828	)		(9,828	)
Purchase of subsidiary shares from noncontrolling interests		(2,792	)		—			(498	)		—			—			—		—			(498	)
Other reclassifications of noncontrolling interests		(2,004	)		—			—			—			—			—		272			272
Adjustment to redemption value of redeemable noncontrolling interests		(11,842	)		—			11,842			—			—			—		—			11,842
Repurchases of common stock		—			(18	)		(50,002	)		—			—			—		—			(50,020	)
Issuance of common stock in connection with the exercise of stock options		—			6			18,831			—			—			—		—			18,837
Cancellation of restricted stock for tax withholdings on vested shares		—			(3	)		(13,110	)		—			—			—		—			(13,113	)
Excess tax benefit from exercise of stock options		—			—			4,659			—			—			—		—			4,659
Share-based compensation		—			11			20,732			—			—			—		—			20,743
Balance, June 30, 2011	$	376,658		$	932		$	1,119,205		$	(6,678	)	$	(200,533	)	$	1,396,095	$	61,305		$	2,370,326

     The following schedule discloses the effects of changes in the Company’s ownership interest in its less-than-wholly-owned subsidiaries on Community Health Systems, Inc. stockholders’ equity (in thousands):

	Six Months Ended
	June 30, 2011
Net income attributable to Community Health Systems, Inc.	$	96,713
Transfers to the noncontrolling interests:
Net decrease in Community Health Systems, Inc. paid-in capital for purchase of subsidiary partnership interests		(498	)
Net transfers to the noncontrolling interests		(498	)
Change to Community Health Systems, Inc. stockholders’ equity from net income attributable to Community Health Systems, Inc. and transfers to noncontrolling interests	$	96,215

XML



Fair Value

6 Months Ended

Jun. 30, 2011

Fair Value [Abstract]

FAIR VALUE

14. FAIR VALUE

Fair Value Hierarchy

     Fair value is a market-based measurement, not an entity-specific measurement. Therefore, a fair value measurement should be determined based on the assumptions that market participants would use in pricing the asset or liability. As a basis for considering market participant assumptions in fair value measurements, the Company utilizes the U.S. GAAP fair value hierarchy that distinguishes between market participant assumptions based on market data obtained from sources independent of the reporting entity (observable inputs that are classified within Levels 1 and 2 of the hierarchy) and the reporting entity’s own assumption about market participant assumptions (unobservable inputs classified within Level 3 of the hierarchy).

     The inputs used to measure fair value are classified into the following fair value hierarchy:

Level 1:	Quoted market prices in active markets for identical assets or liabilities.
Level 2:	Observable market-based inputs or unobservable inputs that are corroborated by market data.
Level 3:	Unobservable inputs that are supported by little or no market activity and are significant to the fair value of the assets or liabilities. Level 3 includes values determined using pricing models, discounted cash flow methodologies, or similar techniques reflecting the Company’s own assumptions.

     In instances where the determination of the fair value hierarchy measurement is based on inputs from different levels of the fair value hierarchy, the level in the fair value hierarchy within which the entire fair value measurement falls is based on the lowest level input that is significant to the fair value measurement in its entirety. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment of factors specific to the asset or liability.

     The following table sets forth, by level within the fair value hierarchy, the financial assets and liabilities recorded at fair value on a recurring basis as of June 30, 2011 and December 31, 2010 (in thousands):

	June 30,
	2011		Level 1		Level 2		Level 3
Available-for-sale securities	$	33,097	$	33,097	$	—	$	—
Trading securities		38,709		38,709		—		—
Total assets	$	71,806	$	71,806	$	—	$	—
Fair value of interest rate swap agreements	$	297,526	$	—	$	297,526	$	—
Total liabilities	$	297,526	$	—	$	297,526	$	—

	December 31,
	2010		Level 1		Level 2		Level 3
Available-for-sale securities	$	31,570	$	31,570	$	—	$	—
Trading securities		35,092		35,092		—		—
Total assets	$	66,662	$	66,662	$	—	$	—
Fair value of interest rate swap agreements	$	340,526	$	—	$	340,526	$	—
Total liabilities	$	340,526	$	—	$	340,526	$	—

     Available-for-sale securities and trading securities classified as Level 1 are measured using quoted market prices.

     The valuation of the Company’s interest rate swap agreements is determined using market valuation techniques, including discounted cash flow analysis on the expected cash flows of each agreement. This analysis reflects the contractual terms of the agreement, including the period to maturity, and uses observable market-based inputs, including forward interest rate curves. The fair value of interest rate swap agreements are determined by netting the discounted future fixed cash payments and the discounted expected variable cash receipts. The variable cash receipts are based on the expectation of future interest rates based on observable market forward interest rate curves and the notional amount being hedged.

     The Company incorporates CVAs to appropriately reflect both its own nonperformance or credit risk and the respective counterparty’s nonperformance or credit risk in the fair value measurements. In adjusting the fair value of its interest rate swap agreements for the effect of nonperformance or credit risk, the Company has considered the impact of any netting features included in the agreements. The CVA on the Company’s interest rate swap agreements at June 30, 2011 resulted in a decrease in the fair value of the related liability of $11.6 million and an after-tax adjustment of $7.4 million to OCI. The CVA on the Company’s interest rate swap agreements at December 31, 2010 resulted in a decrease in the fair value of the related liability of $3.9 million and an after-tax adjustment of $2.5 million to OCI.

     The majority of the inputs used to value its interest rate swap agreements, including the forward interest rate curves and market perceptions of the Company’s credit risk used in the CVAs, are observable inputs available to a market participant. As a result, the Company has determined that the interest rate swap valuations are classified in Level 2 of the fair value hierarchy.

     The following table sets forth, by level within the fair value hierarchy, the assets recorded at fair value on a nonrecurring basis as of June 30, 2011 (in thousands):

	June 30,
	2011		Level 1		Level 2		Level 3
Hospitals held for sale	$	122,632	$	—	$	—	$	122,632
Total	$	122,632	$	—	$	—	$	122,632

     During the six months ended June 30, 2011, the Company made the decision to sell three of its hospitals. The carrying value of these hospitals held for sale, including an allocation of $45.3 million of reporting unit goodwill, was adjusted to the fair value, which equals the price in the definitive sale agreements less costs to sell, resulting in an after-tax impairment charge of $47.9 million.

XML



Comprehensive Income

6 Months Ended

Jun. 30, 2011

Stockholders' Equity & Comprehensive Income [Abstract]

COMPREHENSIVE INCOME

10. COMPREHENSIVE INCOME

     The following table presents the components of comprehensive income, net of related taxes (in thousands):

	Three Months Ended						Six Months Ended
	June 30,						June 30,
	2011			2010			2011		2010
Net income	$	53,547		$	86,342		$	131,872	$	171,338
Net change in fair value of interest rate swaps		(8,969	)		(33,694	)		27,477		(45,051	)
Net change in fair value of available-for-sale securities		268			476			1,338		630
Amortization and recognition of unrecognized pension cost components		807			758			1,579		5,233
Comprehensive income		45,653			53,882			162,266		132,150
Less: Comprehensive income attributable to noncontrolling interests		18,158			16,277			35,159		31,266
Comprehensive income attributable to Community Health Systems, Inc.	$	27,495		$	37,605		$	127,107	$	100,884

     The net change in fair value of the interest rate swaps, the net change in fair value of available-for-sale securities and the amortization and recognition of unrecognized pension cost components are included in accumulated other comprehensive loss on the accompanying condensed consolidated balance sheets.

XML



Equity Investments (Tables)

6 Months Ended

Jun. 30, 2011

Equity Investments [Abstract]

Summarized combined financial information of entities in which Company owns equity interest

	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2011		2010		2011		2010
Revenues	$	373,448	$	358,586	$	746,039	$	716,065
Operating costs and expenses		334,765		321,457		652,752		645,977
Income from continuing operations before taxes		38,652		37,113		93,236		70,045

XML



Earnings per Share

6 Months Ended

Jun. 30, 2011

Earnings per Share [Abstract]

EARNINGS PER SHARE

8. EARNINGS PER SHARE

     The following table sets forth the components of the numerator and denominator for the computation of basic and diluted earnings per share for income from continuing operations, discontinued operations and net income attributable to Community Health Systems, Inc. common stockholders (in thousands, except share data):

	Three Months Ended						Six Months Ended
	June 30,						June 30,
	2011			2010			2011			2010
Numerator:
Income from continuing operations, net of taxes	$	92,874		$	88,379		$	184,479		$	172,736
Less: Income from continuing operations attributable to noncontrolling interests, net of taxes		18,158			16,313			35,159			31,332
Income from continuing operations attributable to Community Health Systems, Inc. common stockholders — basic and diluted	$	74,716		$	72,066		$	149,320		$	141,404
Loss from discontinued operations, net of taxes	$	(39,327	)	$	(2,037	)	$	(52,607	)	$	(1,398	)
Less: Loss from discontinued operations attributable to noncontrolling interests, net of taxes		—			(36	)		—			(66	)
Loss from discontinued operations attributable to Community Health Systems, Inc. common stockholders — basic and diluted	$	(39,327	)	$	(2,001	)	$	(52,607	)	$	(1,332	)
Denominator:
Weighted-average number of shares outstanding — basic		91,130,672			93,358,771			91,069,876			92,491,839
Effect of dilutive securities:
Restricted stock awards		263,876			522,496			258,871			423,442
Employee stock options		381,632			815,455			623,662			847,380
Other equity-based awards		7,545			15,197			8,201			16,340
Weighted-average number of shares outstanding — diluted		91,783,725			94,711,919			91,960,610			93,779,001

Dilutive securities outstanding not included in the computation of earnings per share because their effect is antidilutive:

Employee stock options 6,726,417 3,503,906 5,560,855 4,432,069

XML



Long-Term Debt (Details)	6 Months Ended
	Jun. 30, 2011
Redemption of Long-Term Debt
2011	104.438%
2012	102.219%
2013 and thereafter	100.00%

XML



Basis of Presentation

6 Months Ended

Jun. 30, 2011

Basis of Presentation [Abstract]

BASIS OF PRESENTATION

1. BASIS OF PRESENTATION

     The unaudited condensed consolidated financial statements of Community Health Systems, Inc. and its subsidiaries (the “Company”) as of June 30, 2011 and December 31, 2010 and for the three-month and six-month periods ended June 30, 2011 and June 30, 2010, have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). In the opinion of management, such information contains all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the results for such periods. All intercompany transactions and balances have been eliminated. The results of operations for the three and six months ended June 30, 2011, are not necessarily indicative of the results to be expected for the full fiscal year ending December 31, 2011. Certain information and disclosures normally included in the notes to consolidated financial statements have been condensed or omitted as permitted by the rules and regulations of the Securities and Exchange Commission (the “SEC”). The Company believes the disclosures are adequate to make the information presented not misleading. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto for the year ended December 31, 2010, contained in the Company’s Annual Report on Form 10-K.

     Noncontrolling interests in less-than-wholly-owned consolidated subsidiaries of the parent are presented as a component of total equity on the condensed consolidated balance sheets to distinguish between the interests of the parent company and the interests of the noncontrolling owners. Noncontrolling interests that are redeemable or may become redeemable at a fixed or determinable price at the option of the holder or upon the occurrence of an event outside of the control of the Company are presented in mezzanine equity on the condensed consolidated balance sheets.

     During the three months ended March 31, 2011, the Company sold a multi-specialty physician clinic and made the decision to sell a hospital. In June 2011, the Company entered into a definitive agreement to sell two of its hospitals in Oklahoma. As of June 30, 2011, the Company has three hospitals held for sale. The condensed consolidated statement of income for the three and six months ended June 30, 2010 has been restated to reclassify the results of operations for these entities to discontinued operations. The condensed consolidated balance sheet as of December 31, 2010 has been restated to present the long-lived assets of the disposal group as held for sale in other assets, net for comparative purposes with the June 30, 2011 presentation.

     Throughout these notes to the condensed consolidated financial statements, Community Health Systems, Inc. (the “Parent”), and its consolidated subsidiaries are referred to on a collective basis as the “Company.” This drafting style is not meant to indicate that the publicly-traded Parent or any subsidiary of the Parent owns or operates any asset, business, or property. The hospitals, operations and businesses described in this filing are owned and operated, and management services provided, by distinct and indirect subsidiaries of Community Health Systems, Inc.

XML



Use of Estimates

6 Months Ended

Jun. 30, 2011

Use of Estimates [Abstract]

USE OF ESTIMATES

4. USE OF ESTIMATES

     The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements. Actual results could differ from these estimates under different assumptions or conditions.

XML



Accounting for Stock-Based Compensation (Details Textual) (USD $)	3 Months Ended			6 Months Ended			3 Months Ended	6 Months Ended							6 Months Ended
	Jun. 30, 2011	Mar. 31, 2011	Jun. 30, 2010	Jun. 30, 2011	Jun. 30, 2010	Dec. 31, 2010	Jun. 30, 2011 Phantom Stock and Restricted stock [Member]	Jun. 30, 2011 Phantom Stock and Restricted stock [Member]	Jun. 30, 2011 Phantom Stock and Restricted stock [Member] Plan 2000 [Member]	Feb. 23, 2011 Phantom Stock and Restricted stock [Member] Plan 2000 [Member]	Feb. 24, 2010 Phantom Stock and Restricted stock [Member] Plan 2000 [Member]	May 19, 2009 Phantom Stock and Restricted stock [Member] Plan 2000 [Member]	Feb. 25, 2009 Phantom Stock and Restricted stock [Member] Plan 2000 [Member]	Feb. 23, 2011 Phantom Stock and Restricted stock [Member] Plan 2009 [Member]	Jun. 30, 2011 Contractual term of option granted prior to 2005 [Member]	Jun. 30, 2011 Contractual term of option granted from 2005 through 2007 [Member]	Jun. 30, 2011 Contractual term of option granted from 2008 through 2011 [Member]	Jun. 30, 2011 Plan 2000 [Member]	Feb. 23, 2011 Plan 2000 [Member]	Feb. 24, 2010 Plan 2000 [Member]	May 19, 2009 Plan 2000 [Member]	Feb. 25, 2009 Plan 2000 [Member]	Jun. 30, 2011 Plan 2009 [Member]	Jun. 30, 2011 Employee Stock Option [Member]	Jun. 30, 2011 Restricted Stock Restricted Stock Units And Phantom Shares [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unissued common stock reserved for grants																		127,250					2,897,129
Employee Service Share-based Compensation, Unrecognized Compensation Costs on Nonvested Awards	$ 79,500,000			$ 79,500,000																				$ 17,200,000	$ 62,300,000
Closing price of Company's common stock	$ 25.68			$ 25.68															$ 37.96	$ 33.90	$ 25.27	$ 18.18
Grant received by Director as phantom stock										140,000	140,000	180,706	130,000
Number of shares received by Director											4,130	7,151	7,151	3,688
Total shares of phantom stock	8,000	1,084,949							42,906
Shares vested at weighted-average grant date	(12,000)	(962,662)					2,384	22,560
Weighted-average grant date fair value, Vested	$ 33.49	$ 27.27					$ 25.27	$ 24.68
Phantom stock and restricted stock units unvested	2,243,578	2,247,578		2,243,578		2,125,291	52,596	52,596
Weighted-average grant date fair value, Vested	$ 33.02	$ 33.04		$ 33.02		$ 27.92	$ 31.67	$ 31.67
Contractual term of option granted															10 years	8 years	10 years
Accounting For Stock Based Compensation (Textuals) [Abstract]
Weighted Average Period in months				26
Weighted-average grant date fair value of stock options	$ 8.89		$ 10.07	$ 10.29	$ 8.54
Aggregate intrinsic value of options exercised	200,000		18,600,000	6,100,000	28,200,000
Share equivalent units, Deferred in the plan	22,318			22,318
Aggregate fair value, Deferred in the plan	$ 600,000			$ 600,000
Valuation method used to estimate the fair value of stock options				Black Scholes option pricing model

XML



Comprehensive Income (Tables)

6 Months Ended

Jun. 30, 2011

Stockholders' Equity & Comprehensive Income [Abstract]

Components of comprehensive income, net of related taxes

	Three Months Ended						Six Months Ended
	June 30,						June 30,
	2011			2010			2011		2010
Net income	$	53,547		$	86,342		$	131,872	$	171,338
Net change in fair value of interest rate swaps		(8,969	)		(33,694	)		27,477		(45,051	)
Net change in fair value of available-for-sale securities		268			476			1,338		630
Amortization and recognition of unrecognized pension cost components		807			758			1,579		5,233
Comprehensive income		45,653			53,882			162,266		132,150
Less: Comprehensive income attributable to noncontrolling interests		18,158			16,277			35,159		31,266
Comprehensive income attributable to Community Health Systems, Inc.	$	27,495		$	37,605		$	127,107	$	100,884

XML



Fair Value of Financial Instruments (Details Textual) (USD $) In Millions	Jun. 30, 2011
Fair Value of Financial Instruments (Textuals) [Abstract]
Interest expenses due to spread between fixed and floating rates	$ 176.7

XML



Fair Value (Details 1) (Fair Value, Measurements, Nonrecurring [Member], USD $) In Thousands	Jun. 30, 2011
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Hospitals held for sale	$ 122,632
Total	122,632
Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Hospitals held for sale	0
Total	0
Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Hospitals held for sale	0
Total	0
Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Hospitals held for sale	122,632
Total	$ 122,632

XML



Equity Investments (Details Textual) (USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2011	Jun. 30, 2010	Jun. 30, 2011	Jun. 30, 2010	Dec. 31, 2010
Additional Equity Investments (Textuals) [Abstract]
Total company's investment	$ 421,000,000		$ 421,000,000		$ 409,500,000
Income from equity methods investments	$ 12,017,000	$ 10,980,000	$ 30,151,000	$ 23,570,000
Four Hospitals in Las Vegas, Nevada [Member]
Equity Investments (Textuals) [Abstract]
Company owned equity interests	27.50%		27.50%
One Hospital in Las Vegas, Nevada [Member]
Equity Investments (Textuals) [Abstract]
Company owned equity interests	26.10%		26.10%
Three Hospitals in Macon Georgia, [Member]
Equity Investments (Textuals) [Abstract]
Company owned equity interests	38.00%		38.00%

XML



Contingencies (Details) (USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2011	Jun. 30, 2010	Jun. 30, 2011	Jun. 30, 2010	Jan. 22, 2008	Oct. 04, 2007
Pre tax charges in connection with lawsuits
Professional fees and other related costs	$ 6,174,000	$ 0	$ 6,174,000	$ 0
Contingencies (Textuals) [Abstract]
Number of New Mexico hospitals violated the norms under Federal False Claims Act						3
Civil Division notified that hospitals received ineligible federal participation payments					$ 27,500,000

XML



Acquisitions and Divestitures

6 Months Ended

Jun. 30, 2011

Acquisitions and Divestitures [Abstract]

ACQUISITIONS AND DIVESTITURES

5. ACQUISITIONS AND DIVESTITURES

   Acquisitions

     The Company accounts for all transactions that represent business combinations after January 1, 2009 using the acquisition method of accounting, where the identifiable assets acquired, the liabilities assumed and any noncontrolling interest in the acquired entity are recognized and measured at their fair values on the date the Company obtains control in the acquiree. Such fair values that are not finalized for reporting periods following the acquisition date are estimated and recorded as provisional amounts. Adjustments to these provisional amounts during the measurement period (defined as the date through which all information required to identify and measure the consideration transferred, the assets acquired, the liabilities assumed and any noncontrolling interests has been obtained, limited to one year from the acquisition date) are recorded as of the date of acquisition. Any material impact to comparative information for periods after acquisition, but before the period in which adjustments are identified, is reflected in those prior periods as if the adjustments were considered as of the acquisition date. Goodwill is determined as the excess of the fair value of the consideration conveyed in the acquisition over the fair value of the net assets acquired.

     Effective May 1, 2011, one or more subsidiaries of the Company completed the acquisition of Mercy Health Partners based in Scranton, Pennsylvania, a healthcare system of two acute care hospitals, a long-term acute care facility and other healthcare providers. This healthcare system includes Regional Hospital of Scranton (198 licensed beds) located in Scranton, Pennsylvania, and Tyler Memorial Hospital (48 licensed beds) located in Tunkhannock, Pennsylvania. This healthcare system also includes a long-term acute care facility, Special Care Hospital (67 licensed beds) located in Nanticoke, Pennsylvania, as well as several outpatient clinics and other ancillary facilities. The total cash consideration paid for fixed assets was approximately $150.5 million, with additional consideration of $12.3 million assumed in liabilities as well as a credit applied at closing of $2.1 million for negative acquired working capital, for a total consideration of $160.7 million. Based upon the Company’s preliminary purchase price allocation relating to this acquisition as of June 30, 2011, approximately $42.1 million of goodwill has been recorded. The preliminary allocation of the purchase price has been determined by the Company based on available information and is subject to settling amounts related to purchased working capital and final appraisals of tangible and intangible assets. Adjustments to the purchase price allocation are not expected to be material.

     Effective October 1, 2010, one or more subsidiaries of the Company completed the acquisition of Forum Health based in Youngstown, Ohio, a healthcare system of two acute care hospitals, a rehabilitation hospital and other healthcare providers. This healthcare system includes Northside Medical Center (355 licensed beds) located in Youngstown, Ohio, and Trumbull Memorial Hospital (311 licensed beds) located in Warren, Ohio. This healthcare system also includes Hillside Rehabilitation Hospital (69 licensed beds) located in Warren, Ohio, as well as several outpatient clinics and other ancillary facilities. The total cash consideration paid for fixed assets and working capital was approximately $93.4 million and $27.8 million, respectively, with additional consideration of $40.3 million assumed in liabilities, for a total consideration of $161.5 million. Based upon the Company’s final purchase price allocation relating to this acquisition as of June 30, 2011, approximately $8.1 million of goodwill has been recorded.

     Effective October 1, 2010, one or more subsidiaries of the Company completed the acquisition of Bluefield Regional Medical Center (240 licensed beds) located in Bluefield, West Virginia. The total cash consideration paid for fixed assets was approximately $35.4 million, with additional consideration of $8.9 million assumed in liabilities as well as a credit applied at closing of $1.8 million for negative acquired working capital, for a total consideration of $42.5 million. Based upon the Company’s final purchase price allocation relating to this acquisition as of June 30, 2011, approximately $2.4 million of goodwill has been recorded.

     Effective July 7, 2010, one or more subsidiaries of the Company completed the acquisition of Marion Regional Healthcare System located in Marion, South Carolina. This healthcare system includes Marion Regional Hospital (124 licensed beds), an acute care hospital, along with a related skilled nursing facility and other ancillary services. The total cash consideration paid for fixed assets and working capital was approximately $18.6 million and $5.8 million, respectively, with additional consideration of $3.9 million assumed in liabilities, for a total consideration of $28.3 million. Based upon the Company’s final purchase price allocation relating to this acquisition as of June 30, 2011, no goodwill has been recorded.

     Additionally, during the six months ended June 30, 2011, the Company paid approximately $55.1 million to acquire the operating assets and related businesses of certain physician practices, clinics and other ancillary businesses that operate within the communities served by its hospitals. In connection with these acquisitions, the Company allocated approximately $14.7 million of the consideration paid to property and equipment, $3.4 million to net working capital, $1.5 million to other intangible assets, and the remainder, approximately $35.5 million consisting of intangible assets that do not qualify for separate recognition, was allocated to goodwill.

     Approximately $5.3 million and $1.2 million of acquisition costs related to prospective and closed acquisitions were expensed during the three months ended June 30, 2011 and 2010, respectively, and $8.7 million and $1.8 million during the six months ended June 30, 2011 and 2010, respectively.

   Discontinued Operations

     Effective February 1, 2011, the Company sold Willamette Community Medical Group, which is a physician clinic operating as Oregon Medical Group (“OMG”), located in Springfield, Oregon, with a carrying amount of net assets, including an allocation of reporting unit goodwill, of $19.7 million to Oregon Healthcare Resources, LLC, for $14.6 million in cash.

     In March 2011, the Company made the decision to sell one of its hospitals. In June 2011, the Company entered into a definitive agreement to sell two of its hospitals. Accordingly, these three hospitals are classified as held for sale at June 30, 2011.

     The Company has classified the results of operations for OMG and the three hospitals held for sale as discontinued operations in the accompanying condensed consolidated statements of income for the three and six months ended June 30, 2011 and 2010.

     Net operating revenues and loss from discontinued operations for the respective periods are as follows (in thousands):

	Three Months Ended						Six Months Ended
	June 30,						June 30,
	2011			2010			2011			2010
Net operating revenues	$	68,479		$	90,378		$	140,563		$	182,448
Income (loss) from operations of entities sold and held for sale before income taxes		392			(3,232	)		(2,280	)		(1,994	)
Impairment of hospitals held for sale		(38,600	)		—			(51,695	)		—
Loss on sale		—			—			(5,061	)		—
Loss from discontinued operations, before taxes		(38,208	)		(3,232	)		(59,036	)		(1,994	)
Income tax expense (benefit)		1,119			(1,195	)		(6,429	)		(596	)
Loss from discontinued operations, net of taxes	$	(39,327	)	$	(2,037	)	$	(52,607	)	$	(1,398	)

     Interest expense was allocated to discontinued operations based on sale proceeds available for debt repayment.

     The long-lived assets and allocated goodwill as of December 31, 2010 of the physician clinic sold during the quarter ended March 31, 2011 and the three hospitals classified as held for sale at June 30, 2011 totaled approximately $182.7 million, and are included in the accompanying condensed consolidated balance sheet in other assets, net.

     The long-lived assets and allocated goodwill as of June 30, 2011 of the three hospitals held for sale, net of impairment, totaled approximately $122.6 million and are included in the accompanying condensed consolidated balance sheet in other assets, net.

XML



Acquisitions and Divestitures (Details) (USD $)	3 Months Ended		6 Months Ended												1 Months Ended	6 Months Ended
	Jun. 30, 2011	Jun. 30, 2010	Jun. 30, 2011	Jun. 30, 2010	Dec. 31, 2010	Jun. 30, 2011 Mercy health partners [Member]	May 01, 2011 Mercy health partners [Member]	Jun. 30, 2011 Youngstown Ohio [Member]	Oct. 01, 2010 Youngstown Ohio [Member]	Jun. 30, 2011 Bluefield Regional Medical Center [Member]	Oct. 01, 2010 Bluefield Regional Medical Center [Member]	Jun. 30, 2011 Marion Regional Healthcare System [Member]	Jul. 07, 2010 Marion Regional Healthcare System [Member]	Jun. 30, 2011 Physician practices, clinics and other ancillary businesses [Member]	Jan. 31, 2011 Oregon Healthcare Resources LLC [Member]	Jun. 30, 2011 Oregon Healthcare Resources LLC [Member]
Net operating revenues and income from discontinued operations
Net operating revenues	$ 68,479,000	$ 90,378,000	$ 140,563,000	$ 182,448,000
Income (loss) from operations of entities sold or held for sale before income taxes	392,000	(3,232,000)	(2,280,000)	(1,994,000)
Impairment of hospitals held for sale	38,600,000		51,695,000
Loss on sale			(5,061,000)
Loss from discontinued operations, before taxes	(38,208,000)	(3,232,000)	(59,036,000)	(1,994,000)
Income taxes expense (benefit)	1,119,000	(1,195,000)	(6,429,000)	(596,000)
Loss from discontinued operations, net of taxes	(39,327,000)	(2,037,000)	(52,607,000)	(1,398,000)
Acquisitions and Divestitures (Textuals) [Abstract]
Cash paid for fixed assets							150,500,000		93,400,000		35,400,000		18,600,000
Purchase price allocation to property and equipment														14,700,000
Purchase price for physician practices, clinics, and other ancillary businesses														55,100,000
Cash paid for working capital							(2,100,000)		27,800,000		(1,800,000)		5,800,000
Purchase price allocation to net working capital														3,400,000
Assumed liabilities in business combination							12,300,000		40,300,000		8,900,000		3,900,000
Total Consideration							160,700,000		161,500,000		42,500,000		28,300,000
Purchase price allocation to Goodwill						42,100,000		8,100,000		2,400,000		0		35,500,000
Purchase price to other intangible assets														1,500,000
Acquisition costs related to prospective and closed acquisitions expensed	5,300,000	1,200,000	8,700,000	1,800,000
Carrying amount of net assets including allocation of reporting unit goodwill															19.7
Cash consideration			18,464,000													14,600,000
Long-lived assets of hospitals held for sale	$ 122,600,000		$ 122,600,000		$ 182,700,000

XML



Goodwill and Other Intangibles Assets (Tables)

6 Months Ended

Jun. 30, 2011

Goodwill and Other Intangible Assets [Abstract]

Carrying amount of goodwill

Balance as of December 31, 2010 (as previously reported)	$	4,199,905
Goodwill allocated to disposal and hospitals held for sale		(49,658	)
Balance as of December 31, 2010 (as adjusted)		4,150,247
Goodwill acquired as part of acquisitions during 2011		77,760
Consideration adjustments and purchase price allocation adjustments for prior year’s acquisitions		(37	)
Balance as of June 30, 2011	$	4,227,970

XML



Supplemental Condensed Consolidating Financial Information (Details 1) (USD $) In Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2011	Jun. 30, 2010	Jun. 30, 2011	Jun. 30, 2010
Condensed Consolidated Statements of Income (Unaudited)
Net operating revenues	$ 3,433,829	$ 3,080,646	$ 6,787,881	$ 6,149,258
Operating costs and expenses:
Salaries and benefits	1,384,096	1,231,559	2,763,463	2,478,240
Provision for bad debts	433,002	367,002	832,971	733,503
Supplies	449,279	430,574	907,096	852,686
Other operating expenses	654,737	559,962	1,269,530	1,116,581
Rent	62,431	60,851	125,601	122,908
Depreciation and amortization	161,376	149,779	319,531	293,682
Total operating costs and expenses	3,144,921	2,799,727	6,218,192	5,597,600
Income from operations	288,908	280,919	569,689	551,658
Interest expense, net	163,230	160,759	326,448	320,182
Equity in earnings of unconsolidated affiliates	(12,017)	(10,980)	(30,151)	(23,570)
Income from continuing operations before income taxes	137,695	131,140	273,392	255,046
Provision for (benefit from) income taxes	44,821	42,761	88,913	82,310
Income from continuing operations	92,874	88,379	184,479	172,736
Discontinued operations, net of taxes:
Income (loss) from operations of entities sold and held for sale	235	(2,037)	(1,443)	(1,398)
Impairment of hospitals held for sale	(39,562)		(47,930)
Loss on sale			(3,234)
Loss from discontinued operations, net of taxes	(39,327)	(2,037)	(52,607)	(1,398)
Net income	53,547	86,342	131,872	171,338
Less: Net income attributable to noncontrolling interests	18,158	16,277	35,159	31,266
Net income attributable to Community Health Systems, Inc.	35,389	70,065	96,713	140,072
Parent Guarantor [Member]
Operating costs and expenses:
Equity in earnings of unconsolidated affiliates	(35,389)	(70,065)	(96,713)	(140,072)
Income from continuing operations before income taxes	35,389	70,065	96,713	140,072
Provision for (benefit from) income taxes	0
Income from continuing operations	35,389	70,065	96,713	140,072
Discontinued operations, net of taxes:
Net income	35,389	70,065	96,713	140,072
Net income attributable to Community Health Systems, Inc.	35,389	70,065	96,713	140,072
Issuer [Member]
Operating costs and expenses:
Interest expense, net	22,212	28,433	50,315	57,447
Equity in earnings of unconsolidated affiliates	(39,072)	(82,583)	(114,604)	(166,296)
Income from continuing operations before income taxes	16,860	54,150	64,289	108,849
Provision for (benefit from) income taxes	(18,529)	(15,915)	(32,424)	(31,223)
Income from continuing operations	35,389	70,065	96,713	140,072
Discontinued operations, net of taxes:
Net income	35,389	70,065	96,713	140,072
Net income attributable to Community Health Systems, Inc.	35,389	70,065	96,713	140,072
Other Guarantors [Member]
Condensed Consolidated Statements of Income (Unaudited)
Net operating revenues	2,002,412	1,770,800	3,932,956	3,546,129
Operating costs and expenses:
Salaries and benefits	767,262	663,919	1,510,301	1,342,015
Provision for bad debts	259,583	220,065	499,434	442,530
Supplies	262,909	242,931	525,911	482,632
Other operating expenses	393,916	309,698	738,800	613,430
Rent	31,007	28,838	61,608	58,253
Depreciation and amortization	95,559	86,401	189,419	170,605
Total operating costs and expenses	1,810,236	1,551,852	3,525,473	3,109,465
Income from operations	192,176	218,948	407,483	436,664
Interest expense, net	123,347	118,682	244,740	235,294
Equity in earnings of unconsolidated affiliates	(45,752)	(27,298)	(77,710)	(50,851)
Income from continuing operations before income taxes	114,581	127,564	240,453	252,221
Provision for (benefit from) income taxes	41,364	46,694	86,803	92,817
Income from continuing operations	73,217	80,870	153,650	159,404
Discontinued operations, net of taxes:
Income (loss) from operations of entities sold and held for sale	2,813	1,789	4,158	6,231
Impairment of hospitals held for sale			(47,930)
Loss from discontinued operations, net of taxes	(36,749)	1,789	(43,772)	6,231
Net income	36,468	82,659	109,878	165,635
Net income attributable to Community Health Systems, Inc.	36,468	82,659	109,878	165,635
Non-Guarantors [Member]
Condensed Consolidated Statements of Income (Unaudited)
Net operating revenues	1,431,417	1,309,846	2,854,925	2,603,129
Operating costs and expenses:
Salaries and benefits	616,834	567,640	1,253,162	1,136,225
Provision for bad debts	173,419	146,937	333,537	290,973
Supplies	186,370	187,643	381,185	370,054
Other operating expenses	260,821	250,264	530,730	503,151
Rent	31,424	32,013	63,993	64,655
Depreciation and amortization	65,817	63,378	130,112	123,077
Total operating costs and expenses	1,334,685	1,247,875	2,692,719	2,488,135
Income from operations	96,732	61,971	162,206	114,994
Interest expense, net	17,671	13,644	31,393	27,441
Equity in earnings of unconsolidated affiliates	0
Income from continuing operations before income taxes	79,061	48,327	130,813	87,553
Provision for (benefit from) income taxes	21,986	11,982	34,534	20,716
Income from continuing operations	57,075	36,345	96,279	66,837
Discontinued operations, net of taxes:
Income (loss) from operations of entities sold and held for sale	(2,578)	(3,826)	(5,601)	(7,629)
Loss on sale			(3,234)
Loss from discontinued operations, net of taxes	(2,578)	(3,826)	(8,835)	(7,629)
Net income	54,497	32,519	87,444	59,208
Less: Net income attributable to noncontrolling interests	18,158	16,277	35,159	31,266
Net income attributable to Community Health Systems, Inc.	36,339	16,242	52,285	27,942
Eliminations [Member]
Condensed Consolidated Statements of Income (Unaudited)
Net operating revenues	0
Operating costs and expenses:
Salaries and benefits	0
Provision for bad debts	0
Supplies	0
Other operating expenses	0
Rent	0
Depreciation and amortization	0
Total operating costs and expenses	0
Income from operations	0
Interest expense, net	0
Equity in earnings of unconsolidated affiliates	108,196	168,966	258,876	333,649
Income from continuing operations before income taxes	(108,196)	(168,966)	(258,876)	(333,649)
Provision for (benefit from) income taxes	0
Income from continuing operations	(108,196)	(168,966)	(258,876)	(333,649)
Discontinued operations, net of taxes:
Net income	(108,196)	(168,966)	(258,876)	(333,649)
Less: Net income attributable to noncontrolling interests	0
Net income attributable to Community Health Systems, Inc.	$ (108,196)	$ (168,966)	$ (258,876)	$ (333,649)

XML



Recent Accounting Pronouncements (Details) (USD $) In Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2011	Jun. 30, 2010	Jun. 30, 2011	Jun. 30, 2010
Charity Care [Abstract]
Estimated cost incurred patients unable to pay	$ 28.0	$ 25.3	$ 54.1	$ 50.8
Charity Care, Methodology			The estimated cost of these charity care services was determined using a ratio of cost to gross charges and applying that ratio to the gross charges associated with providing care to charity patients for the period
Professional Liability Balance Sheet Disclosure [Abstract]
Increase in the other current assets	2.5		2.5
Increase in the other assets	41.1		41.1
Increase in the long term liabilities	$ 43.6		$ 43.6

XML



Long-Term Debt (Tables)

6 Months Ended

Jun. 30, 2011

Long-Term Debt [Abstract]

Redemption Price of Senior Notes in Long Term Debt

Period	Redemption Price
2011		104.438	%
2012		102.219	%
2013 and thereafter		100.000	%

XML



Cost of Revenue (Details) (USD $) In Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2011	Jun. 30, 2010	Jun. 30, 2011	Jun. 30, 2010
Cost of Revenue (Textuals) [Abstract]
Corporate office costs	$ 47.8	$ 42.4	$ 89.5	$ 80.2
Stock-based compensation expenses	$ 10.8	$ 10.7	$ 20.7	$ 20.4

XML



Stockholders' Equity (Tables)

6 Months Ended

Jun. 30, 2011

Stockholders' Equity & Comprehensive Income [Abstract]

Reconciliation of the carrying amount of total equity, equity attributable to the Company, and equity attributable to the noncontrolling interests

				Community Health Systems, Inc. Stockholders
													Accumulated
	Redeemable						Additional						Other								Total
	Noncontrolling			Common			Paid-in			Treasury			Comprehensive			Retained		Noncontrolling			Stockholders’
	Interests			Stock			Capital			Stock			Income (Loss)			Earnings		Interests			Equity
Balance, December 31, 2010	$	387,472		$	936		$	1,126,751		$	(6,678	)	$	(230,927	)	$	1,299,382	$	60,913		$	2,250,377
Comprehensive income:
Net income		25,211			—			—			—			—			96,713		9,948			106,661
Net change in fair value of interest rate swaps		—			—			—			—			27,477			—		—			27,477
Net change in fair value of available-for-sale securities		—			—			—			—			1,338			—		—			1,338
Amortization and recognition of unrecognized pension cost components		—			—			—			—			1,579			—		—			1,579
Total comprehensive income		25,211			—			—			—			30,394			96,713		9,948			137,055
Distributions to noncontrolling interests, net of contributions		(19,387	)		—			—			—			—			—		(9,828	)		(9,828	)
Purchase of subsidiary shares from noncontrolling interests		(2,792	)		—			(498	)		—			—			—		—			(498	)
Other reclassifications of noncontrolling interests		(2,004	)		—			—			—			—			—		272			272
Adjustment to redemption value of redeemable noncontrolling interests		(11,842	)		—			11,842			—			—			—		—			11,842
Repurchases of common stock		—			(18	)		(50,002	)		—			—			—		—			(50,020	)
Issuance of common stock in connection with the exercise of stock options		—			6			18,831			—			—			—		—			18,837
Cancellation of restricted stock for tax withholdings on vested shares		—			(3	)		(13,110	)		—			—			—		—			(13,113	)
Excess tax benefit from exercise of stock options		—			—			4,659			—			—			—		—			4,659
Share-based compensation		—			11			20,732			—			—			—		—			20,743
Balance, June 30, 2011	$	376,658		$	932		$	1,119,205		$	(6,678	)	$	(200,533	)	$	1,396,095	$	61,305		$	2,370,326

Effects of changes in the ownership interest in less-than-wholly-owned subsidiaries

	Six Months Ended
	June 30, 2011
Net income attributable to Community Health Systems, Inc.	$	96,713
Transfers to the noncontrolling interests:
Net decrease in Community Health Systems, Inc. paid-in capital for purchase of subsidiary partnership interests		(498	)
Net transfers to the noncontrolling interests		(498	)
Change to Community Health Systems, Inc. stockholders’ equity from net income attributable to Community Health Systems, Inc. and transfers to noncontrolling interests	$	96,215

XML



Fair Value of Financial Instruments

6 Months Ended

Jun. 30, 2011

Fair Value of Financial Instruments [Abstract]

FAIR VALUE OF FINANCIAL INSTRUMENTS

13. FAIR VALUE OF FINANCIAL INSTRUMENTS

     The fair value of financial instruments has been estimated by the Company using available market information as of June 30, 2011 and December 31, 2010, and valuation methodologies considered appropriate. The estimates presented are not necessarily indicative of amounts the Company could realize in a current market exchange (in thousands):

	June 30, 2011				December 31, 2010
	Carrying		Estimated Fair		Carrying		Estimated Fair
	Amount		Value		Amount		Value
Assets:
Cash and cash equivalents	$	191,432	$	191,432	$	299,169	$	299,169
Available-for-sale securities		33,097		33,097		31,570		31,570
Trading securities		38,709		38,709		35,092		35,092
Liabilities:
Credit Facility		5,974,321		5,806,274		5,999,337		5,882,124
Senior notes		2,784,331		2,846,978		2,784,331		2,923,548
Other debt		43,478		43,478		36,122		36,122

     Cash and cash equivalents. The carrying amount approximates fair value due to the short-term maturity of these instruments (less than three months).

     Available-for-sale securities. Estimated fair value is based on closing price as quoted in public markets.

     Trading securities. Estimated fair value is based on closing price as quoted in public markets.

     Credit Facility. Estimated fair value is based on information from the Company’s bankers regarding relevant pricing for trading activity among the Company’s lending institutions.

     Senior notes. Estimated fair value is based on the average bid and ask price as quoted by the bank who served as underwriter in the sale of these notes.

     Other debt. The carrying amount of all other debt approximates fair value due to the nature of these obligations.

     Interest rate swaps. The fair value of interest rate swap agreements is the amount at which they could be settled, based on estimates calculated by the Company using a discounted cash flow analysis based on observable market inputs and validated by comparison to estimates obtained from the counterparty. The Company incorporates credit valuation adjustments (“CVAs”) to appropriately reflect both its own nonperformance or credit risk and the respective counterparty’s nonperformance or credit risk in the fair value measurements. In adjusting the fair value of its interest rate swap agreements for the effect of nonperformance or credit risk, the Company has considered the impact of any netting features included in the agreements.

     The Company assesses the effectiveness of its hedge instruments on a quarterly basis. For the three and six months ended June 30, 2011 and 2010, the Company completed an assessment of the cash flow hedge instruments and determined the hedges to be highly effective. The Company has also determined that the ineffective portion of the hedges do not have a material effect on the Company’s consolidated financial position, operations or cash flows. The counterparties to the interest rate swap agreements expose the Company to credit risk in the event of nonperformance. However, at June 30, 2011, each swap agreement entered into by the Company was in a net liability position so that the Company would be required to make the net settlement payments to the counterparties; the Company does not anticipate nonperformance by those counterparties. The Company does not hold or issue derivative financial instruments for trading purposes.

     Interest rate swaps consisted of the following at June 30, 2011:

	Notional
	Amount		Fixed Interest			Termination	Fair Value
Swap #	(in 000’s)		Rate			Date	(in 000’s)
1	$	300,000		5.1140	%	August 8, 2011	$	1,533
2		100,000		4.7185	%	August 19, 2011		605
3		100,000		4.7040	%	August 19, 2011		603
4		100,000		4.6250	%	August 19, 2011		592
5		200,000		4.9300	%	August 30, 2011		1,551
6		200,000		3.0920	%	September 18, 2011		1,248
7		100,000		3.0230	%	October 23, 2011		869
8		200,000		4.4815	%	October 26, 2011		2,712
9		200,000		4.0840	%	December 3, 2011		3,279
10		100,000		3.8470	%	January 4, 2012		1,822
11		100,000		3.8510	%	January 4, 2012		1,824
12		100,000		3.8560	%	January 4, 2012		1,826
13		200,000		3.7260	%	January 8, 2012		3,610
14		200,000		3.5065	%	January 16, 2012		3,514
15		250,000		5.0185	%	May 30, 2012		10,654
16		150,000		5.0250	%	May 30, 2012		6,401
17		200,000		4.6845	%	September 11, 2012		10,208
18		100,000		3.3520	%	October 23, 2012		3,798
19		125,000		4.3745	%	November 23, 2012		6,794
20		75,000		4.3800	%	November 23, 2012		4,082
21		150,000		5.0200	%	November 30, 2012		9,618
22		200,000		2.2420	%	February 28, 2013		5,561
23		100,000		5.0230	%	May 30, 2013		8,262
24		300,000		5.2420	%	August 6, 2013		27,964
25		100,000		5.0380	%	August 30, 2013		9,101
26		50,000		3.5860	%	October 23, 2013		3,130
27		50,000		3.5240	%	October 23, 2013		3,063
28		100,000		5.0500	%	November 30, 2013		9,857
29		200,000		2.0700	%	December 19, 2013		5,715
30		100,000		5.2310	%	July 25, 2014		11,994
31		100,000		5.2310	%	July 25, 2014		11,998
32		200,000		5.1600	%	July 25, 2014		23,584
33		75,000		5.0405	%	July 25, 2014		8,571
34		125,000		5.0215	%	July 25, 2014		14,218
35		100,000		2.6210	%	July 25, 2014		4,349
36		100,000		3.1100	%	July 25, 2014		5,788
37		100,000		3.2580	%	July 25, 2014		6,222
38		200,000		2.6930	%	October 26, 2014		7,504	(1)
39		300,000		3.4470	%	August 8, 2016		18,662	(2)
40		200,000		3.4285	%	August 19, 2016		12,096	(3)
41		100,000		3.4010	%	August 19, 2016		6,019	(4)
42		200,000		3.5000	%	August 30, 2016		12,529	(5)
43		100,000		3.0050	%	November 30, 2016		4,196

(1)	This interest rate swap becomes effective October 26, 2011, concurrent with the termination of swap #8.
(2)	This interest rate swap becomes effective August 8, 2011, concurrent with the termination of swap #1.
(3)	This interest rate swap becomes effective August 19, 2011, concurrent with the termination of swaps #2 and #4.
(4)	This interest rate swap becomes effective August 19, 2011, concurrent with the termination of swap #3.
(5)	This interest rate swap becomes effective August 30, 2011, concurrent with the termination of swap #5.

     The Company is exposed to certain risks relating to its ongoing business operations. The risk managed by using derivative instruments is interest rate risk. Interest rate swaps are entered into to manage interest rate fluctuation risk associated with the term loans in the Credit Facility. Companies are required to recognize all derivative instruments as either assets or liabilities at fair value in the condensed consolidated balance sheet. The Company designates its interest rate swaps as cash flow hedges. For derivative instruments that are designated and qualify as cash flow hedges, the effective portion of the gain or loss on the derivative is reported as a component of other comprehensive income (“OCI”) and reclassified into earnings in the same period or periods during which the hedged transactions affect earnings. Gains and losses on the derivative representing either hedge ineffectiveness or hedge components excluded from the assessment of effectiveness are recognized in current earnings.

     Assuming no change in June 30, 2011 interest rates, approximately $176.7 million of interest expense resulting from the spread between the fixed and floating rates defined in each interest rate swap agreement will be recognized during the next 12 months. If interest rate swaps do not remain highly effective as a cash flow hedge, the derivatives’ gains or losses resulting from the change in fair value reported through OCI will be reclassified into earnings.

     The following tabular disclosure provides the amount of pre-tax loss recognized in the condensed consolidated balance sheets as a component of OCI during the three and six months ended June 30, 2011 and 2010 (in thousands):

Derivatives in Cash Flow Hedging	Amount of Pre-Tax Loss Recognized in OCI on Derivative (Effective Portion)
Relationships	Three Months Ended June 30,						Six Months Ended June 30,
	2011			2010			2011			2010
Interest rate swaps	$	(67,685	)	$	(107,656	)	$	(63,572	)	$	(178,564	)

     The following tabular disclosure provides the location of the effective portion of the pre-tax loss reclassified from accumulated other comprehensive loss (“AOCL”) into interest expense on the condensed consolidated statements of income during the three and six months ended June 30, 2011 and 2010 (in thousands):

Location of Loss Reclassified from
AOCL into Income (Effective	Amount of Pre-Tax Loss Reclassified from AOCL into Income (Effective Portion)
Portion)	Three Months Ended June 30,				Six Months Ended June 30,
	2011		2010		2011		2010
Interest expense, net	$	53,649	$	55,009	$	106,573	$	108,173

     The fair values of derivative instruments in the condensed consolidated balance sheets as of June 30, 2011 and December 31, 2010 were as follows (in thousands):

Asset Derivatives

Liability Derivatives

June 30, 2011

December 31, 2010

June 30, 2011

December 31, 2010

Balance

Balance

Balance

Balance

Sheet

Fair

Sheet

Fair

Sheet

Fair

Sheet

Fair

Location

Value

Location

Value

Location

Value

Location

Value

Derivatives designated as hedging instruments

Other assets, net

$

—

Other assets, net

$

—

Other long-term liabilities

$

297,526

Other long-term liabilities

$

340,526

XML



Fair Value of Financial Instruments (Details 2) (USD $) In Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2011	Jun. 30, 2010	Jun. 30, 2011	Jun. 30, 2010
Derivatives in Cash Flow Hedging Relationships [Member] | Interest rate swaps [Member]
Amount of pre-tax loss recognized in the condensed consolidated balance sheets as a component of other comprehensive income
Amount of Pre-Tax Gain (Loss) Recognized in OCI on Derivative (Effective Portion)	$ (67,685)	$ (107,656)	$ (63,572)	$ (178,564)
Interest expense, net [Member]
Effective portion of the pre-tax loss reclassified from accumulated other comprehensive loss ("OCL') into interest expense on the condensed consolidated statements of income
Amount of Pre-Tax Loss Reclassified from AOCL into Income (Effective Portion)	$ 53,649	$ 55,009	$ 106,573	$ 108,173

XML



Fair Value (Details Textual) (USD $)	3 Months Ended	6 Months Ended
	Jun. 30, 2011	Jun. 30, 2011	Dec. 31, 2010
Fair Value (Textuals) [Abstract]
Decrease in fair value of liability related to interest rate swap agreements	$ 11,600,000	$ 11,600,000	$ 3,900,000
After tax adjustment to other comprehensive due to interest rate swap agreement	7,400,000	7,400,000	2,500,000
Impairment charge , after tax	39,562,000	47,930,000
Disposal Group, Including Discontinued Operation, Goodwill Allocated Prior to Impairment	$ 45,300,000	$ 45,300,000

XML



Income Taxes

6 Months Ended

Jun. 30, 2011

Income Taxes [Abstract]

INCOME TAXES

6. INCOME TAXES

     The total amount of unrecognized benefit that would affect the effective tax rate, if recognized, was approximately $7.7 million as of June 30, 2011. It is the Company’s policy to recognize interest and penalties related to unrecognized benefits in its condensed consolidated statements of income as income tax expense. During the six months ended June 30, 2011, the Company increased liabilities by $0.1 million and increased interest and penalties by approximately $0.2 million. A total of approximately $1.5 million of interest and penalties is included in the amount of the liability for uncertain tax positions at June 30, 2011.

     The Company believes that it is reasonably possible that approximately $2.3 million of its current unrecognized tax benefit may be recognized within the next 12 months as a result of a lapse of the statute of limitations and settlements with taxing authorities.

     The Company, or one of its subsidiaries, files income tax returns in the U.S. federal jurisdiction and various state jurisdictions. The Company has extended the federal statute of limitations for Triad Hospitals, Inc. (“Triad”) for the tax periods ended December 31, 1999, December 31, 2000, April 30, 2001, June 30, 2001, December 31, 2001, December 31, 2002 and December 31, 2003. The Company is currently under examination by the Internal Revenue Service (“IRS”) regarding the federal tax return of Triad for the tax periods ended December 31, 2004, December 31, 2005, December 31, 2006 and July 25, 2007. The Company believes the results of this examination will not be material to its consolidated results of operations or consolidated financial position. With few exceptions, the Company is no longer subject to state income tax examinations for years prior to 2007 and federal income tax examinations with respect to Community Health Systems, Inc. federal returns for years prior to 2007. The Company’s federal income tax returns for the 2007 and 2008 tax years are currently under examination by the IRS. The Company believes the results of this examination will not be material to its consolidated results of operations or consolidated financial position.

     Cash paid for income taxes, net of refunds received, resulted in a net cash refund of $25.0 million and net cash paid of $78.8 million for the three months ended June 30, 2011 and June 30, 2010, respectively. Cash paid for income taxes, net of refunds received, resulted in a net cash refund of $25.7 million and net cash paid of $79.7 million for the six months ended June 30, 2011 and June 30, 2010, respectively.

XML



Segment Information

6 Months Ended

Jun. 30, 2011

Segment Information [Abstract]

SEGMENT INFORMATION

16. SEGMENT INFORMATION

     The Company operates in three distinct operating segments, represented by hospital operations (which includes its general acute care hospitals and related healthcare entities that provide inpatient and outpatient healthcare services), home care agency operations (which provide in-home outpatient care), and hospital management services (which provides executive management and consulting services to non-affiliated acute care hospitals). Only the hospital operations segment meets the criteria as a separate reportable segment. The financial information for the home care agencies and hospital management services segments do not meet the quantitative thresholds for a separate identifiable reportable segment and are combined into the corporate and all other reportable segment.

     The distribution between reportable segments of the Company’s revenues and income from continuing operations before income taxes is summarized in the following tables (in thousands):

	Three Months Ended						Six Months Ended
	June 30,						June 30,
	2011			2010			2011			2010
Revenues:
Hospital operations	$	3,361,706		$	3,018,147		$	6,646,174		$	6,018,587
Corporate and all other		72,123			62,499			141,707			130,671
Total	$	3,433,829		$	3,080,646		$	6,787,881		$	6,149,258
Income from continuing operations before income taxes:
Hospital operations	$	184,426		$	171,711		$	362,539		$	331,010
Corporate and all other		(46,731	)		(40,571	)		(89,147	)		(75,964	)
Total	$	137,695		$	131,140		$	273,392		$	255,046

XML



Supplemental Condensed Consolidating Financial Information (Details) (USD $) In Thousands	Jun. 30, 2011	Dec. 31, 2010	Jun. 30, 2010	Dec. 31, 2009
Current assets
Cash and cash equivalents	$ 191,432	$ 299,169	$ 548,754	$ 344,541
Patient accounts receivable, net of allowance for doubtful accounts	1,792,404	1,714,542
Supplies	342,268	329,114
Deferred income taxes	115,819	115,819
Prepaid expenses and taxes	117,458	100,754
Other current assets	175,109	193,331
Total current assets	2,734,490	2,871,193
Intercompany receivable	0	0
Property and equipment	6,506,424	6,324,437
Goodwill	4,227,970	4,150,247
Other assets, net of accumulated amortization	1,356,531	1,352,246
Net investment in subsidiaries	0	0
Total assets	14,825,415	14,698,123
Current liabilities
Current maturities of long-term debt	70,112	63,139
Accounts payable	583,924	526,338
Current income tax payable	349	0
Deferred income taxes	8,882	8,882
Accrued interest	145,146	146,415
Accrued liabilities	854,329	897,266
Total current liabilities	1,662,742	1,642,040
Long-term debt	8,781,443	8,808,382
Intercompany payable	0	0
Deferred income taxes	608,177	608,177
Other long-term liabilities	1,026,069	1,001,675
Total liabilities	12,078,431	12,060,274
Redeemable noncontrolling interests in equity of consolidated subsidiaries	376,658	387,472
Community Health Systems, Inc. stockholders' equity
Preferred stock	0	0
Common stock	932	936
Additional paid-in capital	1,119,205	1,126,751
Treasury stock, at cost, 975,549 shares at June 30, 2011 and December 31, 2010	(6,678)	(6,678)
Accumulated other comprehensive (loss) income	(200,533)	(230,927)
Retained earnings	1,396,095	1,299,382
Total Community Health Systems, Inc. stockholders' equity	2,309,021	2,189,464
Noncontrolling interests in equity of consolidated subsidiaries	61,305	60,913
Total equity	2,370,326	2,250,377
Total liabilities and equity	14,825,415	14,698,123
Parent Guarantor [Member]
Current assets
Cash and cash equivalents	0	0
Patient accounts receivable, net of allowance for doubtful accounts	0	0
Supplies	0	0
Deferred income taxes	115,819	115,819
Prepaid expenses and taxes	0	118,464
Other current assets	0	0
Total current assets	115,819	234,283
Intercompany receivable	1,190,786	1,079,295
Property and equipment	0	0
Goodwill	0	0
Other assets, net of accumulated amortization	0	0
Net investment in subsidiaries	1,637,169	1,510,062
Total assets	2,943,774	2,823,640
Current liabilities
Current maturities of long-term debt	0	0
Accounts payable	0	0
Current income tax payable	349
Deferred income taxes	8,882	8,882
Accrued interest	0	0
Accrued liabilities	7,580	7,595
Total current liabilities	16,811	16,477
Long-term debt	0	0
Intercompany payable	0	0
Deferred income taxes	608,177	608,177
Other long-term liabilities	9,765	9,522
Total liabilities	634,753	634,176
Redeemable noncontrolling interests in equity of consolidated subsidiaries	0	0
Community Health Systems, Inc. stockholders' equity
Preferred stock	0	0
Common stock	932	936
Additional paid-in capital	1,119,205	1,126,751
Treasury stock, at cost, 975,549 shares at June 30, 2011 and December 31, 2010	(6,678)	(6,678)
Accumulated other comprehensive (loss) income	(200,533)	(230,927)
Retained earnings	1,396,095	1,299,382
Total Community Health Systems, Inc. stockholders' equity	2,309,021	2,189,464
Noncontrolling interests in equity of consolidated subsidiaries	0	0
Total equity	2,309,021	2,189,464
Total liabilities and equity	2,943,774	2,823,640
Issuer [Member]
Current assets
Cash and cash equivalents	0	0
Patient accounts receivable, net of allowance for doubtful accounts	0	0
Supplies	0	0
Deferred income taxes	0	0
Prepaid expenses and taxes	17	116
Other current assets	0	41
Total current assets	17	157
Intercompany receivable	9,441,127	9,002,158
Property and equipment	0	0
Goodwill	0	0
Other assets, net of accumulated amortization	117,845	131,352
Net investment in subsidiaries	5,856,743	5,315,871
Total assets	15,415,732	14,449,538
Current liabilities
Current maturities of long-term debt	49,954	49,953
Accounts payable	40	0
Current income tax payable	0
Deferred income taxes	0	0
Accrued interest	145,034	146,297
Accrued liabilities	567	567
Total current liabilities	195,595	196,817
Long-term debt	8,709,456	8,734,473
Intercompany payable	4,575,989	3,667,662
Deferred income taxes	0	0
Other long-term liabilities	297,525	340,526
Total liabilities	13,778,565	12,939,478
Redeemable noncontrolling interests in equity of consolidated subsidiaries	0	0
Community Health Systems, Inc. stockholders' equity
Preferred stock	0	0
Common stock	0	0
Additional paid-in capital	663,410	640,683
Treasury stock, at cost, 975,549 shares at June 30, 2011 and December 31, 2010	0	0
Accumulated other comprehensive (loss) income	(200,533)	(230,927)
Retained earnings	1,174,290	1,100,304
Total Community Health Systems, Inc. stockholders' equity	1,637,167	1,510,060
Noncontrolling interests in equity of consolidated subsidiaries	0	0
Total equity	1,637,167	1,510,060
Total liabilities and equity	15,415,732	14,449,538
Other Guarantors [Member]
Current assets
Cash and cash equivalents	80,552	212,035	495,168	238,495
Patient accounts receivable, net of allowance for doubtful accounts	1,043,386	971,220
Supplies	212,873	196,957
Deferred income taxes	0	0
Prepaid expenses and taxes	85,760	89,172
Other current assets	110,501	138,923
Total current assets	1,533,072	1,608,307
Intercompany receivable	1,438,751	1,145,185
Property and equipment	4,069,371	3,816,098
Goodwill	2,380,891	2,331,452
Other assets, net of accumulated amortization	594,289	625,472
Net investment in subsidiaries	2,306,109	2,061,532
Total assets	12,322,483	11,588,046
Current liabilities
Current maturities of long-term debt	17,073	11,063
Accounts payable	402,806	362,154
Current income tax payable	0
Deferred income taxes	0	0
Accrued interest	111	116
Accrued liabilities	576,614	569,991
Total current liabilities	996,604	943,324
Long-term debt	46,194	44,819
Intercompany payable	8,923,510	8,285,414
Deferred income taxes	0	0
Other long-term liabilities	401,585	372,693
Total liabilities	10,367,893	9,746,250
Redeemable noncontrolling interests in equity of consolidated subsidiaries	0	0
Community Health Systems, Inc. stockholders' equity
Preferred stock	0	0
Common stock	1	1
Additional paid-in capital	709,243	682,686
Treasury stock, at cost, 975,549 shares at June 30, 2011 and December 31, 2010	0	0
Accumulated other comprehensive (loss) income	(10,074)	(12,990)
Retained earnings	1,255,420	1,172,099
Total Community Health Systems, Inc. stockholders' equity	1,954,590	1,841,796
Noncontrolling interests in equity of consolidated subsidiaries	0	0
Total equity	1,954,590	1,841,796
Total liabilities and equity	12,322,483	11,588,046
Non-Guarantors [Member]
Current assets
Cash and cash equivalents	110,880	87,134	53,586	106,046
Patient accounts receivable, net of allowance for doubtful accounts	749,018	743,322
Supplies	129,395	132,157
Deferred income taxes	0	0
Prepaid expenses and taxes	31,681	11,466
Other current assets	64,608	54,367
Total current assets	1,085,582	1,028,446
Intercompany receivable	1,534,314	1,484,130
Property and equipment	2,437,053	2,508,339
Goodwill	1,847,079	1,818,795
Other assets, net of accumulated amortization	644,397	595,422
Net investment in subsidiaries	0	0
Total assets	7,548,425	7,435,132
Current liabilities
Current maturities of long-term debt	3,085	2,123
Accounts payable	181,078	164,184
Current income tax payable	0
Deferred income taxes	0	0
Accrued interest	1	2
Accrued liabilities	269,568	319,113
Total current liabilities	453,732	485,422
Long-term debt	25,793	29,090
Intercompany payable	5,979,987	5,911,829
Deferred income taxes	0	0
Other long-term liabilities	317,194	278,934
Total liabilities	6,776,706	6,705,275
Redeemable noncontrolling interests in equity of consolidated subsidiaries	376,658	387,472
Community Health Systems, Inc. stockholders' equity
Preferred stock	0	0
Common stock	2	2
Additional paid-in capital	120,485	103,401
Treasury stock, at cost, 975,549 shares at June 30, 2011 and December 31, 2010	0	0
Accumulated other comprehensive (loss) income	0	0
Retained earnings	213,269	178,069
Total Community Health Systems, Inc. stockholders' equity	333,756	281,472
Noncontrolling interests in equity of consolidated subsidiaries	61,305	60,913
Total equity	395,061	342,385
Total liabilities and equity	7,548,425	7,435,132
Eliminations [Member]
Current assets
Cash and cash equivalents	0	0
Patient accounts receivable, net of allowance for doubtful accounts	0	0
Supplies	0	0
Deferred income taxes	0	0
Prepaid expenses and taxes	0	0
Other current assets	0	0
Total current assets	0	0
Intercompany receivable	(13,604,978)	(12,710,768)
Property and equipment	0	0
Goodwill	0	0
Other assets, net of accumulated amortization	0	0
Net investment in subsidiaries	(9,800,021)	(8,887,465)
Total assets	(23,404,999)	(21,598,233)
Current liabilities
Current maturities of long-term debt	0	0
Accounts payable	0	0
Current income tax payable	0
Deferred income taxes	0	0
Accrued interest	0	0
Accrued liabilities	0	0
Total current liabilities	0	0
Long-term debt	0	0
Intercompany payable	(19,479,486)	(17,964,905)
Deferred income taxes	0	0
Other long-term liabilities	0	0
Total liabilities	(19,479,486)	(17,964,905)
Redeemable noncontrolling interests in equity of consolidated subsidiaries	0	0
Community Health Systems, Inc. stockholders' equity
Preferred stock	0	0
Common stock	(3)	(3)
Additional paid-in capital	(1,493,138)	(1,426,770)
Treasury stock, at cost, 975,549 shares at June 30, 2011 and December 31, 2010	0	0
Accumulated other comprehensive (loss) income	210,607	243,917
Retained earnings	(2,642,979)	(2,450,472)
Total Community Health Systems, Inc. stockholders' equity	(3,925,513)	(3,633,328)
Noncontrolling interests in equity of consolidated subsidiaries	0	0
Total equity	(3,925,513)	(3,633,328)
Total liabilities and equity	$ (23,404,999)	$ (21,598,233)

XML



Segment Information (Details) (USD $) In Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2011	Jun. 30, 2010	Jun. 30, 2011	Jun. 30, 2010
Revenues and Income from continuing operations before income taxes
Total Revenues	$ 3,433,829	$ 3,080,646	$ 6,787,881	$ 6,149,258
Income from continuing operations before income taxes	137,695	131,140	273,392	255,046
Hospital operations [Member]
Revenues and Income from continuing operations before income taxes
Total Revenues	3,361,706	3,018,147	6,646,174	6,018,587
Income from continuing operations before income taxes	184,426	171,711	362,539	331,010
Corporate and all other [Member]
Revenues and Income from continuing operations before income taxes
Total Revenues	72,123	62,499	141,707	130,671
Income from continuing operations before income taxes	$ (46,731)	$ (40,571)	$ (89,147)	$ (75,694)

XML



Accounting for Stock-Based Compensation (Details) (USD $) In Thousands, except Share data, unless otherwise specified	3 Months Ended			6 Months Ended
	Jun. 30, 2011	Mar. 31, 2011	Jun. 30, 2010	Jun. 30, 2011	Jun. 30, 2010	Dec. 31, 2010
Impact of Total Compensation Expense
Effect on income from continuing operations before income taxes	$ (10,814)		$ (10,655)	$ (20,732)	$ (20,418)
Effect on net income	(6,867)		(6,473)	(13,165)	(12,204)
Fair value of stock options
Expected volatility	38.10%		35.30%	31.50%	33.60%
Expected dividends
Expected term	4		3	4	3.1
Risk-free interest rate	1.35%		1.20%	1.73%	1.47%
Options outstanding and exercisable
Beginning Balance, shares	8,503,393	7,834,332		7,834,332
Granted, Shares	45,000	1,329,000
Exercised, Shares	(23,579)	(595,431)
Forfeited and cancelled, Shares	(50,342)	(64,508)
Ending Balance, shares	8,474,472	8,503,393		8,474,472
Beginning of Period, Weighted Average Exercise Price	$ 33.10	$ 32.08		$ 32.08
Granted, Weighted Average Exercise Price	$ 28.12	$ 37.96		$ 28.12
Exercised, Weighted Average Exercise Price	$ 29.98	$ 30.44		$ 29.98
Forfeited and cancelled, Weighted Average Exercise Price	$ 32.70	$ 34.84
End of Period, Weighted Average Exercise Price	$ 33.08	$ 33.10		$ 33.08
Weighted Average Remaining Contractual Term	5.8			5.8
Aggregate Intrinsic Value	9,910			9,910
Exercisable, Shares	5,804,556			5,804,556
Exercisable, Weighted Average Exercise Price	$ 32.78			$ 32.78
Exercisable, Weighted Average Remaining Contractual Term	4.3
Exercisable, Intrinsic Value	7,468			7,468
Restricted stock outstanding
Beginning Balance, Shares	2,247,578	2,125,291		2,125,291
Granted, Shares	8,000	1,084,949
Vested, Shares	(12,000)	(962,662)
Forfeited, Shares
Ending Balance, Shares	2,243,578	2,247,578		2,243,578
Beginning of Period, Weighted Average Grant Date Fair Value	$ 33.04	$ 27.92		$ 27.92
Granted, Weighted Average Grant Date Fair Value	$ 28.12	$ 37.96
Vested, Weighted Average Grant Date Fair Value	$ 33.49	$ 27.27
Forfeited, Weighted Average Grant Date Fair Value
End of Period, Weighted Average Grant Date Fair Value	$ 33.02	$ 33.04		$ 33.02
Deferred Director's Fee
Directors' fees earned and deferred into plan	$ 55		$ 45	$ 110	$ 90
Share equivalent units	2,142		1,331	3,517	2,549

XML



Earnings per Share (Tables)

6 Months Ended

Jun. 30, 2011

Earnings per Share [Abstract]

Components for computation of basic and diluted earnings per share

	Three Months Ended						Six Months Ended
	June 30,						June 30,
	2011			2010			2011			2010
Numerator:
Income from continuing operations, net of taxes	$	92,874		$	88,379		$	184,479		$	172,736
Less: Income from continuing operations attributable to noncontrolling interests, net of taxes		18,158			16,313			35,159			31,332
Income from continuing operations attributable to Community Health Systems, Inc. common stockholders — basic and diluted	$	74,716		$	72,066		$	149,320		$	141,404
Loss from discontinued operations, net of taxes	$	(39,327	)	$	(2,037	)	$	(52,607	)	$	(1,398	)
Less: Loss from discontinued operations attributable to noncontrolling interests, net of taxes		—			(36	)		—			(66	)
Loss from discontinued operations attributable to Community Health Systems, Inc. common stockholders — basic and diluted	$	(39,327	)	$	(2,001	)	$	(52,607	)	$	(1,332	)
Denominator:
Weighted-average number of shares outstanding — basic		91,130,672			93,358,771			91,069,876			92,491,839
Effect of dilutive securities:
Restricted stock awards		263,876			522,496			258,871			423,442
Employee stock options		381,632			815,455			623,662			847,380
Other equity-based awards		7,545			15,197			8,201			16,340
Weighted-average number of shares outstanding — diluted		91,783,725			94,711,919			91,960,610			93,779,001

Schedule of Antidilutive Securities Excluded From Computation of Earnings Per Share

Employee stock options 6,726,417 3,503,906 5,560,855 4,432,069

XML



Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $) In Thousands	6 Months Ended
	Jun. 30, 2011	Jun. 30, 2010
Cash flows from operating activities
Net income	$ 131,872	$ 171,338
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	324,367	301,060
Stock-based compensation expense	20,732	20,418
Loss on sale	3,234
Impairment of hospitals held for sale	47,930
Excess tax benefit relating to stock-based compensation	(4,659)	(10,104)
Other non-cash expenses, net	4,313	(2,342)
Changes in operating assets and liabilities, net of effects of acquisitions and divestitures:
Patient accounts receivable	(83,082)	(63,896)
Supplies, prepaid expenses and other current assets	9,374	(1,147)
Accounts payable, accrued liabilities and income taxes	129,518	114,100
Other	1,086	12,365
Net cash provided by operating activities	584,685	541,792
Cash flows from investing activities
Acquisitions of facilities and other related equipment	(204,264)	(2,413)
Purchases of property and equipment	(351,383)	(263,924)
Proceeds from disposition of ancillary operations	18,464
Proceeds from sale of property and equipment	8,034	2,307
Increase in other non-operating assets	(75,211)	(64,258)
Net cash used in investing activities	(604,360)	(328,288)
Cash flows from financing activities
Proceeds from exercise of stock options	18,831	53,615
Deferred financing costs	(234)
Excess tax benefit relating to stock-based compensation	4,659	10,104
Stock buy-back	(50,002)	(12,242)
Proceeds from noncontrolling investors in joint ventures	863	5,155
Redemption of noncontrolling investments in joint ventures	(3,303)	(2,395)
Distributions to noncontrolling investors in joint ventures	(30,078)	(29,371)
Repayments of long-term indebtedness	(28,798)	(34,157)
Net cash used in financing activities	(88,062)	(9,291)
Net change in cash and cash equivalents	(107,737)	204,213
Cash and cash equivalents at beginning of period	299,169	344,541
Cash and cash equivalents at end of period	191,432	548,754
Supplemental disclosure of cash flow information:
Interest payments	327,717	320,150
Income tax (refunds received) paid, net	$ (25,697)	$ 79,711

XML



Contingencies

6 Months Ended

Jun. 30, 2011

Contingencies [Abstract]

CONTINGENCIES

17. CONTINGENCIES

     The Company is a party to various legal proceedings incidental to its business. In the opinion of management, any ultimate liability with respect to these actions will not have a material adverse effect on the Company’s consolidated financial position, cash flows or results of operations. With respect to all litigation matters, the Company considers the likelihood of a negative outcome. If the Company determines the likelihood of a negative outcome is probable and the amount of the loss can be reasonably estimated, the Company records an estimated loss for the expected outcome of the litigation. If the likelihood of a negative outcome is reasonably possible and the Company is able to determine an estimate of the possible loss or a range of loss, the Company discloses that fact together with the estimate of the possible loss or range of loss. However, it is difficult to predict the outcome or estimate a possible loss or range of loss in some instances because litigation is subject to significant uncertainties.

Reasonably Possible Contingencies

     For all of the legal matters below, the Company believes that a negative outcome is reasonably possible, but the Company is unable to determine an estimate of the possible loss or a range of loss.

     On February 10, 2006, the Company received a letter from the Civil Division of the Department of Justice requesting documents in an investigation it was conducting involving the Company. The inquiry related to the way in which different state Medicaid programs apply to the federal government for matching or supplemental funds that are ultimately used to pay for a small portion of the services provided to Medicaid and indigent patients. These programs are referred to by different names, including “intergovernmental payments,” “upper payment limit programs,” and “Medicaid disproportionate share hospital payments.” The February 2006 letter focused on the Company’s hospitals in three states: Arkansas, New Mexico, and South Carolina. On August 31, 2006, the Company received a follow up letter from the Department of Justice requesting additional documents relating to the programs in New Mexico and the payments to the Company’s three hospitals in that state. Through the beginning of 2009, the Company provided the Department of Justice with requested documents, met with its personnel on numerous occasions, and otherwise cooperated in its investigation. During the course of the investigation, the Civil Division notified the Company that it believed that the Company and its three New Mexico hospitals caused the State of New Mexico to submit improper claims for federal funds, in violation of the Federal False Claims Act. At one point, the Civil Division calculated that the three hospitals received ineligible federal participation payments from August 2000 to June 2006 of approximately $27.5 million and said that if it proceeded to trial, it would seek treble damages plus an appropriate penalty for each of the violations of the Federal False Claims Act. This investigation has culminated in the federal government’s intervention in a qui tam lawsuit styled U.S. ex rel. Baker vs. Community Health Systems, Inc., pending in the United States District Court for the District of New Mexico. The federal government filed its complaint in intervention on June 30, 2009. The relator filed a second amended complaint on July 1, 2009. Both of these complaints expand the time period during which alleged improper payments were made. The Company filed motions to dismiss all of the federal government’s and the relator’s claims on August 28, 2009. On March 19, 2010, the court granted in part and denied in part the Company’s motion to dismiss as to the relator’s complaint. On July 7, 2010, the court denied the Company’s motion to dismiss the federal government’s complaint in intervention. On July 21, 2010, the Company filed its answer and pretrial discovery began. On June 2, 2011, the relator filed a Third Amended Complaint adding subsidiaries Community Health Systems Professional Services Corporation and CHS/Community Health Systems, Inc. as defendants. On June 6, 2011, the government filed its First Amended Complaint in intervention adding Community Health Systems Professional Services Corporation as a defendant. Discovery is continuing. The discovery deadline is currently set for September 30, 2011, the deadline for filing of Motions for Summary Judgment is November 21, 2011 and there is currently no trial date set. The Company is vigorously defending this action.

     On June 12, 2008, two of the Company’s hospitals received letters from the U.S. Attorney’s Office for the Western District of New York requesting documents in an investigation it is conducting into billing practices with respect to kyphoplasty procedures performed during the period January 1, 2002, through June 9, 2008. On September 16, 2008, one of the Company’s hospitals in South Carolina also received an inquiry. Kyphoplasty is a surgical spine procedure that returns a compromised vertebrae (either from trauma or osteoporotic disease process) to its previous height, reducing or eliminating severe pain. The Company has been informed that similar investigations have been initiated at unaffiliated facilities in Alabama, South Carolina, Indiana and other states. The Company believes that this investigation is related to a qui tam settlement between the same U.S. Attorney’s office and the manufacturer and distributor of the Kyphon product, which is used in performing the kyphoplasty procedure. The Company is cooperating with the investigation by collecting and producing material responsive to the requests. The Company is continuing to evaluate and discuss this matter with the federal government.

Matters for which an Outcome Cannot be Assessed

     For all of the legal matters below, the Company cannot at this time assess what the outcome may be and is further unable to determine any estimate of loss or range of loss. Because the allegations were made so recently and the investigations are at a very preliminary stage, there are not sufficient facts available to make these assessments.

     On April 8, 2011, the Company received a document subpoena, dated March 31, 2011, from the U.S. Department of Health and Human Services, Office of Inspector General (the “OIG”), in connection with an investigation of possible improper claims submitted to Medicare and Medicaid. The subpoena, issued from the OIG’s Chicago, Illinois office, requested documents from all of the Company’s hospitals and appears to concern emergency department processes and procedures, including the Company’s hospitals’ use of the Pro-MED Clinical Information System, which is a third-party software system that assists with the management of patient care and provides operational support and data collection for emergency department management and has the ability to track discharge, transfer and admission recommendations of emergency department physicians. The subpoena also requested other information about the Company’s relationships with emergency department physicians, including financial arrangements. The subpoena’s requests were very similar to those contained in the Civil Investigative Demands received by the Company’s Texas hospitals from the Office of the Attorney General of the State of Texas on November 15, 2010. The Company is continuing to cooperate with the government in this investigation.

     On April 11, 2011, Tenet Healthcare Corporation (“Tenet”) filed suit against the Company, Wayne T. Smith and W. Larry Cash in the U.S. District Court for the Northern District of Texas. The suit alleged the Company committed violations of certain federal securities laws by making certain statements in various proxy materials filed with the SEC in connection with the Company’s offer to purchase Tenet. Tenet alleged that the Company engaged in a practice to under-utilize observation status and over-utilize inpatient admission status and asserts that by doing so, the Company created undisclosed financial and legal liability to federal, state and private payors. The suit seeks declaratory and injunctive relief and Tenet’s costs. On April 19, 2011, the Company filed a motion to dismiss the complaint. On April 28, 2011, the Company responded to the allegations during its earnings release conference call as discussed in the Company’s Form 8-K furnished on April 28, 2011. On May 16, 2011, Tenet filed an amended complaint. On June 29, 2011, the Company filed a motion to dismiss the amended complaint. A hearing on the Company’s motion to dismiss is expected to occur in September 2011. The Company will continue to vigorously defend this suit.

     On April 22, 2011, a joint motion was filed by the relator and the U.S. Department of Justice in the case styled United States ex rel. and Reuille vs. Community Health Systems Professional Services Corporation and Lutheran Musculoskeletal Center, LLC d/b/a Lutheran Hospital, in the United States District Court for the Northern District of Indiana, Fort Wayne Division. The lawsuit was originally filed under seal on January 7, 2009. The suit is brought under the False Claims Act and alleges that Lutheran Hospital of Indiana billed the Medicare program for (a) false 23 hour observation after outpatient surgeries and procedures, and (b) intentional assignment of inpatient status to one-day stays for cases that do not meet Medicare criteria for inpatient intensity of service or severity of illness. The relator had worked in the case management department of Lutheran Hospital of Indiana but was reassigned to another department in the fall of 2006. This facility was acquired by the Company as part of the July 25, 2007 merger transaction with Triad. The complaint also includes allegations of age discrimination in Ms. Reuille’s 2006 reassignment and retaliation in connection with her resignation on October 1, 2008. The Company had cooperated fully with the government in its investigation of this matter, but had been unaware of the exact nature of the allegations in the complaint. On December 27, 2010, the government filed a notice that it declined to intervene in this suit. The motion contained additional information about how the government intended to proceed with an investigation regarding “allegations of improper billing for inpatient care at other hospitals associated with Community Health Systems, Inc. . . . asserted in other qui tam complaints in other jurisdictions.” The motion stated that the Department of Justice has “consolidated its investigations” of the Company and other related entities and that “the Civil Division of the Department of Justice, multiple United States Attorneys’ offices, and the Office of Inspector General for the Department of Health and Human Services (the “HHS”) are now closely coordinating their investigation of these overlapping allegations. The Attorney General of Texas has initiated an investigation; the United States intends to work cooperatively with Texas and any other States investigating these allegations.” The motion also stated that the Office of Audit Services for the Office of Investigations for HHS has been engaged to conduct a national audit of certain of the Company’s Medicare claims. The government confirmed that it considers the allegations made in the complaint styled Tenet Healthcare Corporation vs. Community Health Systems, Inc., et al. filed in the United States District Court for the Northern District of Texas, Dallas Division on April 11, 2011 to be related to the allegations in the qui tam and to what the government is now describing as a consolidated investigation. Because qui tam suits are filed “under seal,” no one but the relator and the government knows that the suit has been filed or what allegations are being made by the relator on behalf of the government. Initially, the government has 60 days to make a determination about whether to intervene in a case and to act as the plaintiff or to decline to intervene and allow the relator to act as the plaintiff in the suit, but extensions of time are frequently granted to allow the government additional time to investigate the allegations. Even if, in the course of an investigation, the court partially unseals a complaint to allow the government and a defendant to work to a resolution of the complaint’s allegations, the defendant is prohibited from revealing to anyone even that the partial unsealing has occurred. As the investigation proceeds, the Company may learn of additional qui tam suits filed against the Company or its affiliated hospitals or related entities, or that contact letters, document requests, or medical record requests the Company has received in the past from various governmental agencies are generated from qui tam cases filed under seal. The motion filed on April 22, 2011 concluded by requesting a stay of the litigation in the Reuille case for 180 days, and on April 25, 2011, the court granted the motion. The Company’s management company subsidiary, Community Health Systems Professional Services Corporation, the defendant in the Reuille case, consented to the request for the stay. The Company is cooperating fully with the government in its investigations.

     Three purported class action shareholder federal securities cases have been filed in the United States District Court for the Middle District of Tennessee namely, Norfolk County Retirement System v. Community Health Systems, Inc., Wayne T.

Smith and W. Larry Cash, filed May 5, 2011; De Zheng v. Community Health Systems, Inc., Wayne T. Smith and W. Larry Cash, filed May 12, 2011; and Minneapolis Firefighters Relief Association v. Community Health Systems, Inc., Wayne T. Smith, W. Larry Cash and Thomas Mark Buford, filed June 2, 2011. All three seek class certification on behalf of purchasers of the Company’s common stock between July 27, 2006 and April 11, 2011 and allege that misleading statements resulted in artificially inflated prices for the Company’s common stock. Two shareholder derivative actions have also been filed in the United States District Court for the Middle District of Tennessee; Plumbers and Pipefitters Local Union No. 630 Pension Annuity Trust Fund v. Wayne T. Smith, W. Larry Cash, T. Mark Buford, John A. Clerico, James S. Ely III, John A. Fry, William Norris Jennings, Julia B. North and H. Mitchell Watson, Jr., filed May 24, 2011, and Roofers Local No. 149 Pension Fund v. Wayne T. Smith, W. Larry Cash, John A. Clerico, James S. Ely, III, John A. Fry, William Norris Jennings, Julia B. North and H. Mitchell Watson, Jr., filed June 21, 2011. These two cases allege breach of fiduciary duty arising out of allegedly improper inpatient admission practices, mismanagement, waste and unjust enrichment. The Company believes all of these matters are without merit and will vigorously defend them.

     The Company incurred the following pre-tax charges in connection with the Tenet acquisition lawsuit, government investigations and shareholder lawsuits of possible improper claims submitted to Medicare and Medicaid during the three and six months ending June 30, 2011 and 2010 (in thousands):

	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2011		2010		2011		2010
Professional fees and other related costs	$	6,174	$	—	$	6,174	$	—

XML



Goodwill and Other Intangible Assets (Details) (USD $)	6 Months Ended						3 Months Ended		6 Months Ended		3 Months Ended		6 Months Ended
	Jun. 30, 2011	Dec. 31, 2010	Jun. 30, 2011 Hospital Operations Reporting Unit [Member]	Jun. 30, 2011 Home Care Agency Operations Reporting Unit [Member]	Jun. 30, 2011 Hospital Management Services Reporting Unit [Member]	Dec. 31, 2010 Scenario, Previously Reported [Member]	Jun. 30, 2011 Computer Software, Intangible Asset [Member]	Jun. 30, 2010 Computer Software, Intangible Asset [Member]	Jun. 30, 2011 Computer Software, Intangible Asset [Member]	Jun. 30, 2010 Computer Software, Intangible Asset [Member]	Jun. 30, 2011 Other Intangible Assets [Member]	Jun. 30, 2010 Other Intangible Assets [Member]	Jun. 30, 2011 Other Intangible Assets [Member]	Jun. 30, 2010 Other Intangible Assets [Member]	Jun. 30, 2011 Significant system conversions [Member]	Jun. 30, 2011 All other capitalized internal-use software [Member]
Carrying amount of goodwill
Beginning Balance	$ 4,150,247,000		$ 4,200,000,000	$ 35,900,000	$ 33,300,000	$ 4,199,905,000
Goodwill allocated to disposal and hospital held for sale	(49,658,000)
Goodwill acquired as part of acquisitions during 2011	77,760,000
Consideration adjustments and purchase price allocation adjustments for prior years acquisitions	(37,000)
Ending Balance	4,227,970,000		4,200,000,000	35,900,000	33,300,000	4,199,905,000
Goodwill	4,227,970,000		4,200,000,000	35,900,000	33,300,000	4,199,905,000
Finite-Lived Intangible Assets [Line Items]
Expected residual value							0		0		0		0
Amortization expense							16,700,000	11,000,000	34,700,000	20,200,000	2,300,000	3,100,000	4,200,000	6,300,000
Amortization expense for remaining 2011									37,500,000				3,900,000
Amortization expense for 2012									75,100,000				7,100,000
Amortization expense for 2013									45,100,000				4,500,000
Amortization expense for 2014									18,100,000				2,900,000
Amortization expense for 2015									15,700,000				2,500,000
Amortization expense for 2016 and thereafter									27,600,000				13,200,000
Estimated amortization period															8	3
Goodwill and Other Intangibles Assets (Textuals) [Abstract]
Gross, intangible asset subject to amortization	61,700,000	60,500,000
Net, intangible asset subject to amortization	34,100,000	36,100,000
Net, intangible asset not subject to amortization	44,100,000	44,400,000
Weighted-average amortization	9
Gross carrying amount of capitalized software	396,900,000	356,500,000
Net carrying amount considering accumulated amortization	219,100,000	209,400,000
Capitalized costs for internal-use software in development stage	$ 76,600,000

XML



Supplemental Condensed Consolidating Financial Information

6 Months Ended

Jun. 30, 2011

Supplemental Financial Information [Abstract]

SUPPLEMENTAL CONDENSED CONSOLIDATING FINANCIAL INFORMATION

19. SUPPLEMENTAL CONDENSED CONSOLIDATING FINANCIAL INFORMATION

     In connection with the consummation of the Triad acquisition, CHS obtained approximately $7.2 billion of senior secured financing under the Credit Facility and issued the Notes in the aggregate principal amount of approximately $3.0 billion. The Notes are senior unsecured obligations of CHS and are guaranteed on a senior basis by the Company and by certain of its existing and subsequently acquired or organized 100% owned domestic subsidiaries.

     The Notes are fully and unconditionally guaranteed on a joint and several basis. The following condensed consolidating financial statements present Community Health Systems, Inc. (as parent guarantor), CHS (as the issuer), the subsidiary guarantors, the subsidiary non-guarantors and eliminations. These condensed consolidating financial statements have been prepared and presented in accordance with SEC Regulation S-X Rule 3-10 “Financial Statements of Guarantors and Issuers of Guaranteed Securities Registered or Being Registered.”

     The accounting policies used in the preparation of this financial information are consistent with those elsewhere in the consolidated financial statements of the Company, except as noted below:

• Intercompany receivables and payables are presented gross in the supplemental consolidating balance sheets.

• Cash flows from intercompany transactions are presented in cash flows from financing activities, as changes in intercompany balances with affiliates, net.

• Income tax expense is allocated from the parent guarantor to the income producing operations (other guarantors and non-guarantors) and the issuer through stockholders’ equity. As this approach represents an allocation, the income tax expense allocation is considered non-cash for statement of cash flow purposes.

• Interest expense, net has been presented to reflect net interest expense and interest income from outstanding long-term debt and intercompany balances.

     The Company’s intercompany activity consists primarily of daily cash transfers for purposes of cash management, the allocation of certain expenses and expenditures paid for by the parent on behalf of its subsidiaries, and the push down of investment in its subsidiaries. The Company’s subsidiaries generally do not purchase services from each other; thus, the intercompany transactions do not represent revenue generating transactions. All intercompany transactions eliminate in consolidation.

     From time to time, the Company sells and/or repurchases noncontrolling interests in consolidated subsidiaries, which may change subsidiaries between guarantors and non-guarantors. Amounts for prior periods are restated to reflect the status of guarantors or non-guarantors as of June 30, 2011.

Condensed Consolidating Balance Sheet
June 30, 2011

	Parent						Other			Non-
	Guarantor			Issuer			Guarantors			Guarantors		Eliminations			Consolidated
	(In thousands)
ASSETS
Current assets:
Cash and cash equivalents	$	—		$	—		$	80,552		$	110,880	$	—		$	191,432
Patient accounts receivable, net of allowance for doubtful accounts		—			—			1,043,386			749,018		—			1,792,404
Supplies		—			—			212,873			129,395		—			342,268
Deferred income taxes		115,819			—			—			—		—			115,819
Prepaid expenses and taxes		—			17			85,760			31,681		—			117,458
Other current assets		—			—			110,501			64,608		—			175,109
Total current assets		115,819			17			1,533,072			1,085,582		—			2,734,490
Intercompany receivable		1,190,786			9,441,127			1,438,751			1,534,314		(13,604,978	)		—
Property and equipment, net		—			—			4,069,371			2,437,053		—			6,506,424
Goodwill		—			—			2,380,891			1,847,079		—			4,227,970
Other assets, net of accumulated amortization		—			117,845			594,289			644,397		—			1,356,531
Net investment in subsidiaries		1,637,169			5,856,743			2,306,109			—		(9,800,021	)		—
Total assets	$	2,943,774		$	15,415,732		$	12,322,483		$	7,548,425	$	(23,404,999	)	$	14,825,415
LIABILITIES AND EQUITY
Current liabilities:
Current maturities of long-term debt	$	—		$	49,954		$	17,073		$	3,085	$	—		$	70,112
Accounts payable		—			40			402,806			181,078		—			583,924
Current income tax payable		349			—			—			—		—			349
Deferred income taxes		8,882			—			—			—		—			8,882
Accrued interest		—			145,034			111			1		—			145,146
Accrued liabilities		7,580			567			576,614			269,568		—			854,329
Total current liabilities		16,811			195,595			996,604			453,732		—			1,662,742
Long-term debt		—			8,709,456			46,194			25,793		—			8,781,443
Intercompany payable		—			4,575,989			8,923,510			5,979,987		(19,479,486	)		—
Deferred income taxes		608,177			—			—			—		—			608,177
Other long-term liabilities		9,765			297,525			401,585			317,194		—			1,026,069
Total liabilities		634,753			13,778,565			10,367,893			6,776,706		(19,479,486	)		12,078,431
Redeemable noncontrolling interests in equity of consolidated subsidiaries		—			—			—			376,658		—			376,658
Equity:
Community Health Systems, Inc. stockholders’ equity:
Preferred stock		—			—			—			—		—			—
Common stock		932			—			1			2		(3	)		932
Additional paid-in capital		1,119,205			663,410			709,243			120,485		(1,493,138	)		1,119,205
Treasury stock, at cost		(6,678	)		—			—			—		—			(6,678	)
Accumulated other comprehensive (loss) income		(200,533	)		(200,533	)		(10,074	)		—		210,607			(200,533	)
Retained earnings		1,396,095			1,174,290			1,255,420			213,269		(2,642,979	)		1,396,095
Total Community Health Systems, Inc. stockholders’ equity		2,309,021			1,637,167			1,954,590			333,756		(3,925,513	)		2,309,021
Noncontrolling interests in equity of consolidated subsidiaries		—			—			—			61,305		—			61,305
Total equity		2,309,021			1,637,167			1,954,590			395,061		(3,925,513	)		2,370,326
Total liabilities and equity	$	2,943,774		$	15,415,732		$	12,322,483		$	7,548,425	$	(23,404,999	)	$	14,825,415

Condensed Consolidating Balance Sheet
December 31, 2010

	Parent						Other			Non-
	Guarantor			Issuer			Guarantors			Guarantors		Eliminations			Consolidated
	(In thousands)
ASSETS
Current assets:
Cash and cash equivalents	$	—		$	—		$	212,035		$	87,134	$	—		$	299,169
Patient accounts receivable, net of allowance for doubtful accounts		—			—			971,220			743,322		—			1,714,542
Supplies		—			—			196,957			132,157		—			329,114
Deferred income taxes		115,819			—			—			—		—			115,819
Prepaid expenses and taxes		118,464			116			89,172			11,466		—			219,218
Other current assets		—			41			138,923			54,367		—			193,331
Total current assets		234,283			157			1,608,307			1,028,446		—			2,871,193
Intercompany receivable		1,079,295			9,002,158			1,145,185			1,484,130		(12,710,768	)		—
Property and equipment, net		—			—			3,816,098			2,508,339		—			6,324,437
Goodwill		—			—			2,331,452			1,818,795		—			4,150,247
Other assets, net of accumulated amortization		—			131,352			625,472			595,422		—			1,352,246
Net investment in subsidiaries		1,510,062			5,315,871			2,061,532			—		(8,887,465	)		—
Total assets	$	2,823,640		$	14,449,538		$	11,588,046		$	7,435,132	$	(21,598,233	)	$	14,698,123
LIABILITIES AND EQUITY
Current liabilities:
Current maturities of long-term debt	$	—		$	49,953		$	11,063		$	2,123	$	—		$	63,139
Accounts payable		—			—			362,154			164,184		—			526,338
Current income tax payable		—			—			—			—		—			—
Deferred income taxes		8,882			—			—			—		—			8,882
Accrued interest		—			146,297			116			2		—			146,415
Accrued liabilities		7,595			567			569,991			319,113		—			897,266
Total current liabilities		16,477			196,817			943,324			485,422		—			1,642,040
Long-term debt		—			8,734,473			44,819			29,090		—			8,808,382
Intercompany payable		—			3,667,662			8,385,414			5,911,829		(17,964,905	)		—
Deferred income taxes		608,177			—			—			—		—			608,177
Other long-term liabilities		9,522			340,526			372,693			278,934		—			1,001,675
Total liabilities		634,176			12,939,478			9,746,250			6,705,275		(17,964,905	)		12,060,274
Redeemable noncontrolling interests in equity of consolidated subsidiaries		—			—			—			387,472		—			387,472
Equity:
Community Health Systems, Inc. stockholders’ equity:
Preferred stock		—			—			—			—		—			—
Common stock		936			—			1			2		(3	)		936
Additional paid-in capital		1,126,751			640,683			682,686			103,401		(1,426,770	)		1,126,751
Treasury stock, at cost		(6,678	)		—			—			—		—			(6,678	)
Accumulated other comprehensive (loss) income		(230,927	)		(230,927	)		(12,990	)		—		243,917			(230,927	)
Retained earnings		1,299,382			1,100,304			1,172,099			178,069		(2,450,472	)		1,299,382
Total Community Health Systems, Inc. stockholders’ equity		2,189,464			1,510,060			1,841,796			281,472		(3,633,328	)		2,189,464
Noncontrolling interests in equity of consolidated subsidiaries		—			—			—			60,913		—			60,913
Total equity		2,189,464			1,510,060			1,841,796			342,385		(3,633,328	)		2,250,377
Total liabilities and equity	$	2,823,640		$	14,449,538		$	11,588,046		$	7,435,132	$	(21,598,233	)	$	14,698,123

Condensed Consolidating Statement of Income
Three Months Ended June 30, 2011

	Parent						Other			Non-
	Guarantor			Issuer			Guarantors			Guarantors			Eliminations			Consolidated
	(In thousands)
Net operating revenues	$	—		$	—		$	2,002,412		$	1,431,417		$	—		$	3,433,829
Operating costs and expenses:
Salaries and benefits		—			—			767,262			616,834			—			1,384,096
Provision for bad debts		—			—			259,583			173,419			—			433,002
Supplies		—			—			262,909			186,370			—			449,279
Other operating expenses		—			—			393,916			260,821			—			654,737
Rent		—			—			31,007			31,424			—			62,431
Depreciation and amortization		—			—			95,559			65,817			—			161,376
Total operating costs and expenses		—			—			1,810,236			1,334,685			—			3,144,921
Income from operations		—			—			192,176			96,732			—			288,908
Interest expense, net		—			22,212			123,347			17,671			—			163,230
Equity in earnings of unconsolidated affiliates		(35,389	)		(39,072	)		(45,752	)		—			108,196			(12,017	)
Income from continuing operations before income taxes		35,389			16,860			114,581			79,061			(108,196	)		137,695
Provision for (benefit from) income taxes		—			(18,529	)		41,364			21,986			—			44,821
Income from continuing operations		35,389			35,389			73,217			57,075			(108,196	)		92,874
Discontinued operations, net of taxes:
Income (loss) from operations of entities sold and held for sale		—			—			2,813			(2,578	)		—			235
Impairment of hospitals held for sale		—			—			(39,562	)		—			—			(39,562	)
Loss on sale		—			—			—			—			—			—
Loss from discontinued operations, net of taxes		—			—			(36,749	)		(2,578	)		—			(39,327	)
Net income		35,389			35,389			36,468			54,497			(108,196	)		53,547
Less: Net income attributable to noncontrolling interests		—			—			—			18,158			—			18,158
Net income attributable to Community Health Systems, Inc.	$	35,389		$	35,389		$	36,468		$	36,339		$	(108,196	)	$	35,389

Condensed Consolidating Statement of Income
Three Months Ended June 30, 2010

	Parent						Other			Non-
	Guarantor			Issuer			Guarantors			Guarantors			Eliminations			Consolidated
	(In thousands)
Net operating revenues	$	—		$	—		$	1,770,800		$	1,309,846		$	—		$	3,080,646
Operating costs and expenses:
Salaries and benefits		—			—			663,919			567,640			—			1,231,559
Provision for bad debts		—			—			220,065			146,937			—			367,002
Supplies		—			—			242,931			187,643			—			430,574
Other operating expenses		—			—			309,698			250,264			—			559,962
Rent		—			—			28,838			32,013			—			60,851
Depreciation and amortization		—			—			86,401			63,378			—			149,779
Total operating costs and expenses		—			—			1,551,852			1,247,875			—			2,799,727
Income from operations		—			—			218,948			61,971			—			280,919
Interest expense, net		—			28,433			118,682			13,644			—			160,759
Equity in earnings of unconsolidated affiliates		(70,065	)		(82,583	)		(27,298	)		—			168,966			(10,980	)
Income from continuing operations before income taxes		70,065			54,150			127,564			48,327			(168,966	)		131,140
Provision for (benefit from) income taxes		—			(15,915	)		46,694			11,982			—			42,761
Income from continuing operations		70,065			70,065			80,870			36,345			(168,966	)		88,379
Discontinued operations, net of taxes:
Income (loss) from operations of entities sold and held for sale		—			—			1,789			(3,826	)		—			(2,037	)
Impairment of hospitals held for sale		—			—			—			—			—			—
Loss on sale		—			—			—			—			—			—
Loss from discontinued operations, net of taxes		—			—			1,789			(3,826	)		—			(2,037	)
Net income		70,065			70,065			82,659			32,519			(168,966	)		86,342
Less: Net income attributable to noncontrolling interests		—			—			—			16,277			—			16,277
Net income attributable to Community Health Systems, Inc.	$	70,065		$	70,065		$	82,659		$	16,242		$	(168,966	)	$	70,065

Condensed Consolidating Statement of Income
Six Months Ended June 30, 2011

	Parent						Other			Non-
	Guarantor			Issuer			Guarantors			Guarantors			Eliminations			Consolidated
	(In thousands)
Net operating revenues	$	—		$	—		$	3,932,956		$	2,854,925		$	—		$	6,787,881
Operating costs and expenses:
Salaries and benefits		—			—			1,510,301			1,253,162			—			2,763,463
Provision for bad debts		—			—			499,434			333,537			—			832,971
Supplies		—			—			525,911			381,185			—			907,096
Other operating expenses		—			—			738,800			530,730			—			1,269,530
Rent		—			—			61,608			63,993			—			125,601
Depreciation and amortization		—			—			189,419			130,112			—			319,531
Total operating costs and expenses		—			—			3,525,473			2,692,719			—			6,218,192
Income from operations		—			—			407,483			162,206			—			569,689
Interest expense, net		—			50,315			244,740			31,393			—			326,448
Equity in earnings of unconsolidated affiliates		(96,713	)		(114,604	)		(77,710	)		—			258,876			(30,151	)
Income from continuing operations before income taxes		96,713			64,289			240,453			130,813			(258,876	)		273,392
Provision for (benefit from) income taxes		—			(32,424	)		86,803			34,534			—			88,913
Income from continuing operations		96,713			96,713			153,650			96,279			(258,876	)		184,479
Discontinued operations, net of taxes:
Income (loss) from operations of entities sold and held for sale		—			—			4,158			(5,601	)		—			(1,443	)
Impairment of hospitals held for sale		—			—			(47,930	)		—			—			(47,930	)
Loss on sale		—			—			—			(3,234	)		—			(3,234	)
Loss from discontinued operations, net of taxes		—			—			(43,772	)		(8,835	)		—			(52,607	)
Net income		96,713			96,713			109,878			87,444			(258,876	)		131,872
Less: Net income attributable to noncontrolling interests		—			—			—			35,159			—			35,159
Net income attributable to Community Health Systems, Inc.	$	96,713		$	96,713		$	109,878		$	52,285		$	(258,876	)	$	96,713

Condensed Consolidating Statement of Income
Six Months Ended June 30, 2010

	Parent						Other			Non-
	Guarantor			Issuer			Guarantors			Guarantors			Eliminations			Consolidated
	(In thousands)
Net operating revenues	$	—		$	—		$	3,546,129		$	2,603,129		$	—		$	6,149,258
Operating costs and expenses:
Salaries and benefits		—			—			1,342,015			1,136,225			—			2,478,240
Provision for bad debts		—			—			442,530			290,973			—			733,503
Supplies		—			—			482,632			370,054			—			852,686
Other operating expenses		—			—			613,430			503,151			—			1,116,581
Rent		—			—			58,253			64,655			—			122,908
Depreciation and amortization		—			—			170,605			123,077			—			293,682
Total operating costs and expenses		—			—			3,109,465			2,488,135			—			5,597,600
Income from operations		—			—			436,664			114,994			—			551,658
Interest expense, net		—			57,447			235,294			27,441			—			320,182
Equity in earnings of unconsolidated affiliates		(140,072	)		(166,296	)		(50,851	)		—			333,649			(23,570	)
Income from continuing operations before income taxes		140,072			108,849			252,221			87,553			(333,649	)		255,046
Provision for (benefit from) income taxes		—			(31,223	)		92,817			20,716			—			82,310
Income from continuing operations		140,072			140,072			159,404			66,837			(333,649	)		172,736
Discontinued operations, net of taxes:
Income (loss) from operations of entities sold and held for sale		—			—			6,231			(7,629	)		—			(1,398	)
Impairment of hospitals held for sale		—			—			—			—			—			—
Loss on sale		—			—			—			—			—			—
Loss from discontinued operations, net of taxes		—			—			6,231			(7,629	)		—			(1,398	)
Net income		140,072			140,072			165,635			59,208			(333,649	)		171,338
Less: Net income attributable to noncontrolling interests		—			—			—			31,266			—			31,266
Net income attributable to Community Health Systems, Inc.	$	140,072		$	140,072		$	165,635		$	27,942		$	(333,649	)	$	140,072

Condensed Consolidating Statement of Cash Flows
Six Months Ended June 30, 2011

	Parent						Other			Non-
	Guarantor			Issuer			Guarantors			Guarantors			Eliminations		Consolidated
	(In thousands)
Cash flows from operating activities:
Net cash (used in) provided by operating activities	$	1,490		$	(37,658	)	$	338,117		$	282,736		$	—	$	584,685
Cash flows from investing activities:
Acquisitions of facilities and other related equipment		—			—			(162,692	)		(41,572	)		—		(204,264	)
Purchases of property and equipment		—			—			(187,760	)		(163,623	)		—		(351,383	)
Proceeds from disposition of ancillary operations		—			—			—			18,464			—		18,464
Proceeds from sale of property and equipment		—			—			881			7,153			—		8,034
Increase in other non-operating assets		—			—			(58,120	)		(17,091	)		—		(75,211	)
Net cash used in investing activities		—			—			(407,691	)		(196,669	)		—		(604,360	)
Cash flows from financing activities:
Proceeds from exercise of stock options		18,831			—			—			—			—		18,831
Deferred financing costs		—			(234	)		—			—			—		(234	)
Excess tax benefit relating to stock-based compensation		4,659			—			—			—			—		4,659
Stock buy-back		(50,002	)		—			—			—			—		(50,002	)
Proceeds from noncontrolling investors in joint ventures		—			—			—			863			—		863
Redemption of noncontrolling investments in joint ventures		—			—			—			(3,303	)		—		(3,303	)
Distributions to noncontrolling investors in joint ventures		—			—			—			(30,078	)		—		(30,078	)
Changes in intercompany balances with affiliates, net		25,022			62,908			(59,406	)		(28,524	)		—		—
Repayments of long-term indebtedness		—			(25,016	)		(2,504	)		(1,278	)		—		(28,798	)
Net cash provided by (used in) financing activities		(1,490	)		37,658			(61,910	)		(62,320	)		—		(88,062	)
Net change in cash and cash equivalents		—			—			(131,484	)		23,747			—		(107,737	)
Cash and cash equivalents at beginning of period		—			—			212,035			87,134			—		299,169
Cash and cash equivalents at end of period	$	—		$	—		$	80,551		$	110,881		$	—	$	191,432

Condensed Consolidating Statement of Cash Flows
Six Months Ended June 30, 2010

	Parent						Other			Non-
	Guarantor			Issuer			Guarantors			Guarantors			Eliminations		Consolidated
	(In thousands)
Cash flows from operating activities:
Net cash (used in) provided by operating activities	$	(100,143	)	$	(43,029	)	$	539,874		$	145,090		$	—	$	541,792
Cash flows from investing activities:
Acquisitions of facilities and other related equipment		—			—			(389	)		(2,024	)		—		(2,413	)
Purchases of property and equipment		—			—			(169,311	)		(94,613	)		—		(263,924	)
Proceeds from disposition of ancillary operations		—			—			—			—			—		—
Proceeds from sale of property and equipment		—			—			2,151			156			—		2,307
Increase in other non-operating assets		—			—			(31,750	)		(32,508	)		—		(64,258	)
Net cash used in investing activities		—			—			(199,299	)		(128,989	)		—		(328,288	)
Cash flows from financing activities:
Proceeds from exercise of stock options		53,615			—			—			—			—		53,615
Deferred financing costs		—			—			—			—			—		—
Excess tax benefit relating to stock-based compensation		10,104			—			—			—			—		10,104
Stock buy-back		(12,242	)		—			—			—			—		(12,242	)
Proceeds from noncontrolling investors in joint ventures		—			—			—			5,155			—		5,155
Redemption of noncontrolling investments in joint ventures		—			—			—			(2,395	)		—		(2,395	)
Distributions to noncontrolling investors in joint ventures		—			—			—			(29,371	)		—		(29,371	)
Changes in intercompany balances with affiliates, net		48,666			64,765			(73,906	)		(39,525	)		—		—
Repayments of long-term indebtedness		—			(21,736	)		(9,996	)		(2,425	)		—		(34,157	)
Net cash provided by (used in) financing activities		100,143			43,029			(83,902	)		(68,561	)		—		(9,291	)
Net change in cash and cash equivalents		—			—			256,673			(52,460	)		—		204,213
Cash and cash equivalents at beginning of period		—			—			238,495			106,046			—		344,541
Cash and cash equivalents at end of period	$	—		$	—		$	495,168		$	53,586		$	—	$	548,754

XML



Supplemental Condensed Consolidating Financial Information (Details Textual) (USD $) In Billions, unless otherwise specified	6 Months Ended
	Jun. 30, 2011
Supplemental Condensed Consolidating Financial Information (Textuals) [Abstract]
Percentage of owned domestic subsidiaries which guaranteed senior notes	100.00%
Community Health System [Member]
Supplemental Condensed Consolidating Financial Information (Textuals) [Abstract]
Senior secured financing under a new credit facility	$ 7.2
Community Health System [Member] | Senior Notes 8.875% Due 2015 [Member]
Supplemental Condensed Consolidating Financial Information (Textuals) [Abstract]
Principal amount of senior notes issued	$ 3.0

XML



Accounting for Stock-Based Compensation

6 Months Ended

Jun. 30, 2011

Accounting for Stock-Based Compensation [Abstract]

ACCOUNTING FOR STOCK-BASED COMPENSATION

2. ACCOUNTING FOR STOCK-BASED COMPENSATION

     Stock-based compensation awards are granted under the Community Health Systems, Inc. 2000 Stock Option and Award Plan, amended and restated as of March 24, 2009 (the “2000 Plan”), and the Community Health Systems, Inc. 2009 Stock Option and Award Plan, amended and restated as of March 18, 2011 (the “2009 Plan”).

     The 2000 Plan allows for the grant of incentive stock options intended to qualify under Section 422 of the Internal Revenue Code (“IRC”), as well as stock options which do not so qualify, stock appreciation rights, restricted stock, restricted stock units, performance-based shares or units and other share awards. Prior to being amended in 2009, the 2000 Plan also allowed for the grant of phantom stock. Persons eligible to receive grants under the 2000 Plan include the Company’s directors, officers, employees and consultants. To date, all options granted under the 2000 Plan have been “nonqualified” stock options for tax purposes. Generally, vesting of these granted options occurs in one-third increments on each of the first three anniversaries of the award date. Options granted prior to 2005 have a 10-year contractual term, options granted in 2005 through 2007 have an eight-year contractual term and options granted in 2008 or later have a 10-year contractual term. As of June 30, 2011, 127,250 shares of unissued common stock were reserved for future grants under the 2000 Plan.

     The 2009 Plan provides for the grant of incentive stock options intended to qualify under Section 422 of the IRC and for the grant of stock options which do not so qualify, stock appreciation rights, restricted stock, restricted stock units, performance-based shares or units and other share awards. Persons eligible to receive grants under the 2009 Plan include the Company’s directors, officers, employees and consultants. Options granted in 2011 have a 10-year contractual term. As of June 30, 2011, 2,897,129 shares of unissued common stock were reserved for future grants under the 2009 Plan.

     The exercise price of all options granted is equal to the fair value of the Company’s common stock on the option grant date.

     The following table reflects the impact of total compensation expense related to stock-based equity plans on the reported operating results for the respective periods (in thousands):

	Three Months Ended						Six Months Ended
	June 30,						June 30,
	2011			2010			2011			2010
Effect on income from continuing operations before income taxes	$	(10,814	)	$	(10,655	)	$	(20,732	)	$	(20,418	)
Effect on net income	$	(6,867	)	$	(6,473	)	$	(13,165	)	$	(12,404	)

     At June 30, 2011, $79.5 million of unrecognized stock-based compensation expense was expected to be recognized over a weighted-average period of 26 months. Of that amount, $17.2 million related to outstanding unvested stock options was expected to be recognized over a weighted-average period of 26 months and $62.3 million related to outstanding unvested restricted stock, restricted stock units and phantom shares was expected to be recognized over a weighted-average period of 26 months. There were no modifications to awards during the three and six months ended June 30, 2011.

     The fair value of stock options was estimated using the Black Scholes option pricing model with the following assumptions and weighted-average fair values during the three and six months ended June 30, 2011 and 2010:

	Three Months Ended						Six Months Ended
	June 30,						June 30,
	2011			2010			2011			2010
Expected volatility		38.1	%		35.3	%		31.5	%		33.6	%
Expected dividends		—			—			—			—
Expected term	4 years			3 years			4 years			3.1 years
Risk-free interest rate		1.35	%		1.20	%		1.73	%		1.47	%

     In determining expected term, the Company examined concentrations of option holdings and historical patterns of option exercises and forfeitures, as well as forward-looking factors, in an effort to determine if there were any discernable employee populations. From this analysis, the Company identified two primary employee populations, one consisting of certain senior executives and the other consisting of substantially all other recipients.

     The expected volatility rate was estimated based on historical volatility. In determining expected volatility, the Company also reviewed the market-based implied volatility of actively traded options of its common stock and determined that historical volatility utilized to estimate the expected volatility did not differ significantly from the implied volatility.

     The expected term computation is based on historical exercise and cancellation patterns and forward-looking factors, where present, for each population identified. The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of the grant. The pre-vesting forfeiture rate is based on historical rates and forward-looking factors for each population identified. The Company adjusts the estimated forfeiture rate to its actual experience.

     Options outstanding and exercisable under the 2000 Plan and the 2009 Plan as of June 30, 2011, and changes during each of the three-month periods following December 31, 2010, were as follows (in thousands, except share and per share data):

						Weighted -
				Weighted -		Average	Aggregate
				Average		Remaining	Intrinsic
				Exercise		Contractual	Value as of
	Shares			Price		Term	June 30, 2011
Outstanding at December 31, 2010		7,834,332		$	32.08
Granted		1,329,000			37.96
Exercised		(595,431	)		30.44
Forfeited and cancelled		(64,508	)		34.84
Outstanding at March 31, 2011		8,503,393			33.10
Granted		45,000			28.12
Exercised		(23,579	)		29.98
Forfeited and cancelled		(50,342	)		32.70
Outstanding at June 30, 2011		8,474,472		$	33.08	5.8 years	$	9,910
Exercisable at June 30, 2011		5,804,556		$	32.78	4.3 years	$	7,468

     The weighted-average grant date fair value of stock options granted during the three months ended June 30, 2011 and 2010 was $8.89 and $10.07, respectively, and $10.29 and $8.54 during the six months ended June 30, 2011 and 2010, respectively. The aggregate intrinsic value (the number of in-the-money stock options multiplied by the difference between the Company’s closing stock price on the last trading day of the reporting period ($25.68) and the exercise price of the respective stock options) in the table above represents the amount that would have been received by the option holders had all option holders exercised their options on June 30, 2011. This amount changes based on the market value of the Company’s common stock. The aggregate intrinsic value of options exercised during the three months ended June 30, 2011 and 2010 was $0.2 million and $18.6 million, respectively. The aggregate intrinsic value of options exercised during the six months ended June 30, 2011 and 2010 was $6.1 million and $28.2 million, respectively. The aggregate intrinsic value of options vested and expected to vest approximates that of the outstanding options.

     The Company has also awarded restricted stock under the 2000 Plan and the 2009 Plan to its directors and employees of certain subsidiaries. The restrictions on these shares generally lapse in one-third increments on each of the first three anniversaries of the award date. Certain of the restricted stock awards granted to the Company’s senior executives contain a performance objective that must be met in addition to any vesting requirements. If the performance objective is not attained, the awards will be forfeited in their entirety. Once the performance objective has been attained, restrictions will lapse in one-third increments on each of the first three anniversaries of the award date. Notwithstanding the above-mentioned performance objectives and vesting requirements, the restrictions will lapse earlier in the event of death, disability or termination of employment by the Company for any reason other than for cause of the holder of the restricted stock, or change in control of the Company. Restricted stock awards subject to performance standards are not considered outstanding for purposes of determining earnings per share until the performance objectives have been satisfied.

     Restricted stock outstanding under the 2000 Plan and the 2009 Plan as of June 30, 2011, and changes during each of the three-month periods following December 31, 2010, were as follows:

				Weighted -
				Average
				Grant Date
	Shares			Fair Value
Unvested at December 31, 2010		2,125,291		$	27.92
Granted		1,084,949			37.96
Vested		(962,662	)		27.27
Forfeited		—			—
Unvested at March 31, 2011		2,247,578			33.04
Granted		8,000			28.12
Vested		(12,000	)		33.49
Forfeited		—			—
Unvested at June 30, 2011		2,243,578			33.02

     On February 25, 2009, under the 2000 Plan, each of the Company’s outside directors received a grant of shares of phantom stock equal in value to approximately $130,000 divided by the closing price of the Company’s common stock on that date ($18.18), or 7,151 shares per director (a total of 42,906 shares of phantom stock). Pursuant to a March 24, 2009 amendment to the 2000 Plan, all subsequent grants of this type are denominated as “restricted stock unit” awards. On May 19, 2009, the newly elected outside director received a grant of 7,151 restricted stock units under the 2000 Plan, having a value at the time of $180,706 based upon the closing price of the Company’s common stock on that date of $25.27. On February 24, 2010, six of the Company’s seven outside directors each received a grant of 4,130 restricted stock units under the 2000 Plan, having a value at the time of approximately $140,000 based upon the closing price of the Company’s common stock on that date of $33.90. One outside director, who did not stand for reelection in 2010, did not receive such a grant. On February 23, 2011, each of the Company’s six outside directors received a grant of 3,688 restricted stock units under the 2009 Plan, having a value at the time of approximately $140,000 based upon the closing price of the Company’s common stock on that date of $37.96. Vesting of these shares of phantom stock and restricted stock units occurs in one-third increments on each of the first three anniversaries of the award date. During the three months ended June 30, 2011, 2,384 shares vested at a weighted-average grant date fair value of $25.27. During the six months ended June 30, 2011, 22,560 shares vested at a weighted-average grant date fair value of $24.68. None of these grants were canceled during the three and six months ended June 30, 2011. As of June 30, 2011, there were 52,956 shares of phantom stock and restricted stock units unvested at a weighted-average grant date fair value of $31.67.

     Under the Directors’ Fees Deferral Plan, the Company’s outside directors may elect to receive share equivalent units in lieu of cash for their directors’ fees. These share equivalent units are held in the plan until the director electing to receive the share equivalent units retires or otherwise terminates his/her directorship with the Company. Share equivalent units are converted to shares of common stock of the Company at the time of distribution based on the closing market price of the Company’s common stock on that date. The following table represents the amount of directors’ fees which were deferred during each of the respective periods, and the number of share equivalent units into which such directors’ fees would have converted had each of the directors who had deferred such fees retired or terminated his/her directorship with the Company as of the end of the respective periods (in thousands, except share equivalent units):

	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2011		2010		2011		2010
Directors’ fees earned and deferred into plan	$	55	$	45	$	110	$	90
Share equivalent units		2,142		1,331		3,517		2,549

     At June 30, 2011, a total of 22,318 share equivalent units were deferred in the plan with an aggregate fair value of $0.6 million, based on the closing market price of the Company’s common stock at June 30, 2011 of $25.68.

XML



Equity Investments

6 Months Ended

Jun. 30, 2011

Equity Investments [Abstract]

EQUITY INVESTMENTS

11. EQUITY INVESTMENTS

     As of June 30, 2011, the Company owned equity interests of 27.5% in four hospitals in Las Vegas, Nevada, and 26.1% in one hospital in Las Vegas, Nevada, in which Universal Health Systems, Inc. owns the majority interest, and an equity interest of 38.0% in three hospitals in Macon, Georgia, in which HCA Inc. owns the majority interest.

     Summarized combined financial information for the three and six months ended June 30, 2011 and 2010, for these unconsolidated entities in which the Company owns an equity interest is as follows (in thousands):

	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2011		2010		2011		2010
Revenues	$	373,448	$	358,586	$	746,039	$	716,065
Operating costs and expenses		334,765		321,457		652,752		645,977
Income from continuing operations before taxes		38,652		37,113		93,236		70,045

     The summarized financial information for the three and six months ended June 30, 2011 and 2010 was derived from the unaudited financial information provided to the Company by those unconsolidated entities.

     The Company’s investment in all of its unconsolidated affiliates was $421.0 million and $409.5 million at June 30, 2011 and December 31, 2010, respectively, and is included in other assets, net in the accompanying condensed consolidated balance sheets. Included in the Company’s results of operations is the Company’s equity in pre-tax earnings from all of its investments in unconsolidated affiliates, which was $12.0 million and $11.0 million for the three months ended June 30, 2011 and 2010, respectively, and $30.2 million and $23.6 million for the six months ended June 30, 2011 and 2010, respectively.

XML



Fair Value of Financial Instruments (Details 1) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Jun. 30, 2011
Interest Rate Swaps 1 [Member]
Interest rate swaps
Notional Amount	$ 300,000
Fixed Interest Rate	5.114%
Termination Date	Aug. 08, 2011
Fair Value	1,533
Interest Rate Swaps 2 [Member]
Interest rate swaps
Notional Amount	100,000
Fixed Interest Rate	4.7185%
Termination Date	Aug. 19, 2011
Fair Value	605
Interest Rate Swaps 3 [Member]
Interest rate swaps
Notional Amount	100,000
Fixed Interest Rate	4.704%
Termination Date	Aug. 19, 2011
Fair Value	603
Interest Rate Swaps 4 [Member]
Interest rate swaps
Notional Amount	100,000
Fixed Interest Rate	4.625%
Termination Date	Aug. 19, 2011
Fair Value	592
Interest Rate Swaps 5 [Member]
Interest rate swaps
Notional Amount	200,000
Fixed Interest Rate	4.93%
Termination Date	Aug. 30, 2011
Fair Value	1,551
Interest Rate Swaps 6 [Member]
Interest rate swaps
Notional Amount	200,000
Fixed Interest Rate	3.092%
Termination Date	Sep. 18, 2011
Fair Value	1,248
Interest Rate Swaps 7 [Member]
Interest rate swaps
Notional Amount	100,000
Fixed Interest Rate	3.023%
Termination Date	Oct. 23, 2011
Fair Value	869
Interest Rate Swaps 8 [Member]
Interest rate swaps
Notional Amount	200,000
Fixed Interest Rate	4.4815%
Termination Date	Oct. 26, 2011
Fair Value	2,712
Interest Rate Swaps 9 [Member]
Interest rate swaps
Notional Amount	200,000
Fixed Interest Rate	4.084%
Termination Date	Dec. 03, 2011
Fair Value	3,279
Interest Rate Swaps 10 [Member]
Interest rate swaps
Notional Amount	100,000
Fixed Interest Rate	3.847%
Termination Date	Jan. 04, 2012
Fair Value	1,822
Interest Rate Swaps 11 [Member]
Interest rate swaps
Notional Amount	100,000
Fixed Interest Rate	3.851%
Termination Date	Jan. 04, 2012
Fair Value	1,824
Interest Rate Swaps 12 [Member]
Interest rate swaps
Notional Amount	100,000
Fixed Interest Rate	3.856%
Termination Date	Jan. 04, 2012
Fair Value	1,826
Interest Rate Swaps 13 [Member]
Interest rate swaps
Notional Amount	200,000
Fixed Interest Rate	3.726%
Termination Date	Jan. 08, 2012
Fair Value	3,610
Interest Rate Swaps 14 [Member]
Interest rate swaps
Notional Amount	200,000
Fixed Interest Rate	3.5065%
Termination Date	Jan. 16, 2012
Fair Value	3,514
Interest Rate Swaps 15 [Member]
Interest rate swaps
Notional Amount	250,000
Fixed Interest Rate	5.0185%
Termination Date	May 30, 2012
Fair Value	10,654
Interest Rate Swaps 16 [Member]
Interest rate swaps
Notional Amount	150,000
Fixed Interest Rate	5.025%
Termination Date	May 30, 2012
Fair Value	6,401
Interest Rate Swaps 17 [Member]
Interest rate swaps
Notional Amount	200,000
Fixed Interest Rate	4.6845%
Termination Date	Sep. 11, 2012
Fair Value	10,208
Interest Rate Swaps 18 [Member]
Interest rate swaps
Notional Amount	100,000
Fixed Interest Rate	3.352%
Termination Date	Oct. 23, 2012
Fair Value	3,798
Interest Rate Swaps 19 [Member]
Interest rate swaps
Notional Amount	125,000
Fixed Interest Rate	4.3745%
Termination Date	Nov. 23, 2012
Fair Value	6,794
Interest Rate Swaps 20 [Member]
Interest rate swaps
Notional Amount	75,000
Fixed Interest Rate	4.38%
Termination Date	Nov. 23, 2012
Fair Value	4,082
Interest Rate Swaps 21 [Member]
Interest rate swaps
Notional Amount	150,000
Fixed Interest Rate	5.02%
Termination Date	Nov. 30, 2012
Fair Value	9,618
Interest Rate Swaps 22 [Member]
Interest rate swaps
Notional Amount	200,000
Fixed Interest Rate	2.42%
Termination Date	Feb. 28, 2013
Fair Value	5,561
Interest Rate Swaps 23 [Member]
Interest rate swaps
Notional Amount	100,000
Fixed Interest Rate	5.023%
Termination Date	May 30, 2013
Fair Value	8,262
Interest Rate Swaps 24 [Member]
Interest rate swaps
Notional Amount	300,000
Fixed Interest Rate	5.242%
Termination Date	Aug. 06, 2013
Fair Value	27,964
Interest Rate Swaps 25 [Member]
Interest rate swaps
Notional Amount	100,000
Fixed Interest Rate	5.038%
Termination Date	Aug. 30, 2013
Fair Value	9,101
Interest Rate Swaps 26 [Member]
Interest rate swaps
Notional Amount	50,000
Fixed Interest Rate	3.586%
Termination Date	Oct. 23, 2013
Fair Value	3,130
Interest Rate Swaps 27 [Member]
Interest rate swaps
Notional Amount	50,000
Fixed Interest Rate	3.524%
Termination Date	Oct. 23, 2013
Fair Value	3,063
Interest Rate Swaps 28 [Member]
Interest rate swaps
Notional Amount	100,000
Fixed Interest Rate	5.05%
Termination Date	Nov. 30, 2013
Fair Value	9,857
Interest Rate Swaps 29 [Member]
Interest rate swaps
Notional Amount	200,000
Fixed Interest Rate	2.07%
Termination Date	Dec. 19, 2013
Fair Value	5,715
Interest Rate Swaps 30 [Member]
Interest rate swaps
Notional Amount	100,000
Fixed Interest Rate	5.231%
Termination Date	Jul. 25, 2014
Fair Value	11,994
Interest Rate Swaps 31 [Member]
Interest rate swaps
Notional Amount	100,000
Fixed Interest Rate	5.231%
Termination Date	Jul. 25, 2014
Fair Value	11,998
Interest Rate Swaps 32 [Member]
Interest rate swaps
Notional Amount	200,000
Fixed Interest Rate	5.16%
Termination Date	Jul. 25, 2014
Fair Value	23,584
Interest Rate Swaps 33 [Member]
Interest rate swaps
Notional Amount	75,000
Fixed Interest Rate	5.0405%
Termination Date	Jul. 25, 2014
Fair Value	8,571
Interest Rate Swaps 34 [Member]
Interest rate swaps
Notional Amount	125,000
Fixed Interest Rate	5.0215%
Termination Date	Jul. 25, 2014
Fair Value	14,218
Interest Rate Swaps 35 [Member]
Interest rate swaps
Notional Amount	100,000
Fixed Interest Rate	2.621%
Termination Date	Jul. 25, 2014
Fair Value	4,349
Interest Rate Swaps 36 [Member]
Interest rate swaps
Notional Amount	100,000
Fixed Interest Rate	3.11%
Termination Date	Jul. 25, 2014
Fair Value	5,788
Interest Rate Swaps 37 [Member]
Interest rate swaps
Notional Amount	100,000
Fixed Interest Rate	3.258%
Termination Date	Jul. 25, 2014
Fair Value	6,222
Interest Rate Swaps 38 [Member]
Interest rate swaps
Notional Amount	200,000
Fixed Interest Rate	2.693%
Termination Date	Oct. 26, 2014
Fair Value	7,504	[1]
Interest Rate Swaps 39 [Member]
Interest rate swaps
Notional Amount	300,000
Fixed Interest Rate	3.447%
Termination Date	Aug. 08, 2016
Fair Value	18,662	[2]
Interest Rate Swaps 40 [Member]
Interest rate swaps
Notional Amount	200,000
Fixed Interest Rate	3.4285%
Termination Date	Aug. 19, 2016
Fair Value	12,096	[3]
Interest Rate Swaps 41 [Member]
Interest rate swaps
Notional Amount	100,000
Fixed Interest Rate	3.404%
Termination Date	Aug. 19, 2016
Fair Value	6,019	[4]
Interest Rate Swaps 42 [Member]
Interest rate swaps
Notional Amount	200,000
Fixed Interest Rate	3.50%
Termination Date	Aug. 30, 2016
Fair Value	12,529	[5]
Interest Rate Swaps 43 [Member]
Interest rate swaps
Notional Amount	100,000
Fixed Interest Rate	3.005%
Termination Date	Nov. 30, 2016
Fair Value	$ 4,196

[1] This interest rate swap becomes effective October 26, 2011, concurrent with the termination of swap #8.

[2] This interest rate swap becomes effective August 8, 2011, concurrent with the termination of swap #1

[3] This interest rate swap becomes effective August 19, 2011, concurrent with the termination of swap #2 and #4.

[4] This interest rate swap becomes effective August 19, 2011, concurrent with the termination of swap #3.

[5] This interest rate swap becomes effective August 30, 2011, concurrent with the termination of swap #5.

XML



Fair Value (Details) (Fair Value, Measurements, Recurring [Member], USD $) In Thousands	Jun. 30, 2011	Dec. 31, 2010
Financial assets and liabilities recorded at fair value on a recurring basis
Available-for-sale Securities, Fair Value Disclosure	$ 33,097	$ 31,570
Trading Securities, Fair Value Disclosure	38,709	35,092
Total assets	71,806	66,662
Fair value of interest rate swap agreements	297,526	340,526
Total liabilities	297,526	340,526
Level 1 [Member]
Financial assets and liabilities recorded at fair value on a recurring basis
Available-for-sale Securities, Fair Value Disclosure	33,097	31,570
Trading Securities, Fair Value Disclosure	38,709	35,092
Total assets	71,806	66,662
Fair value of interest rate swap agreements	0	0
Total liabilities	0	0
Level 2 [Member]
Financial assets and liabilities recorded at fair value on a recurring basis
Available-for-sale Securities, Fair Value Disclosure	0	0
Trading Securities, Fair Value Disclosure	0	0
Total assets	0	0
Fair value of interest rate swap agreements	297,526	340,526
Total liabilities	297,526	340,526
Level 3 [Member]
Financial assets and liabilities recorded at fair value on a recurring basis
Available-for-sale Securities, Fair Value Disclosure	0	0
Trading Securities, Fair Value Disclosure	0	0
Total assets	0	0
Fair value of interest rate swap agreements	0	0
Total liabilities	$ 0	$ 0

XML



Fair Value of Financial Instruments (Tables)

6 Months Ended

Jun. 30, 2011

Fair Value of Financial Instruments [Abstract]

Estimated fair value of financial instruments

	June 30, 2011				December 31, 2010
	Carrying		Estimated Fair		Carrying		Estimated Fair
	Amount		Value		Amount		Value
Assets:
Cash and cash equivalents	$	191,432	$	191,432	$	299,169	$	299,169
Available-for-sale securities		33,097		33,097		31,570		31,570
Trading securities		38,709		38,709		35,092		35,092
Liabilities:
Credit Facility		5,974,321		5,806,274		5,999,337		5,882,124
Senior notes		2,784,331		2,846,978		2,784,331		2,923,548
Other debt		43,478		43,478		36,122		36,122

Interest rate swaps

	Notional
	Amount		Fixed Interest			Termination	Fair Value
Swap #	(in 000’s)		Rate			Date	(in 000’s)
1	$	300,000		5.1140	%	August 8, 2011	$	1,533
2		100,000		4.7185	%	August 19, 2011		605
3		100,000		4.7040	%	August 19, 2011		603
4		100,000		4.6250	%	August 19, 2011		592
5		200,000		4.9300	%	August 30, 2011		1,551
6		200,000		3.0920	%	September 18, 2011		1,248
7		100,000		3.0230	%	October 23, 2011		869
8		200,000		4.4815	%	October 26, 2011		2,712
9		200,000		4.0840	%	December 3, 2011		3,279
10		100,000		3.8470	%	January 4, 2012		1,822
11		100,000		3.8510	%	January 4, 2012		1,824
12		100,000		3.8560	%	January 4, 2012		1,826
13		200,000		3.7260	%	January 8, 2012		3,610
14		200,000		3.5065	%	January 16, 2012		3,514
15		250,000		5.0185	%	May 30, 2012		10,654
16		150,000		5.0250	%	May 30, 2012		6,401
17		200,000		4.6845	%	September 11, 2012		10,208
18		100,000		3.3520	%	October 23, 2012		3,798
19		125,000		4.3745	%	November 23, 2012		6,794
20		75,000		4.3800	%	November 23, 2012		4,082
21		150,000		5.0200	%	November 30, 2012		9,618
22		200,000		2.2420	%	February 28, 2013		5,561
23		100,000		5.0230	%	May 30, 2013		8,262
24		300,000		5.2420	%	August 6, 2013		27,964
25		100,000		5.0380	%	August 30, 2013		9,101
26		50,000		3.5860	%	October 23, 2013		3,130
27		50,000		3.5240	%	October 23, 2013		3,063
28		100,000		5.0500	%	November 30, 2013		9,857
29		200,000		2.0700	%	December 19, 2013		5,715
30		100,000		5.2310	%	July 25, 2014		11,994
31		100,000		5.2310	%	July 25, 2014		11,998
32		200,000		5.1600	%	July 25, 2014		23,584
33		75,000		5.0405	%	July 25, 2014		8,571
34		125,000		5.0215	%	July 25, 2014		14,218
35		100,000		2.6210	%	July 25, 2014		4,349
36		100,000		3.1100	%	July 25, 2014		5,788
37		100,000		3.2580	%	July 25, 2014		6,222
38		200,000		2.6930	%	October 26, 2014		7,504	(1)
39		300,000		3.4470	%	August 8, 2016		18,662	(2)
40		200,000		3.4285	%	August 19, 2016		12,096	(3)
41		100,000		3.4010	%	August 19, 2016		6,019	(4)
42		200,000		3.5000	%	August 30, 2016		12,529	(5)
43		100,000		3.0050	%	November 30, 2016		4,196

(1)	This interest rate swap becomes effective October 26, 2011, concurrent with the termination of swap #8.
(2)	This interest rate swap becomes effective August 8, 2011, concurrent with the termination of swap #1.
(3)	This interest rate swap becomes effective August 19, 2011, concurrent with the termination of swaps #2 and #4.
(4)	This interest rate swap becomes effective August 19, 2011, concurrent with the termination of swap #3.
(5)	This interest rate swap becomes effective August 30, 2011, concurrent with the termination of swap #5.

Amount pf pre-tax loss recognized in the condensed consolidated balance sheets as a component of other comprehensive income

Derivatives in Cash Flow Hedging	Amount of Pre-Tax Loss Recognized in OCI on Derivative (Effective Portion)
Relationships	Three Months Ended June 30,						Six Months Ended June 30,
	2011			2010			2011			2010
Interest rate swaps	$	(67,685	)	$	(107,656	)	$	(63,572	)	$	(178,564	)

Effective portion of the pre-tax loss reclassified from accumulated other comprehensive loss ("OCL") into interest expense on the condensed consolidated statements of income

Location of Loss Reclassified from
AOCL into Income (Effective	Amount of Pre-Tax Loss Reclassified from AOCL into Income (Effective Portion)
Portion)	Three Months Ended June 30,				Six Months Ended June 30,
	2011		2010		2011		2010
Interest expense, net	$	53,649	$	55,009	$	106,573	$	108,173

Fair value of derivative instruments in the condensed consolidated balance sheets

Asset Derivatives

Liability Derivatives

June 30, 2011

December 31, 2010

June 30, 2011

December 31, 2010

Balance

Balance

Balance

Balance

Sheet

Fair

Sheet

Fair

Sheet

Fair

Sheet

Fair

Location

Value

Location

Value

Location

Value

Location

Value

Derivatives designated as hedging instruments

Other assets, net

$

—

Other assets, net

$

—

Other long-term liabilities

$

297,526

Other long-term liabilities

$

340,526

XML



Recent Accounting Pronouncements

6 Months Ended

Jun. 30, 2011

Recent Accounting Pronouncements [Abstract]

RECENT ACCOUNTING PRONOUNCEMENTS

15. RECENT ACCOUNTING PRONOUNCEMENTS

     In August 2010, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2010-24, which provides clarification to companies in the healthcare industry on the accounting for professional liability insurance. This ASU states that receivables related to insurance recoveries should not be netted against the related claim liability and such claim liabilities should be determined without considering insurance recoveries. This ASU is effective for fiscal years beginning after December 15, 2010 and was adopted by the Company on January 1, 2011. The adoption of this ASU increased other current assets by $2.5 million, other assets, net by $41.1 million and long-term liabilities by $43.6 million in the condensed consolidated balance sheet at June 30, 2011 and had no impact to the condensed consolidated statement of income for the three and six months ended June 30, 2011.

     In August 2010, the FASB issued ASU 2010-23, which requires a company in the healthcare industry to use its direct and indirect costs of providing charity care as the measurement basis for charity care disclosures. This ASU also requires additional disclosures of the method used to determine such costs. The Company adopted this ASU on January 1, 2011. In the ordinary course of business, the Company renders services to patients who are financially unable to pay for hospital care. Included in the provision for contractual allowances is the value (at the Company’s standard charges) of these services to patients who are unable to pay that is eliminated from net operating revenues when it is determined they qualify under the Company’s charity care policy. The estimated cost incurred by the Company to provide these services to patients who are unable to pay was approximately $28.0 million and $25.3 million for the three months ended June 30, 2011 and 2010, respectively, and $54.1 million and $50.8 million for the six months ended June 30, 2011 and 2010, respectively. The estimated cost of these charity care services was determined using a ratio of cost to gross charges and applying that ratio to the gross charges associated with providing care to charity patients for the period. Gross charges associated with providing care to charity patients includes only the related charges for those patients who are financially unable to pay and qualify under the Company’s charity care policy and that do not otherwise qualify for reimbursement from a governmental program.

     In July 2011, the FASB issued ASU 2011-07, which requires healthcare organizations that perform services for patients for which the ultimate collection of all or a portion of the amounts billed or billable cannot be determined at the time services are rendered to present all bad debt expense associated with patient service revenue as an offset to the patient service revenue line item in the statement of operations. The ASU also requires qualitative disclosures about the Company’s policy for recognizing revenue and bad debt expense for patient service transactions and quantitative information about the effects of changes in the assessment of collectibility of patient service revenue. This ASU is effective for fiscal years beginning after December 15, 2011, and will be adopted by the Company in the first quarter of 2012. The Company is currently assessing the potential impact the adoption of this ASU will have on its consolidated results of operations and consolidated financial position.

XML



Condensed Consolidated Balance Sheets (Unaudited) (USD $) In Thousands	Jun. 30, 2011	Dec. 31, 2010
Current assets
Cash and cash equivalents	$ 191,432	$ 299,169
Patient accounts receivable, net of allowance for doubtful accounts of $1,793,404 and $1,639,198 at June 30, 2011 and December 31, 2010, respectively	1,792,404	1,714,542
Supplies	342,268	329,114
Prepaid income taxes	0	118,464
Deferred income taxes	115,819	115,819
Prepaid expenses and taxes	117,458	100,754
Other current assets	175,109	193,331
Total current assets	2,734,490	2,871,193
Property and equipment	8,798,266	8,383,122
Less accumulated depreciation and amortization	(2,291,842)	(2,058,685)
Property and equipment, net	6,506,424	6,324,437
Goodwill	4,227,970	4,150,247
Other assets, net	1,356,531	1,352,246
Total assets	14,825,415	14,698,123
Current liabilities
Current maturities of long-term debt	70,112	63,139
Accounts payable	583,924	526,338
Current income tax payable	349	0
Deferred income taxes	8,882	8,882
Accrued interest	145,146	146,415
Accrued liabilities	854,329	897,266
Total current liabilities	1,662,742	1,642,040
Long-term debt	8,781,443	8,808,382
Deferred income taxes	608,177	608,177
Other long-term liabilities	1,026,069	1,001,675
Total liabilities	12,078,431	12,060,274
Redeemable noncontrolling interests in equity of consolidated subsidiaries	376,658	387,472
Community Health Systems, Inc. stockholders' equity
Preferred stock, $.01 par value per share, 100,000,000 shares authorized; none issued	0	0
Common stock, $.01 par value per share, 300,000,000 shares authorized; 93,210,424 shares issued and 92,234,875 shares outstanding at June 30, 2011, and 93,644,862 shares issued and 92,669,313 shares outstanding at December 31, 2010	932	936
Additional paid-in capital	1,119,205	1,126,751
Treasury stock, at cost, 975,549 shares at June 30, 2011 and December 31, 2010	(6,678)	(6,678)
Accumulated other comprehensive loss	(200,533)	(230,927)
Retained earnings	1,396,095	1,299,382
Total Community Health Systems, Inc. stockholders' equity	2,309,021	2,189,464
Noncontrolling interests in equity of consolidated subsidiaries	61,305	60,913
Total equity	2,370,326	2,250,377
Total liabilities and equity	$ 14,825,415	$ 14,698,123

XML



Segment Information (Tables)

6 Months Ended

Jun. 30, 2011

Segment Information [Abstract]

Revenues and Income from continuing operations before income taxes

	Three Months Ended						Six Months Ended
	June 30,						June 30,
	2011			2010			2011			2010
Revenues:
Hospital operations	$	3,361,706		$	3,018,147		$	6,646,174		$	6,018,587
Corporate and all other		72,123			62,499			141,707			130,671
Total	$	3,433,829		$	3,080,646		$	6,787,881		$	6,149,258
Income from continuing operations before income taxes:
Hospital operations	$	184,426		$	171,711		$	362,539		$	331,010
Corporate and all other		(46,731	)		(40,571	)		(89,147	)		(75,964	)
Total	$	137,695		$	131,140		$	273,392		$	255,046

XML



Comprehensive Income (Details) (USD $) In Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2011	Jun. 30, 2010	Jun. 30, 2011	Jun. 30, 2010
Components of comprehensive income net of related taxes [Abstract]
Net income	$ 53,547	$ 86,342	$ 131,872	$ 171,338
Net change in fair value of interest rate swaps	(8,969)	(33,694)	27,477	(45,051)
Net change in fair value of available-for-sale securities	268	476	1,338	630
Amortization and recognition of unrecognized pension cost components	807	758	1,579	5,233
Comprehensive income	45,653	53,882	162,266	132,150
Less: Comprehensive income attributable to noncontrolling interests	18,158	16,277	35,159	31,266
Comprehensive income attributable to Community Health Systems, Inc.	$ 27,495	$ 37,605	$ 127,107	$ 100,884

XML



Fair Value of Financial Instruments (Details 3) (Derivatives designated as hedging instruments [Member], USD $) In Thousands	Jun. 30, 2011	Dec. 31, 2010
Other assets, net [Member]
Fair value of derivative instruments in the condensed consolidated balance sheets
Derivatives assets designated as hedging instruments	$ 0	$ 0
Other long-term liabilities [Member]
Fair value of derivative instruments in the condensed consolidated balance sheets
Derivatives liabilities designated as hedging instruments	$ 297,526	$ 340,526

XML



Supplemental Condensed Consolidating Financial Information (Details 2) (USD $) In Thousands	6 Months Ended
	Jun. 30, 2011	Jun. 30, 2010	Jun. 30, 2011 Parent Guarantor [Member]	Jun. 30, 2010 Parent Guarantor [Member]	Jun. 30, 2011 Issuer [Member]	Jun. 30, 2010 Issuer [Member]	Jun. 30, 2011 Other Guarantors [Member]	Jun. 30, 2010 Other Guarantors [Member]	Jun. 30, 2011 Non-Guarantors [Member]	Jun. 30, 2010 Non-Guarantors [Member]	Jun. 30, 2011 Eliminations [Member]	Dec. 31, 2010 Eliminations [Member]
Cash flows from operating activities
Net cash provided by operating activities	$ 584,685	$ 541,792	$ 1,490	$ (100,143)	$ (37,658)	$ (43,029)	$ 338,117	$ 539,874	$ 282,736	$ 145,090
Cash flows from investing activities
Acquisitions of facilities and other related equipment	(204,264)	(2,413)					(162,692)	(389)	(41,572)	(2,024)
Purchases of property and equipment	(351,383)	(263,924)					(187,760)	(169,311)	(163,623)	(94,613)
Proceeds from disposition of ancillary operations	18,464								18,464
Proceeds from sale of property and equipment	8,034	2,307					881	2,151	7,153	156
Increase in other non-operating assets	(75,211)	(64,258)					(58,120)	(31,750)	(17,091)	(32,508)
Net cash used in investing activities	(604,360)	(328,288)					(407,691)	(199,299)	(196,669)	(128,989)
Cash flows from financing activities
Proceeds from exercise of stock options	18,831	53,615	18,831	53,615
Excess tax benefit (income tax payable increase) relating to stock-based compensation	4,659	10,104	4,659	10,104
Deferred financing costs	(234)				(234)
Stock buy-back	(50,002)	(12,242)	(50,002)	(12,242)
Proceeds from noncontrolling investors in joint ventures	863	5,155							863	5,155
Redemption of noncontrolling investments in joint ventures	(3,303)	(2,395)							(3,303)	(2,395)
Distributions to noncontrolling investors in joint ventures	(30,078)	(29,371)							(30,078)	(29,371)
Changes in intercompany balances with affiliates, net			25,022	48,666	62,908	64,765	(59,406)	(73,906)	(28,524)	(39,525)
Repayments of long-term indebtedness	(28,798)	(34,157)			(25,016)	(21,736)	(2,504)	(9,996)	(1,278)	(2,425)
Net cash used in financing activities	(88,062)	(9,291)	(1,490)	100,143	37,658	43,029	(61,910)	(83,902)	(62,320)	(68,561)
Net change in cash and cash equivalents	(107,737)	204,213					(131,484)	256,673	23,747	(52,460)
Cash and cash equivalents at beginning of period	299,169	344,541	0		0		212,035	238,495	87,134	106,046	0	0
Cash and cash equivalents at end of period	$ 191,432	$ 548,754	$ 0		$ 0		$ 80,552	$ 495,168	$ 110,880	$ 53,586	$ 0	$ 0

XML



Earnings per Share (Details) (USD $) In Thousands, except Share data	3 Months Ended		6 Months Ended
	Jun. 30, 2011	Jun. 30, 2010	Jun. 30, 2011	Jun. 30, 2010
Numerator:
Income from continuing operations, net of taxes	$ 92,874	$ 88,379	$ 184,479	$ 172,736
Less: Income from continuing operations attributable to noncontrolling interests, net of taxes	18,158	16,313	35,159	31,332
Income from continuing operations attributable to Community Health Systems, Inc. common stockholders - basic and diluted	74,716	72,066	149,320	141,404
Loss from discontinued operations, net of taxes	(39,327)	(2,037)	(52,607)	(1,398)
Less: Loss from discontinued operations attributable to noncontrolling interests, net of taxes		(36)		(66)
Loss from discontinued operations attributable to Community Health Systems, Inc. common stockholders - basic and diluted	$ (39,327)	$ (2,001)	$ (52,607)	$ (1,332)
Denominator:
Weighted-average number of shares outstanding - basic	91,130,672	93,358,771	91,069,876	92,491,839
Effect of dilutive securities:
Restricted stock awards	263,876	522,496	258,871	423,442
Employee stock options	381,632	815,455	623,662	847,380
Other equity based awards	7,545	15,197	8,201	16,340
Weighted-average number of shares outstanding - diluted	91,783,725	94,711,919	91,960,610	93,779,001

XML



Earnings Per Share (Details 1)	3 Months Ended		6 Months Ended
	Jun. 30, 2011	Jun. 30, 2010	Jun. 30, 2011	Jun. 30, 2010
Dilutive securities outstanding not included in the computation of earnings per share because their effect is antidilutive:
Employee stock options	6,726,417	3,503,906	5,560,855	4,432,069

XML



Fair Value of Financial Instruments (Details) (USD $) In Thousands	Jun. 30, 2011	Dec. 31, 2010	Jun. 30, 2010	Dec. 31, 2009
Assets:
Cash and cash equivalents	$ 191,432	$ 299,169	$ 548,754	$ 344,541
Carrying Amount [Member]
Assets:
Cash and cash equivalents	191,432	299,169
Available-for-sale securities	33,097	31,570
Trading securities	38,709	35,092
Liabilities:
Credit facilities	5,974,321	599,337
Senior notes	2,784,331	2,784,331
Other debt	43,478	36,122
Estimated Fair Value [Member]
Assets:
Cash and cash equivalents	191,432	299,169
Available-for-sale securities	33,097	31,570
Trading securities	38,709	35,092
Liabilities:
Credit facilities	5,806,274	5,882,124
Senior notes	2,846,978	2,923,548
Other debt	$ 43,478	$ 36,122

XML



Contingencies (Tables)

6 Months Ended

Jun. 30, 2011

Contingencies [Abstract]

Pre tax charges in connection with lawsuits

	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2011		2010		2011		2010
Professional fees and other related costs	$	6,174	$	—	$	6,174	$	—